Over-Representation Analysis (ORA) vs. Gene Set Enrichment Analysis (GSEA)
Over-Representation Analysis (ORA)
ORA is a statistical method used to determine whether a predefined set of genes (e.g., genes associated with a specific biological pathway or function) is over-represented in a list of genes of interest (e.g., differentially expressed genes) compared to a reference list (e.g., all expressed genes).
Gene Set Enrichment Analysis (GSEA)
GSEA is a method used to determine whether predefined sets of genes show statistically significant, concordant differences between two biological states (e.g., phenotypes) across an entire ranked list of genes, rather than focusing only on a subset of significant genes.
Differences Between ORA and GSEA
Feature | ORA | GSEA |
---|---|---|
Input | List of significant genes and predefined gene sets | Ranked list of all genes and predefined gene sets |
Method | Statistical tests (e.g., Fisher’s exact test) | Enrichment score computed across the ranked list |
Focus | Identifies over-represented gene sets in a subset of genes | Identifies gene sets enriched at the extremes of the entire ranked list |
Multiple Testing | Adjusts p-values for multiple comparisons | Uses permutation tests and adjusts for multiple comparisons |
Output | p-values indicating over-representation | Enrichment score, p-value, and FDR for each gene set |
Gene sets and pathway
A gene set is an unordered collection of genes that are functionally related. A pathway can be interpreted as a gene set by ignoring functional relationships among genes.
Gene Ontology (GO)
Gene Ontology defines concepts/classes used to describe gene function, and relationships between these concepts. It classifies functions along three aspects:
- MF: Molecular Function
- molecular activities of gene products
- CC: Cellular Component
- where gene products are active
- BP: Biological Process
- pathways and larger processes made up of the activities of multiple gene products
GO terms are organized in a directed acyclic graph, where edges between terms represent parent-child relationship.
Kyoto Encyclopedia of Genes and Genomes (KEGG)
KEGG is a collection of manually drawn pathway maps representing molecular interaction and reaction networks. These pathways cover a wide range of biochemical processes that can be divided into 7 broad categories:
- Metabolism
- Genetic information processing
- Environmental information processing
- Cellular processes
- Organismal systems
- Human diseases
- Drug development.
Other gene sets
GO and KEGG are the most frequently used for functional analysis. They are typically the first choice because of their long-standing curation and availability for a wide range of species. Other gene sets include but are not limited to Disease Ontology (DO), Disease Gene Network (DisGeNET), wikiPathways, Molecular Signatures Database MSigDb)
# Install and load necessary packages
install.packages("pheatmap")
if (!requireNamespace("BiocManager", quietly = TRUE))
install.packages("BiocManager")
BiocManager::install("biomaRt")
BiocManager::install("DESeq2")
BiocManager::install("clusterProfiler")
BiocManager::install("org.Hs.eg.db")
BiocManager::install("ReactomePA")
BiocManager::install("fgsea")
BiocManager::install("msigdbr")
BiocManager::install("EnhancedVolcano")
install.packages('ggridges')
library(ReactomePA)
library(ggridges)
library(EnhancedVolcano)
library(pheatmap)
library(biomaRt)
library(DESeq2)
library(clusterProfiler)
library(org.Hs.eg.db)
library(fgsea)
library(msigdbr)
# Load count data (replace the file path with your actual path)
count_data <- read.csv("/content/count_data.csv", row.names = 1)
# Create metadata for the full dataset
metadata <- data.frame(
row.names = colnames(count_data),
condition = c(rep("Normal", 3), rep("HER2", 5), rep("NonTNBC", 6), rep("TNBC", 5))
)
# Convert non-integer values to integers by rounding
count_data <- round(count_data)
# Create DESeq2 dataset for the full dataset
dds <- DESeqDataSetFromMatrix(countData = count_data, colData = metadata, design = ~ condition)
# Pre-filtering (Optional) Remove rows with low counts to improve computation
dds <- dds[rowSums(counts(dds)) > 1, ]
# Normalize the data and run DESeq2 analysis
dds <- DESeq(dds)
# Extract normalized counts
normalized_counts <- counts(dds, normalized = TRUE)
# Perform differential expression analysis for each condition vs Normal
res_her2_vs_normal <- results(dds, contrast = c("condition", "HER2", "Normal"))
res_non_tnbc_vs_normal <- results(dds, contrast = c("condition", "NonTNBC", "Normal"))
res_tnbc_vs_normal <- results(dds, contrast = c("condition", "TNBC", "Normal"))
# Define significance thresholds
padj_threshold <- 0.05
log2fc_threshold <- 1
# Extract significant results (adjusted p-value < 0.05, log2FoldChange > 1)
extract_significant <- function(res, padj_threshold, log2fc_threshold) {
subset(res, padj < padj_threshold & abs(log2FoldChange) > log2fc_threshold)
}
sig_HER2_vs_Normal <- extract_significant(res_her2_vs_normal, padj_threshold, log2fc_threshold)
sig_NonTNBC_vs_Normal <- extract_significant(res_non_tnbc_vs_normal, padj_threshold, log2fc_threshold)
sig_TNBC_vs_Normal <- extract_significant(res_tnbc_vs_normal, padj_threshold, log2fc_threshold)
# Top genes for each comparison
top_genes <- function(sig_res) {
rownames(head(sig_res[order(sig_res$padj), ], 50))
}
top_genes_HER2 <- top_genes(sig_HER2_vs_Normal)
top_genes_NonTNBC <- top_genes(sig_NonTNBC_vs_Normal)
top_genes_TNBC <- top_genes(sig_TNBC_vs_Normal)
# Convert Ensembl IDs to Gene Symbols and Entrez IDs
mart <- useDataset("hsapiens_gene_ensembl", useMart("ensembl"))
convert_ids <- function(ensembl_ids) {
ids <- getBM(filters = "ensembl_gene_id",
attributes = c("ensembl_gene_id", "hgnc_symbol", "entrezgene_id"),
values = ensembl_ids,
mart = mart)
ids <- ids[match(ensembl_ids, ids$ensembl_gene_id), ] # Ensure the order matches the input
ids$hgnc_symbol[is.na(ids$hgnc_symbol)] <- ids$ensembl_gene_id[is.na(ids$hgnc_symbol)]
return(ids)
}
# Convert top genes to gene symbols and Entrez IDs
top_genes_HER2_ids <- convert_ids(top_genes_HER2)
top_genes_NonTNBC_ids <- convert_ids(top_genes_NonTNBC)
top_genes_TNBC_ids <- convert_ids(top_genes_TNBC)
# Add gene symbols to significant results
add_gene_symbols <- function(sig_res) {
sig_res$gene_symbol <- convert_ids(rownames(sig_res))
sig_res <- sig_res[, c("gene_symbol", names(sig_res)[-ncol(sig_res)])]
sig_res[order(sig_res$padj), ]
}
sig_HER2_vs_Normal <- add_gene_symbols(sig_HER2_vs_Normal)
sig_NonTNBC_vs_Normal <- add_gene_symbols(sig_NonTNBC_vs_Normal)
sig_TNBC_vs_Normal <- add_gene_symbols(sig_TNBC_vs_Normal)
# Save significant results to CSV files
write.csv(sig_HER2_vs_Normal, "sig_her2_vs_normal.csv", row.names = FALSE)
write.csv(sig_NonTNBC_vs_Normal, "sig_non_tnbc_vs_normal.csv", row.names = FALSE)
write.csv(sig_TNBC_vs_Normal, "sig_tnbc_vs_normal.csv", row.names = FALSE)
# Extract Entrez IDs for enrichment analysis
extract_entrez_ids <- function(sig_res) {
na.omit(convert_ids(rownames(sig_res))$entrezgene_id)
}
entrez_ids_her2_vs_normal <- extract_entrez_ids(sig_HER2_vs_Normal)
entrez_ids_non_tnbc_vs_normal <- extract_entrez_ids(sig_NonTNBC_vs_Normal)
entrez_ids_tnbc_vs_normal <- extract_entrez_ids(sig_TNBC_vs_Normal)
# Perform GO enrichment analysis
perform_go_enrichment <- function(entrez_ids, comparison_name) {
ego <- enrichGO(gene = entrez_ids,
OrgDb = org.Hs.eg.db,
keyType = "ENTREZID",
ont = "ALL",
pAdjustMethod = "BH",
pvalueCutoff = 0.05,
qvalueCutoff = 0.05)
write.csv(as.data.frame(ego), paste0("go_enrichment_", comparison_name, ".csv"))
return(ego)
}
ego_her2_vs_normal <- perform_go_enrichment(entrez_ids_her2_vs_normal, "her2_vs_normal")
ego_non_tnbc_vs_normal <- perform_go_enrichment(entrez_ids_non_tnbc_vs_normal, "non_tnbc_vs_normal")
ego_tnbc_vs_normal <- perform_go_enrichment(entrez_ids_tnbc_vs_normal, "tnbc_vs_normal")
# Perform KEGG pathway enrichment analysis
perform_kegg_enrichment <- function(entrez_ids, comparison_name) {
ekegg <- enrichKEGG(gene = entrez_ids,
organism = "hsa",
pvalueCutoff = 0.05)
write.csv(as.data.frame(ekegg), paste0("kegg_enrichment_", comparison_name, ".csv"))
return(ekegg)
}
ekegg_her2_vs_normal <- perform_kegg_enrichment(entrez_ids_her2_vs_normal, "her2_vs_normal")
ekegg_non_tnbc_vs_normal <- perform_kegg_enrichment(entrez_ids_non_tnbc_vs_normal, "non_tnbc_vs_normal")
ekegg_tnbc_vs_normal <- perform_kegg_enrichment(entrez_ids_tnbc_vs_normal, "tnbc_vs_normal")
# Perform Reactome Pathway enrichment analysis
reactome_her2_vs_normal <- enrichPathway(gene = entrez_ids_her2_vs_normal,
organism = "human",
pvalueCutoff = 0.05,
pAdjustMethod = "BH")
reactome_non_tnbc_vs_normal <- enrichPathway(gene = entrez_ids_non_tnbc_vs_normal,
organism = "human",
pvalueCutoff = 0.05,
pAdjustMethod = "BH")
reactome_tnbc_vs_normal <- enrichPathway(gene = entrez_ids_tnbc_vs_normal,
organism = "human",
pvalueCutoff = 0.05,
pAdjustMethod = "BH")
# Save Reactome enrichment results to CSV files
write.csv(as.data.frame(reactome_her2_vs_normal), "reactome_enrichment_her2_vs_normal.csv")
write.csv(as.data.frame(reactome_non_tnbc_vs_normal), "reactome_enrichment_non_tnbc_vs_normal.csv")
write.csv(as.data.frame(reactome_tnbc_vs_normal), "reactome_enrichment_tnbc_vs_normal.csv")
go_enrichment_her2_vs_normal.csv
ID | ONTOLOGY | Description | pvalue |
---|---|---|---|
GO:0000353 | BP | formation of quadruple SL/U4/U5/U6 snRNP | 0.00293391921681584 |
GO:0000365 | BP | mRNA trans splicing, via spliceosome | 0.00293391921681584 |
GO:0001915 | BP | negative regulation of T cell mediated cytotoxicity | 0.00293391921681584 |
GO:0032819 | BP | positive regulation of natural killer cell proliferation | 0.00293391921681584 |
GO:0045291 | BP | mRNA trans splicing, SL addition | 0.00293391921681584 |
GO:0019864 | MF | IgG binding | 0.00130555087993089 |
GO:1904238 | BP | pericyte cell differentiation | 0.00115795466794248 |
GO:0032817 | BP | regulation of natural killer cell proliferation | 0.0032832728407047 |
GO:0005652 | CC | nuclear lamina | 0.00305668230957094 |
GO:0035259 | MF | nuclear glucocorticoid receptor binding | 0.000514218130060217 |
GO:0005172 | MF | vascular endothelial growth factor receptor binding | 0.00156248820174195 |
GO:0019763 | MF | immunoglobulin receptor activity | 0.00156248820174195 |
GO:0035325 | MF | Toll-like receptor binding | 0.00156248820174195 |
GO:0061459 | MF | L-arginine transmembrane transporter activity | 0.00156248820174195 |
GO:0034154 | BP | toll-like receptor 7 signaling pathway | 0.000106353631344948 |
GO:0051256 | BP | mitotic spindle midzone assembly | 0.000106353631344948 |
GO:0000022 | BP | mitotic spindle elongation | 0.000449515277021739 |
GO:0045628 | BP | regulation of T-helper 2 cell differentiation | 0.000449515277021739 |
GO:0031272 | BP | regulation of pseudopodium assembly | 0.00137428464512341 |
GO:0031274 | BP | positive regulation of pseudopodium assembly | 0.00137428464512341 |
GO:0001833 | BP | inner cell mass cell proliferation | 0.00339907636303267 |
GO:0060330 | BP | regulation of response to type II interferon | 0.00339907636303267 |
GO:0060334 | BP | regulation of type II interferon-mediated signaling pathway | 0.00339907636303267 |
GO:0071415 | BP | cellular response to purine-containing compound | 0.00339907636303267 |
GO:0098761 | BP | cellular response to interleukin-7 | 0.00339907636303267 |
GO:0099523 | CC | presynaptic cytosol | 0.000413186041728091 |
GO:0045028 | MF | G protein-coupled purinergic nucleotide receptor activity | 0.000199737108555698 |
GO:0051371 | MF | muscle alpha-actinin binding | 0.00170745173899234 |
GO:0035589 | BP | G protein-coupled purinergic nucleotide receptor signaling pathway | 0.00017208446659124 |
GO:0050930 | BP | induction of positive chemotaxis | 0.000564367957959695 |
GO:0051231 | BP | spindle elongation | 0.000564367957959695 |
GO:0051255 | BP | spindle midzone assembly | 0.000564367957959695 |
GO:0001732 | BP | formation of cytoplasmic translation initiation complex | 0.00148939545964691 |
GO:0034501 | BP | protein localization to kinetochore | 0.00148939545964691 |
GO:0044771 | BP | meiotic cell cycle phase transition | 0.00148939545964691 |
GO:0070885 | BP | negative regulation of calcineurin-NFAT signaling cascade | 0.00148939545964691 |
GO:0098760 | BP | response to interleukin-7 | 0.00148939545964691 |
GO:0106057 | BP | negative regulation of calcineurin-mediated signaling | 0.00148939545964691 |
GO:1903083 | BP | protein localization to condensed chromosome | 0.00148939545964691 |
GO:1903826 | BP | L-arginine transmembrane transport | 0.00148939545964691 |
GO:0023035 | BP | CD40 signaling pathway | 0.00335900675895591 |
GO:0031269 | BP | pseudopodium assembly | 0.00335900675895591 |
GO:0032048 | BP | cardiolipin metabolic process | 0.00335900675895591 |
GO:1900034 | BP | regulation of cellular response to heat | 0.00335900675895591 |
GO:0008429 | MF | phosphatidylethanolamine binding | 0.00176491624121788 |
GO:0030213 | BP | hyaluronan biosynthetic process | 6.50980598543882e-05 |
GO:1901741 | BP | positive regulation of myoblast fusion | 0.000227994320982526 |
GO:0002524 | BP | hypersensitivity | 0.0032208237623346 |
GO:0045064 | BP | T-helper 2 cell differentiation | 0.0032208237623346 |
GO:0005852 | CC | eukaryotic translation initiation factor 3 complex | 0.000581760770757391 |
GO:0016282 | CC | eukaryotic 43S preinitiation complex | 0.0029519274645071 |
GO:0033038 | MF | bitter taste receptor activity | 0.00175848454907962 |
GO:0007379 | BP | segment specification | 0.00026983835688237 |
GO:0072540 | BP | T-helper 17 cell lineage commitment | 0.00026983835688237 |
GO:1902969 | BP | mitotic DNA replication | 0.00026983835688237 |
GO:2000318 | BP | positive regulation of T-helper 17 type immune response | 0.00067998795712999 |
GO:0009301 | BP | snRNA transcription | 0.00302512739210583 |
GO:0001614 | MF | purinergic nucleotide receptor activity | 0.000818820172947752 |
GO:0015174 | MF | basic amino acid transmembrane transporter activity | 0.000818820172947752 |
GO:0016502 | MF | nucleotide receptor activity | 0.000818820172947752 |
GO:0005123 | MF | death receptor binding | 0.00170774090247257 |
GO:0007076 | BP | mitotic chromosome condensation | 0.000297355547868777 |
GO:1990822 | BP | basic amino acid transmembrane transport | 0.000297355547868777 |
GO:1901739 | BP | regulation of myoblast fusion | 0.000692661933270127 |
GO:0006268 | BP | DNA unwinding involved in DNA replication | 0.00145366772957035 |
GO:0051383 | BP | kinetochore organization | 0.00145366772957035 |
GO:0048025 | BP | negative regulation of mRNA splicing, via spliceosome | 0.00279961580911357 |
GO:0071305 | BP | cellular response to vitamin D | 0.00279961580911357 |
GO:2000319 | BP | regulation of T-helper 17 cell differentiation | 0.00279961580911357 |
GO:0045653 | BP | negative regulation of megakaryocyte differentiation | 0.000127938525553911 |
GO:0050849 | BP | negative regulation of calcium-mediated signaling | 0.000312159035120018 |
GO:0051988 | BP | regulation of attachment of spindle microtubules to kinetochore | 0.000312159035120018 |
GO:0045063 | BP | T-helper 1 cell differentiation | 0.0013745896363325 |
GO:0050686 | BP | negative regulation of mRNA processing | 0.0025627619139174 |
GO:0033691 | MF | sialic acid binding | 0.000168357558153585 |
GO:0008527 | MF | taste receptor activity | 0.00153028947684624 |
GO:0002888 | BP | positive regulation of myeloid leukocyte mediated immunity | 5.42503217274676e-05 |
GO:0048169 | BP | regulation of long-term neuronal synaptic plasticity | 0.00128187390305192 |
GO:0001911 | BP | negative regulation of leukocyte mediated cytotoxicity | 0.00232658906220824 |
GO:0034138 | BP | toll-like receptor 3 signaling pathway | 0.00232658906220824 |
GO:0032753 | BP | positive regulation of interleukin-4 production | 0.00399039319413609 |
GO:0061098 | BP | positive regulation of protein tyrosine kinase activity | 0.00399039319413609 |
GO:0016493 | MF | C-C chemokine receptor activity | 7.45931286188571e-05 |
GO:0042974 | MF | nuclear retinoic acid receptor binding | 0.000761605264149915 |
GO:0061644 | BP | protein localization to CENP-A containing chromatin | 6.72173312141074e-08 |
GO:0002295 | BP | T-helper cell lineage commitment | 7.43666486639641e-06 |
GO:0015802 | BP | basic amino acid transport | 2.27037677797463e-05 |
GO:0046599 | BP | regulation of centriole replication | 6.04288713318793e-05 |
GO:0060143 | BP | positive regulation of syncytium formation by plasma membrane fusion | 6.04288713318793e-05 |
GO:0043373 | BP | CD4-positive, alpha-beta T cell lineage commitment | 0.000143960600941059 |
GO:0051315 | BP | attachment of mitotic spindle microtubules to kinetochore | 0.000143960600941059 |
GO:0002363 | BP | alpha-beta T cell lineage commitment | 0.000628926928579227 |
GO:0033119 | BP | negative regulation of RNA splicing | 0.00118272372150783 |
GO:0051984 | BP | positive regulation of chromosome segregation | 0.00118272372150783 |
GO:0034508 | BP | centromere complex assembly | 0.00209866615643078 |
GO:0043369 | BP | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment | 0.00209866615643078 |
GO:0031342 | BP | negative regulation of cell killing | 0.00353872581074336 |
GO:0043505 | CC | CENP-A containing nucleosome | 5.77403178221e-08 |
GO:0061638 | CC | CENP-A containing chromatin | 5.77403178221e-08 |
GO:0034506 | CC | chromosome, centromeric core domain | 3.81400675799143e-07 |
GO:0019957 | MF | C-C chemokine binding | 3.26043697767385e-05 |
GO:0001637 | MF | G protein-coupled chemoattractant receptor activity | 0.000179868466439203 |
GO:0004950 | MF | chemokine receptor activity | 0.000179868466439203 |
GO:0051019 | MF | mitogen-activated protein kinase binding | 0.000720243444303388 |
GO:0045624 | BP | positive regulation of T-helper cell differentiation | 2.60334532575114e-05 |
GO:0046641 | BP | positive regulation of alpha-beta T cell proliferation | 2.60334532575114e-05 |
GO:0050927 | BP | positive regulation of positive chemotaxis | 6.44923067641475e-05 |
GO:0045954 | BP | positive regulation of natural killer cell mediated cytotoxicity | 0.00108215345926895 |
GO:0002438 | BP | acute inflammatory response to antigenic stimulus | 0.00188351265680173 |
GO:1901798 | BP | positive regulation of signal transduction by p53 class mediator | 0.00188351265680173 |
GO:0000940 | CC | outer kinetochore | 1.36529043780676e-07 |
GO:0050926 | BP | regulation of positive chemotaxis | 2.84952530245841e-05 |
GO:0060142 | BP | regulation of syncytium formation by plasma membrane fusion | 0.000289328304181844 |
GO:0002825 | BP | regulation of T-helper 1 type immune response | 0.000983552310790401 |
GO:0035590 | BP | purinergic nucleotide receptor signaling pathway | 0.000983552310790401 |
GO:0002828 | BP | regulation of type 2 immune response | 0.0043601028692683 |
GO:0010863 | BP | positive regulation of phospholipase C activity | 0.0043601028692683 |
GO:0071353 | BP | cellular response to interleukin-4 | 0.0043601028692683 |
GO:1902894 | BP | negative regulation of miRNA transcription | 1.2431586124402e-05 |
GO:2000629 | BP | negative regulation of miRNA metabolic process | 3.01094126498727e-05 |
GO:0050858 | BP | negative regulation of antigen receptor-mediated signaling pathway | 0.000889122201191815 |
GO:0050869 | BP | negative regulation of B cell activation | 0.000889122201191815 |
GO:0002360 | BP | T cell lineage commitment | 0.00149993057674036 |
GO:0002717 | BP | positive regulation of natural killer cell mediated immunity | 0.00149993057674036 |
GO:1903725 | BP | regulation of phospholipid metabolic process | 0.00149993057674036 |
GO:0001580 | BP | detection of chemical stimulus involved in sensory perception of bitter taste | 0.00380811133571011 |
GO:1900274 | BP | regulation of phospholipase C activity | 0.00380811133571011 |
GO:2000406 | BP | positive regulation of T cell migration | 0.00380811133571011 |
GO:0042805 | MF | actinin binding | 0.00164473722427742 |
GO:2000316 | BP | regulation of T-helper 17 type immune response | 0.000133686559928232 |
GO:0030212 | BP | hyaluronan metabolic process | 0.000461556338307837 |
GO:0045577 | BP | regulation of B cell differentiation | 0.000800209313385884 |
GO:0070229 | BP | negative regulation of lymphocyte apoptotic process | 0.00214012203876514 |
GO:0070670 | BP | response to interleukin-4 | 0.00214012203876514 |
GO:0045652 | BP | regulation of megakaryocyte differentiation | 0.00332429778514726 |
GO:0019956 | MF | chemokine binding | 8.29401926800983e-05 |
GO:0072539 | BP | T-helper 17 cell differentiation | 6.45713651623094e-05 |
GO:0001782 | BP | B cell homeostasis | 0.000126545939434781 |
GO:0004520 | MF | DNA endonuclease activity | 0.00205602066160266 |
GO:0033280 | BP | response to vitamin D | 0.000216866283421364 |
GO:0042119 | BP | neutrophil activation | 0.00253049073296544 |
GO:0050912 | BP | detection of chemical stimulus involved in sensory perception of taste | 0.00253049073296544 |
GO:0060236 | BP | regulation of mitotic spindle organization | 0.00253049073296544 |
GO:0046640 | BP | regulation of alpha-beta T cell proliferation | 0.00377570441687021 |
GO:0051233 | CC | spindle midzone | 0.000185883122982904 |
GO:0004712 | MF | protein serine/threonine/tyrosine kinase activity | 0.00181738280039726 |
GO:0032743 | BP | positive regulation of interleukin-2 production | 6.59524006022376e-06 |
GO:0043372 | BP | positive regulation of CD4-positive, alpha-beta T cell differentiation | 2.99658162980289e-05 |
GO:0006270 | BP | DNA replication initiation | 5.88810390789255e-05 |
GO:0033260 | BP | nuclear DNA replication | 0.000571952942866806 |
GO:2000403 | BP | positive regulation of lymphocyte migration | 0.00144769622522216 |
GO:1901976 | BP | regulation of cell cycle checkpoint | 0.0022069394380568 |
GO:0033173 | BP | calcineurin-NFAT signaling cascade | 0.00327897879030897 |
GO:0030890 | BP | positive regulation of B cell proliferation | 0.000814993547859965 |
GO:1900744 | BP | regulation of p38MAPK cascade | 0.00126890500483617 |
GO:0090224 | BP | regulation of spindle organization | 0.00192442182337517 |
GO:0010824 | BP | regulation of centrosome duplication | 0.00284811410136915 |
GO:0001772 | CC | immunological synapse | 0.00109401070345732 |
GO:0007095 | BP | mitotic G2 DNA damage checkpoint signaling | 3.09356880734139e-06 |
GO:0036297 | BP | interstrand cross-link repair | 5.17663511633766e-05 |
GO:0007099 | BP | centriole replication | 0.000163640127619353 |
GO:0030261 | BP | chromosome condensation | 0.000451864382279 |
GO:0031295 | BP | T cell costimulation | 0.00167785417859772 |
GO:0097720 | BP | calcineurin-mediated signaling | 0.00167785417859772 |
GO:0098534 | BP | centriole assembly | 0.00167785417859772 |
GO:0031294 | BP | lymphocyte costimulation | 0.00247431797981706 |
GO:0032813 | MF | tumor necrosis factor receptor superfamily binding | 0.00125057989361164 |
GO:0043368 | BP | positive T cell selection | 4.80374449816627e-05 |
GO:0044786 | BP | cell cycle DNA replication | 0.000147812438911875 |
GO:0050856 | BP | regulation of T cell receptor signaling pathway | 0.000246936309214069 |
GO:0001774 | BP | microglial cell activation | 0.000632411298861244 |
GO:0046578 | BP | regulation of Ras protein signal transduction | 0.000632411298861244 |
GO:0036230 | BP | granulocyte activation | 0.000973290046749846 |
GO:2000404 | BP | regulation of T cell migration | 0.0014627435523941 |
GO:0010332 | BP | response to gamma radiation | 0.00309480343466375 |
GO:0010517 | BP | regulation of phospholipase activity | 0.00309480343466375 |
GO:0060324 | BP | face development | 0.00309480343466375 |
GO:0002204 | BP | somatic recombination of immunoglobulin genes involved in immune response | 0.00436828678103109 |
GO:0002208 | BP | somatic diversification of immunoglobulins involved in immune response | 0.00436828678103109 |
GO:0002639 | BP | positive regulation of immunoglobulin production | 0.00436828678103109 |
GO:0045190 | BP | isotype switching | 0.00436828678103109 |
GO:0045622 | BP | regulation of T-helper cell differentiation | 1.28386912590462e-05 |
GO:0140894 | BP | endolysosomal toll-like receptor signaling pathway | 0.000133108326357522 |
GO:0002673 | BP | regulation of acute inflammatory response | 0.000220309587233089 |
GO:0042088 | BP | T-helper 1 type immune response | 0.000220309587233089 |
GO:0090329 | BP | regulation of DNA-templated DNA replication | 0.000220309587233089 |
GO:0031297 | BP | replication fork processing | 0.000354658245026089 |
GO:0042269 | BP | regulation of natural killer cell mediated cytotoxicity | 0.000354658245026089 |
GO:0001914 | BP | regulation of T cell mediated cytotoxicity | 0.000556348171571408 |
GO:0030159 | MF | signaling receptor complex adaptor activity | 0.000414540168404513 |
GO:0051287 | MF | NAD binding | 0.000972616287986683 |
GO:0007094 | BP | mitotic spindle assembly checkpoint signaling | 2.26420160970935e-05 |
GO:0071173 | BP | spindle assembly checkpoint signaling | 2.26420160970935e-05 |
GO:0071174 | BP | mitotic spindle checkpoint signaling | 2.26420160970935e-05 |
GO:0031577 | BP | spindle checkpoint signaling | 4.0703435685052e-05 |
GO:0033046 | BP | negative regulation of sister chromatid segregation | 7.0821711446405e-05 |
GO:0033048 | BP | negative regulation of mitotic sister chromatid segregation | 7.0821711446405e-05 |
GO:0045841 | BP | negative regulation of mitotic metaphase/anaphase transition | 7.0821711446405e-05 |
GO:2000816 | BP | negative regulation of mitotic sister chromatid separation | 7.0821711446405e-05 |
GO:0051985 | BP | negative regulation of chromosome segregation | 0.000196187588454766 |
GO:1902100 | BP | negative regulation of metaphase/anaphase transition of cell cycle | 0.000196187588454766 |
GO:1905819 | BP | negative regulation of chromosome separation | 0.000196187588454766 |
GO:0002269 | BP | leukocyte activation involved in inflammatory response | 0.000313596344210117 |
GO:0002686 | BP | negative regulation of leukocyte migration | 0.00162414397248155 |
GO:0002823 | BP | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 0.0023279055002227 |
GO:0070228 | BP | regulation of lymphocyte apoptotic process | 0.0045330937508307 |
GO:2000516 | BP | positive regulation of CD4-positive, alpha-beta T cell activation | 6.01243611844833e-06 |
GO:0072538 | BP | T-helper 17 type immune response | 1.1431479801119e-05 |
GO:0046605 | BP | regulation of centrosome cycle | 0.000429670702160328 |
GO:1902895 | BP | positive regulation of miRNA transcription | 0.000968917722515644 |
GO:0031663 | BP | lipopolysaccharide-mediated signaling pathway | 0.00141200315980968 |
GO:0045005 | BP | DNA-templated DNA replication maintenance of fidelity | 0.00141200315980968 |
GO:2000107 | BP | negative regulation of leukocyte apoptotic process | 0.00141200315980968 |
GO:0002381 | BP | immunoglobulin production involved in immunoglobulin-mediated immune response | 0.00201994352618456 |
GO:0001706 | BP | endoderm formation | 0.00392559957589632 |
GO:0071459 | BP | protein localization to chromosome, centromeric region | 7.44858403747104e-09 |
GO:0002715 | BP | regulation of natural killer cell mediated immunity | 9.57846464694141e-05 |
GO:0044818 | BP | mitotic G2/M transition checkpoint | 9.57846464694141e-05 |
GO:0033047 | BP | regulation of mitotic sister chromatid segregation | 0.000154846064014047 |
GO:0046638 | BP | positive regulation of alpha-beta T cell differentiation | 0.000154846064014047 |
GO:0045839 | BP | negative regulation of mitotic nuclear division | 0.000377271424586922 |
GO:0038066 | BP | p38MAPK cascade | 0.00122778291545613 |
GO:0016447 | BP | somatic recombination of immunoglobulin gene segments | 0.00246155322107998 |
GO:0032233 | BP | positive regulation of actin filament bundle assembly | 0.00246155322107998 |
GO:0006968 | BP | cellular defense response | 1.77386182873761e-05 |
GO:0010965 | BP | regulation of mitotic sister chromatid separation | 0.000498484364116861 |
GO:0001961 | BP | positive regulation of cytokine-mediated signaling pathway | 0.000736225853740336 |
GO:0002820 | BP | negative regulation of adaptive immune response | 0.0010677765059031 |
GO:0034113 | BP | heterotypic cell-cell adhesion | 0.00152217717928471 |
GO:0051306 | BP | mitotic sister chromatid separation | 0.00152217717928471 |
GO:0101003 | CC | ficolin-1-rich granule membrane | 0.000896759327836149 |
GO:0015026 | MF | coreceptor activity | 0.000105242486425678 |
GO:0045058 | BP | T cell selection | 4.66448110785223e-05 |
GO:0002886 | BP | regulation of myeloid leukocyte mediated immunity | 7.61852423835561e-05 |
GO:0007080 | BP | mitotic metaphase chromosome alignment | 0.000290460560696321 |
GO:0032731 | BP | positive regulation of interleukin-1 beta production | 0.000641775874607837 |
GO:0006949 | BP | syncytium formation | 0.00255550650779922 |
GO:0016445 | BP | somatic diversification of immunoglobulins | 0.00255550650779922 |
GO:0060760 | BP | positive regulation of response to cytokine stimulus | 0.00347607209692744 |
GO:0008608 | BP | attachment of spindle microtubules to kinetochore | 1.32460567450165e-06 |
GO:0035825 | BP | homologous recombination | 0.00221638298213769 |
GO:0045576 | BP | mast cell activation | 0.00221638298213769 |
GO:0002711 | BP | positive regulation of T cell mediated immunity | 0.00301432250508861 |
GO:0002548 | BP | monocyte chemotaxis | 0.00404512689121225 |
GO:0002562 | BP | somatic diversification of immune receptors via germline recombination within a single locus | 0.00404512689121225 |
GO:0016444 | BP | somatic cell DNA recombination | 0.00404512689121225 |
GO:0022627 | CC | cytosolic small ribosomal subunit | 3.39223916820027e-09 |
GO:0051784 | BP | negative regulation of nuclear division | 0.000147108017530991 |
GO:2000630 | BP | positive regulation of miRNA metabolic process | 0.000703028728326778 |
GO:0010972 | BP | negative regulation of G2/M transition of mitotic cell cycle | 0.000997707001317851 |
GO:2000573 | BP | positive regulation of DNA biosynthetic process | 0.00192288256684007 |
GO:0045670 | BP | regulation of osteoclast differentiation | 0.0026147716586683 |
GO:0032732 | BP | positive regulation of interleukin-1 production | 0.00465246155533557 |
GO:0043370 | BP | regulation of CD4-positive, alpha-beta T cell differentiation | 1.19599732811607e-06 |
GO:0002704 | BP | negative regulation of leukocyte mediated immunity | 0.000425189213792332 |
GO:0006919 | BP | activation of cysteine-type endopeptidase activity involved in apoptotic process | 0.000425189213792332 |
GO:1902750 | BP | negative regulation of cell cycle G2/M phase transition | 0.000867066732536282 |
GO:0071677 | BP | positive regulation of mononuclear cell migration | 0.00121122521524537 |
GO:0071260 | BP | cellular response to mechanical stimulus | 0.00226888625787142 |
GO:0002637 | BP | regulation of immunoglobulin production | 0.00403979146171751 |
GO:0045123 | BP | cellular extravasation | 0.00403979146171751 |
GO:0005657 | CC | replication fork | 0.00255896622666999 |
GO:0071168 | BP | protein localization to chromatin | 3.70527540330714e-06 |
GO:0030888 | BP | regulation of B cell proliferation | 2.97476511675288e-05 |
GO:2000401 | BP | regulation of lymphocyte migration | 0.000370695030467603 |
GO:0002200 | BP | somatic diversification of immune receptors | 0.00264429782296917 |
GO:0051101 | BP | regulation of DNA binding | 0.00460291406076925 |
GO:0097110 | MF | scaffold protein binding | 0.000211400872394193 |
GO:0032623 | BP | interleukin-2 production | 5.87157996786602e-06 |
GO:0032663 | BP | regulation of interleukin-2 production | 5.87157996786602e-06 |
GO:0071479 | BP | cellular response to ionizing radiation | 0.00015018291015032 |
GO:0030330 | BP | DNA damage response, signal transduction by p53 class mediator | 0.000655280231158879 |
GO:0051298 | BP | centrosome duplication | 0.000913854758049069 |
GO:0030968 | BP | endoplasmic reticulum unfolded protein response | 0.00125788221002322 |
GO:0030239 | BP | myofibril assembly | 0.00170980122653313 |
GO:0050853 | BP | B cell receptor signaling pathway | 0.00229620765224099 |
GO:0070227 | BP | lymphocyte apoptotic process | 0.00304818658350602 |
GO:0070821 | CC | tertiary granule membrane | 0.000378142287658191 |
GO:0001618 | MF | virus receptor activity | 0.00201235337573292 |
GO:0050854 | BP | regulation of antigen receptor-mediated signaling pathway | 2.35580211841319e-05 |
GO:0032722 | BP | positive regulation of chemokine production | 0.000131525751189773 |
GO:1905818 | BP | regulation of chromosome separation | 0.000281803960581713 |
GO:0055002 | BP | striated muscle cell development | 0.00148486196324453 |
GO:0043406 | BP | positive regulation of MAP kinase activity | 0.00347948769975091 |
GO:0005876 | CC | spindle microtubule | 0.00290415827997589 |
GO:0005901 | CC | caveola | 0.00290415827997589 |
GO:0002260 | BP | lymphocyte homeostasis | 0.000245722365472521 |
GO:0042267 | BP | natural killer cell mediated cytotoxicity | 0.000245722365472521 |
GO:0015935 | CC | small ribosomal subunit | 0.000562109979164555 |
GO:0001912 | BP | positive regulation of leukocyte mediated cytotoxicity | 4.34649226041295e-06 |
GO:0046637 | BP | regulation of alpha-beta T cell differentiation | 4.47033634268423e-05 |
GO:0072678 | BP | T cell migration | 4.47033634268423e-05 |
GO:0051304 | BP | chromosome separation | 0.000599940543913503 |
GO:0001892 | BP | embryonic placenta development | 0.00441959294382186 |
GO:0001725 | CC | stress fiber | 0.00164807076340986 |
GO:0097517 | CC | contractile actin filament bundle | 0.00164807076340986 |
GO:1902893 | BP | regulation of miRNA transcription | 2.56681571301462e-05 |
GO:0061614 | BP | miRNA transcription | 3.93454653962723e-05 |
GO:2000106 | BP | regulation of leukocyte apoptotic process | 0.00298421283716512 |
GO:0002228 | BP | natural killer cell mediated immunity | 5.20872517173513e-05 |
GO:0043299 | BP | leukocyte degranulation | 5.20872517173513e-05 |
GO:0002720 | BP | positive regulation of cytokine production involved in immune response | 0.000112950537847824 |
GO:1905897 | BP | regulation of response to endoplasmic reticulum stress | 0.000326419688858155 |
GO:0002312 | BP | B cell activation involved in immune response | 0.000846587927498486 |
GO:0031343 | BP | positive regulation of cell killing | 5.1445975914538e-06 |
GO:0050871 | BP | positive regulation of B cell activation | 9.86594582220616e-05 |
GO:0048145 | BP | regulation of fibroblast proliferation | 0.000989328401759663 |
GO:0071103 | BP | DNA conformation change | 0.0017342353561243 |
GO:0015030 | CC | Cajal body | 5.29355248171544e-05 |
GO:0046635 | BP | positive regulation of alpha-beta T cell activation | 3.43523714017438e-07 |
GO:0042093 | BP | T-helper cell differentiation | 5.99775758015287e-07 |
GO:0002294 | BP | CD4-positive, alpha-beta T cell differentiation involved in immune response | 1.72182624236841e-06 |
GO:0007422 | BP | peripheral nervous system development | 0.000471231307074355 |
GO:0002690 | BP | positive regulation of leukocyte chemotaxis | 0.00114515960150398 |
GO:0002287 | BP | alpha-beta T cell activation involved in immune response | 9.29349591033859e-07 |
GO:0002293 | BP | alpha-beta T cell differentiation involved in immune response | 9.29349591033859e-07 |
GO:2000514 | BP | regulation of CD4-positive, alpha-beta T cell activation | 1.55014789386117e-06 |
GO:0070098 | BP | chemokine-mediated signaling pathway | 0.000556672721181263 |
GO:0032755 | BP | positive regulation of interleukin-6 production | 0.0045944135813594 |
GO:0022625 | CC | cytosolic large ribosomal subunit | 2.26094249831821e-12 |
GO:0032729 | BP | positive regulation of type II interferon production | 2.89082203869852e-07 |
GO:0008625 | BP | extrinsic apoptotic signaling pathway via death domain receptors | 8.93414711621676e-06 |
GO:0034620 | BP | cellular response to unfolded protein | 9.43113579976313e-05 |
GO:0120162 | BP | positive regulation of cold-induced thermogenesis | 0.00249264900969707 |
GO:0044773 | BP | mitotic DNA damage checkpoint signaling | 3.24001122490971e-06 |
GO:2001251 | BP | negative regulation of chromosome organization | 0.000116527277850889 |
GO:0042542 | BP | response to hydrogen peroxide | 0.00130357752608778 |
GO:0002292 | BP | T cell differentiation involved in immune response | 1.81101396226666e-06 |
GO:0033273 | BP | response to vitamin | 2.36461511207808e-05 |
GO:0002275 | BP | myeloid cell activation involved in immune response | 0.000196917418631944 |
GO:1903312 | BP | negative regulation of mRNA metabolic process | 0.000493057075987267 |
GO:0010389 | BP | regulation of G2/M transition of mitotic cell cycle | 0.00147468401952681 |
GO:2000628 | BP | regulation of miRNA metabolic process | 6.14599458756283e-06 |
GO:0039531 | BP | regulation of cytoplasmic pattern recognition receptor signaling pathway | 0.00211914618973353 |
GO:1901796 | BP | regulation of signal transduction by p53 class mediator | 0.00211914618973353 |
GO:0048144 | BP | fibroblast proliferation | 0.00338694898836864 |
GO:0044774 | BP | mitotic DNA integrity checkpoint signaling | 8.98014629239058e-07 |
GO:0002709 | BP | regulation of T cell mediated immunity | 7.7160978395049e-05 |
GO:1990868 | BP | response to chemokine | 0.000149274048694612 |
GO:1990869 | BP | cellular response to chemokine | 0.000149274048694612 |
GO:0032642 | BP | regulation of chemokine production | 0.000373585926195625 |
GO:0045639 | BP | positive regulation of myeloid cell differentiation | 0.000498074051184663 |
GO:0001776 | BP | leukocyte homeostasis | 0.00112170773227381 |
GO:0007229 | BP | integrin-mediated signaling pathway | 0.00235184076275978 |
GO:0045638 | BP | negative regulation of myeloid cell differentiation | 1.589870996129e-05 |
GO:0140747 | BP | regulation of ncRNA transcription | 1.589870996129e-05 |
GO:0032602 | BP | chemokine production | 0.000241774970324884 |
GO:0030316 | BP | osteoclast differentiation | 0.00043374881910563 |
GO:0043280 | BP | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process | 0.00126286148457816 |
GO:0044853 | CC | plasma membrane raft | 0.00164613355614346 |
GO:0004896 | MF | cytokine receptor activity | 6.830136885468e-06 |
GO:0008630 | BP | intrinsic apoptotic signaling pathway in response to DNA damage | 1.77273483031627e-05 |
GO:0042100 | BP | B cell proliferation | 3.6287757212524e-05 |
GO:0002526 | BP | acute inflammatory response | 0.000183303279997645 |
GO:0042116 | BP | macrophage activation | 0.000246639914684633 |
GO:0071887 | BP | leukocyte apoptotic process | 0.00123494279127486 |
GO:0033209 | BP | tumor necrosis factor-mediated signaling pathway | 0.00157326920801138 |
GO:0045582 | BP | positive regulation of T cell differentiation | 0.00250069130924717 |
GO:0035967 | BP | cellular response to topologically incorrect protein | 7.27722723130644e-06 |
GO:0010586 | BP | miRNA metabolic process | 6.21761705456439e-05 |
GO:0001824 | BP | blastocyst development | 0.000840228638415574 |
GO:0007265 | BP | Ras protein signal transduction | 0.00174236298386678 |
GO:2000278 | BP | regulation of DNA biosynthetic process | 0.00024975697352 |
GO:1902749 | BP | regulation of cell cycle G2/M phase transition | 0.000330726335008179 |
GO:0001838 | BP | embryonic epithelial tube formation | 0.00192056548704773 |
GO:0032434 | BP | regulation of proteasomal ubiquitin-dependent protein catabolic process | 0.00298680193979749 |
GO:0043367 | BP | CD4-positive, alpha-beta T cell differentiation | 2.27329332954201e-08 |
GO:0001910 | BP | regulation of leukocyte mediated cytotoxicity | 6.52035053210402e-08 |
GO:0032760 | BP | positive regulation of tumor necrosis factor production | 1.69892742891445e-05 |
GO:0002698 | BP | negative regulation of immune effector process | 0.000640487913030299 |
GO:0002688 | BP | regulation of leukocyte chemotaxis | 0.00105230462516949 |
GO:0045834 | BP | positive regulation of lipid metabolic process | 0.00105230462516949 |
GO:0071902 | BP | positive regulation of protein serine/threonine kinase activity | 0.00262328350220179 |
GO:0002761 | BP | regulation of myeloid leukocyte differentiation | 0.00324503317195004 |
GO:0051310 | BP | metaphase chromosome alignment | 1.57758073594792e-07 |
GO:0002444 | BP | myeloid leukocyte mediated immunity | 2.10455468529998e-05 |
GO:0002718 | BP | regulation of cytokine production involved in immune response | 0.000251286464680165 |
GO:0002367 | BP | cytokine production involved in immune response | 0.000219065799185093 |
GO:0072676 | BP | lymphocyte migration | 0.00048830173709365 |
GO:0030018 | CC | Z disc | 0.00159122872046173 |
GO:1903557 | BP | positive regulation of tumor necrosis factor superfamily cytokine production | 5.49173620911701e-06 |
GO:0032609 | BP | type II interferon production | 4.31596699032032e-05 |
GO:0032649 | BP | regulation of type II interferon production | 4.31596699032032e-05 |
GO:0071675 | BP | regulation of mononuclear cell migration | 0.00014404721578324 |
GO:0045621 | BP | positive regulation of lymphocyte differentiation | 0.00177595606708577 |
GO:0030879 | BP | mammary gland development | 0.00272133732652051 |
GO:0000086 | BP | G2/M transition of mitotic cell cycle | 0.00334001659803182 |
GO:0035591 | MF | signaling adaptor activity | 2.61216537997594e-06 |
GO:0042826 | MF | histone deacetylase binding | 0.000444162036574988 |
GO:0042102 | BP | positive regulation of T cell proliferation | 4.29833395894249e-08 |
GO:2001056 | BP | positive regulation of cysteine-type endopeptidase activity | 0.000219280011328439 |
GO:0030218 | BP | erythrocyte differentiation | 0.00155904820285508 |
GO:0072175 | BP | epithelial tube formation | 0.00155904820285508 |
GO:0051303 | BP | establishment of chromosome localization | 5.87945564896092e-07 |
GO:0002456 | BP | T cell mediated immunity | 0.000191282543345294 |
GO:0043405 | BP | regulation of MAP kinase activity | 0.000685869325185661 |
GO:0031341 | BP | regulation of cell killing | 8.9498077954133e-08 |
GO:0046634 | BP | regulation of alpha-beta T cell activation | 7.83108608016402e-07 |
GO:0015934 | CC | large ribosomal subunit | 1.7987829464494e-06 |
GO:0031674 | CC | I band | 0.00326756528358759 |
GO:0007088 | BP | regulation of mitotic nuclear division | 1.02827510893884e-06 |
GO:0050000 | BP | chromosome localization | 9.03343532488436e-07 |
GO:0002286 | BP | T cell activation involved in immune response | 4.04678537351478e-06 |
GO:0050852 | BP | T cell receptor signaling pathway | 0.00176940721690192 |
GO:0002020 | MF | protease binding | 0.000388518063269303 |
GO:0002824 | BP | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 2.46729367941204e-06 |
GO:0034341 | BP | response to type II interferon | 0.000402326866335357 |
GO:0034101 | BP | erythrocyte homeostasis | 0.000645979464914081 |
GO:0010950 | BP | positive regulation of endopeptidase activity | 0.00416440592250159 |
GO:0030527 | MF | structural constituent of chromatin | 4.58000872051609e-13 |
GO:0034502 | BP | protein localization to chromosome | 6.96808039248911e-07 |
GO:0051053 | BP | negative regulation of DNA metabolic process | 0.000213866616272024 |
GO:0035148 | BP | tube formation | 0.00110768704849364 |
GO:0031960 | BP | response to corticosteroid | 0.00443022224288564 |
GO:0046718 | BP | symbiont entry into host cell | 0.00443022224288564 |
GO:0035710 | BP | CD4-positive, alpha-beta T cell activation | 4.98648389949094e-08 |
GO:0002708 | BP | positive regulation of lymphocyte mediated immunity | 1.30863042584371e-06 |
GO:0007052 | BP | mitotic spindle organization | 3.83811915330813e-06 |
GO:0007098 | BP | centrosome cycle | 4.81047386929161e-05 |
GO:0050921 | BP | positive regulation of chemotaxis | 0.000110681410302847 |
GO:0035264 | BP | multicellular organism growth | 0.000392137667486854 |
GO:0120161 | BP | regulation of cold-induced thermogenesis | 0.000973648863214047 |
GO:0019838 | MF | growth factor binding | 1.15201735001683e-05 |
GO:0000077 | BP | DNA damage checkpoint signaling | 1.61076745699467e-07 |
GO:0002821 | BP | positive regulation of adaptive immune response | 1.6527042264857e-06 |
GO:0002702 | BP | positive regulation of production of molecular mediator of immune response | 4.71868610287923e-06 |
GO:0006986 | BP | response to unfolded protein | 1.71644674396182e-05 |
GO:0010212 | BP | response to ionizing radiation | 1.71644674396182e-05 |
GO:0031023 | BP | microtubule organizing center organization | 0.000686557029776673 |
GO:0106106 | BP | cold-induced thermogenesis | 0.000686557029776673 |
GO:0006334 | BP | nucleosome assembly | 2.26289278944406e-09 |
GO:0044839 | BP | cell cycle G2/M phase transition | 0.000381200828812066 |
GO:0030183 | BP | B cell differentiation | 0.000421533700479545 |
GO:0043281 | BP | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 0.00124866363088133 |
GO:0046632 | BP | alpha-beta T cell differentiation | 7.92211673965817e-09 |
GO:0010952 | BP | positive regulation of peptidase activity | 0.00290876288726343 |
GO:0070820 | CC | tertiary granule | 0.00125213252112152 |
GO:0050729 | BP | positive regulation of inflammatory response | 7.33500110228135e-05 |
GO:0007254 | BP | JNK cascade | 0.00369646063591254 |
GO:0000786 | CC | nucleosome | 1.4450677487712e-07 |
GO:0050864 | BP | regulation of B cell activation | 9.98736018826285e-09 |
GO:0034728 | BP | nucleosome organization | 2.79570704465074e-07 |
GO:0098781 | BP | ncRNA transcription | 4.61703549031501e-06 |
GO:0051250 | BP | negative regulation of lymphocyte activation | 0.000692063155354939 |
GO:1990845 | BP | adaptive thermogenesis | 0.00156153064848721 |
GO:0019955 | MF | cytokine binding | 2.76429698282323e-06 |
GO:0031570 | BP | DNA integrity checkpoint signaling | 2.14961188128821e-08 |
GO:0002753 | BP | cytoplasmic pattern recognition receptor signaling pathway | 0.000249261524219593 |
GO:0007204 | BP | positive regulation of cytosolic calcium ion concentration | 0.00092500269410253 |
GO:1902905 | BP | positive regulation of supramolecular fiber organization | 0.00291457046492342 |
GO:0002687 | BP | positive regulation of leukocyte migration | 2.54195518161352e-06 |
GO:0007584 | BP | response to nutrient | 0.000172519245196238 |
GO:0050731 | BP | positive regulation of peptidyl-tyrosine phosphorylation | 0.000172519245196238 |
GO:0000922 | CC | spindle pole | 0.00197050467576624 |
GO:0008201 | MF | heparin binding | 0.00140422546920994 |
GO:0001909 | BP | leukocyte mediated cytotoxicity | 1.88670908717372e-07 |
GO:0051783 | BP | regulation of nuclear division | 5.66811969623062e-07 |
GO:0035966 | BP | response to topologically incorrect protein | 1.39196366966611e-06 |
GO:0000781 | CC | chromosome, telomeric region | 0.000302993865507703 |
GO:0007093 | BP | mitotic cell cycle checkpoint signaling | 2.00527798694597e-08 |
GO:0000724 | BP | double-strand break repair via homologous recombination | 0.000452049584545366 |
GO:0045580 | BP | regulation of T cell differentiation | 0.00180526043887189 |
GO:0001726 | CC | ruffle | 0.000667613776504095 |
GO:0050671 | BP | positive regulation of lymphocyte proliferation | 2.79609720597687e-09 |
GO:0002262 | BP | myeloid cell homeostasis | 0.000180226233064306 |
GO:0006109 | BP | regulation of carbohydrate metabolic process | 0.000533204873626826 |
GO:1904018 | BP | positive regulation of vasculature development | 0.00243250879708624 |
GO:0000725 | BP | recombinational repair | 0.000247797085401358 |
GO:0043484 | BP | regulation of RNA splicing | 0.000705105270648575 |
GO:0071706 | BP | tumor necrosis factor superfamily cytokine production | 0.00304819397225809 |
GO:1903555 | BP | regulation of tumor necrosis factor superfamily cytokine production | 0.00304819397225809 |
GO:0140375 | MF | immune receptor activity | 2.56364021057556e-08 |
GO:0032946 | BP | positive regulation of mononuclear cell proliferation | 1.40969533058131e-09 |
GO:0006261 | BP | DNA-templated DNA replication | 3.59372873623997e-07 |
GO:0002705 | BP | positive regulation of leukocyte mediated immunity | 3.03058387911871e-09 |
GO:0072331 | BP | signal transduction by p53 class mediator | 2.81184896819805e-05 |
GO:0051495 | BP | positive regulation of cytoskeleton organization | 0.00015307100959066 |
GO:2000116 | BP | regulation of cysteine-type endopeptidase activity | 0.00054972287736948 |
GO:0001659 | BP | temperature homeostasis | 6.67373278159235e-05 |
GO:0046777 | BP | protein autophosphorylation | 0.000485249472964311 |
GO:0071897 | BP | DNA biosynthetic process | 0.000485249472964311 |
GO:0031099 | BP | regeneration | 0.00215285984537246 |
GO:0044703 | BP | multi-organism reproductive process | 0.00415833917628879 |
GO:0000776 | CC | kinetochore | 1.2746505468124e-06 |
GO:0072686 | CC | mitotic spindle | 5.91516818689053e-05 |
GO:1902850 | BP | microtubule cytoskeleton organization involved in mitosis | 1.19225615392951e-07 |
GO:0042129 | BP | regulation of T cell proliferation | 2.14981598711168e-05 |
GO:1902107 | BP | positive regulation of leukocyte differentiation | 0.000184431067249448 |
GO:1903708 | BP | positive regulation of hemopoiesis | 0.000184431067249448 |
GO:0000302 | BP | response to reactive oxygen species | 0.00143015749258523 |
GO:0022626 | CC | cytosolic ribosome | 1.15923158856269e-18 |
GO:0002695 | BP | negative regulation of leukocyte activation | 9.09876691332338e-05 |
GO:1901991 | BP | negative regulation of mitotic cell cycle phase transition | 0.000177406052737909 |
GO:0022408 | BP | negative regulation of cell-cell adhesion | 0.000883057890180518 |
GO:0044706 | BP | multi-multicellular organism process | 0.00407373833905521 |
GO:0003735 | MF | structural constituent of ribosome | 1.21269973097752e-06 |
GO:0002700 | BP | regulation of production of molecular mediator of immune response | 1.4371333904887e-05 |
GO:0045732 | BP | positive regulation of protein catabolic process | 0.0007826743335272 |
GO:0070665 | BP | positive regulation of leukocyte proliferation | 3.33726187213981e-09 |
GO:0051216 | BP | cartilage development | 0.00100201212840979 |
GO:0032200 | BP | telomere organization | 6.44666309238076e-06 |
GO:1903046 | BP | meiotic cell cycle process | 0.00188514422358914 |
GO:0010810 | BP | regulation of cell-substrate adhesion | 0.00305712056984626 |
GO:0000779 | CC | condensed chromosome, centromeric region | 1.82539986733544e-07 |
GO:0030017 | CC | sarcomere | 0.00163455036993487 |
GO:0031396 | BP | regulation of protein ubiquitination | 1.81000053505635e-05 |
GO:0050730 | BP | regulation of peptidyl-tyrosine phosphorylation | 0.00372670796970757 |
GO:0000228 | CC | nuclear chromosome | 0.00323436677875257 |
GO:0050851 | BP | antigen receptor-mediated signaling pathway | 0.000102281969461109 |
GO:0045055 | BP | regulated exocytosis | 0.00244705369073249 |
GO:0045619 | BP | regulation of lymphocyte differentiation | 0.000255223719007704 |
GO:0050866 | BP | negative regulation of cell activation | 0.000255223719007704 |
GO:0002706 | BP | regulation of lymphocyte mediated immunity | 6.24170562076208e-08 |
GO:0007051 | BP | spindle organization | 1.88451770092466e-06 |
GO:0000070 | BP | mitotic sister chromatid segregation | 5.45503263261557e-08 |
GO:0042770 | BP | signal transduction in response to DNA damage | 5.45503263261557e-08 |
GO:0071674 | BP | mononuclear cell migration | 1.06331944483934e-05 |
GO:0019887 | MF | protein kinase regulator activity | 0.00221969028613349 |
GO:0007163 | BP | establishment or maintenance of cell polarity | 0.000462274430489706 |
GO:0051098 | BP | regulation of binding | 0.00340089192743752 |
GO:0002573 | BP | myeloid leukocyte differentiation | 0.00262496787854983 |
GO:0046631 | BP | alpha-beta T cell activation | 2.76742747444193e-10 |
GO:0001906 | BP | cell killing | 0.000167674428947498 |
GO:0006909 | BP | phagocytosis | 0.00124415915309831 |
GO:0044391 | CC | ribosomal subunit | 1.54674444456683e-08 |
GO:0009612 | BP | response to mechanical stimulus | 1.02737900257092e-05 |
GO:0042098 | BP | T cell proliferation | 2.50770303381412e-06 |
GO:0050920 | BP | regulation of chemotaxis | 0.00010672878384738 |
GO:0097191 | BP | extrinsic apoptotic signaling pathway | 0.000130804295790343 |
GO:0022618 | BP | protein-RNA complex assembly | 0.000285457770052499 |
GO:0007160 | BP | cell-matrix adhesion | 0.000990358499812974 |
GO:0030016 | CC | myofibril | 0.00058988497822815 |
GO:0002822 | BP | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.38150923759839e-09 |
GO:0033044 | BP | regulation of chromosome organization | 0.00169105013179052 |
GO:0002181 | BP | cytoplasmic translation | 4.35438101037418e-17 |
GO:0000075 | BP | cell cycle checkpoint signaling | 3.77071986943057e-10 |
GO:0002285 | BP | lymphocyte activation involved in immune response | 4.79199457172144e-07 |
GO:0071826 | BP | protein-RNA complex organization | 0.00066388854292593 |
GO:0045444 | BP | fat cell differentiation | 0.00129090419857403 |
GO:0071356 | BP | cellular response to tumor necrosis factor | 0.000239812224812814 |
GO:0097305 | BP | response to alcohol | 0.0044294691040014 |
GO:0000819 | BP | sister chromatid segregation | 1.09496212442891e-05 |
GO:0097529 | BP | myeloid leukocyte migration | 9.73470760589092e-05 |
GO:0001649 | BP | osteoblast differentiation | 0.00224645373573947 |
GO:0045637 | BP | regulation of myeloid cell differentiation | 3.19104219329014e-07 |
GO:1903320 | BP | regulation of protein modification by small protein conjugation or removal | 8.59699391724016e-05 |
GO:0043292 | CC | contractile fiber | 0.000322507435273224 |
GO:0065004 | BP | protein-DNA complex assembly | 4.06763989733767e-05 |
GO:0032886 | BP | regulation of microtubule-based process | 0.00113667274230217 |
GO:0030595 | BP | leukocyte chemotaxis | 1.18076180162418e-05 |
GO:0045930 | BP | negative regulation of mitotic cell cycle | 0.000121790838357035 |
GO:0071222 | BP | cellular response to lipopolysaccharide | 2.83116891183428e-07 |
GO:0002685 | BP | regulation of leukocyte migration | 1.11714460139963e-06 |
GO:1901873 | BP | regulation of post-translational protein modification | 4.81353727874701e-05 |
GO:1901681 | MF | sulfur compound binding | 0.0022709612048038 |
GO:0002819 | BP | regulation of adaptive immune response | 1.35126584936859e-10 |
GO:0019722 | BP | calcium-mediated signaling | 4.98778296248013e-07 |
GO:0034612 | BP | response to tumor necrosis factor | 0.000440134792810971 |
GO:0090068 | BP | positive regulation of cell cycle process | 0.000440134792810971 |
GO:0003018 | BP | vascular process in circulatory system | 0.00283614632045646 |
GO:0002221 | BP | pattern recognition receptor signaling pathway | 0.000133037843065826 |
GO:0018108 | BP | peptidyl-tyrosine phosphorylation | 0.000490648246948815 |
GO:0018212 | BP | peptidyl-tyrosine modification | 0.000682092312196391 |
GO:0010721 | BP | negative regulation of cell development | 0.00372925842526455 |
GO:0150034 | CC | distal axon | 0.000220871610396266 |
GO:0050670 | BP | regulation of lymphocyte proliferation | 6.14804743026247e-08 |
GO:0071219 | BP | cellular response to molecule of bacterial origin | 8.23178546534559e-08 |
GO:0043122 | BP | regulation of canonical NF-kappaB signal transduction | 0.0019390176183092 |
GO:0005840 | CC | ribosome | 1.57223146003975e-06 |
GO:0002274 | BP | myeloid leukocyte activation | 9.58810313767841e-08 |
GO:0071900 | BP | regulation of protein serine/threonine kinase activity | 4.90869786578129e-05 |
GO:0001227 | MF | DNA-binding transcription repressor activity, RNA polymerase II-specific | 2.13193179621151e-05 |
GO:0032944 | BP | regulation of mononuclear cell proliferation | 4.68789578818399e-08 |
GO:0051321 | BP | meiotic cell cycle | 0.00181367491831062 |
GO:0045860 | BP | positive regulation of protein kinase activity | 1.74204074210206e-06 |
GO:0050870 | BP | positive regulation of T cell activation | 3.33086746900751e-07 |
GO:0008017 | MF | microtubule binding | 9.11394863577796e-05 |
GO:1901988 | BP | negative regulation of cell cycle phase transition | 6.58787485606432e-06 |
GO:0002758 | BP | innate immune response-activating signaling pathway | 1.90620670785148e-05 |
GO:0001217 | MF | DNA-binding transcription repressor activity | 5.32419231527841e-06 |
GO:0006260 | BP | DNA replication | 1.10817789083879e-05 |
GO:0061448 | BP | connective tissue development | 4.88001707185915e-05 |
GO:0034504 | BP | protein localization to nucleus | 0.00203046950977637 |
GO:0031625 | MF | ubiquitin protein ligase binding | 0.000719738762877524 |
GO:0002703 | BP | regulation of leukocyte mediated immunity | 2.15039376340449e-10 |
GO:0007162 | BP | negative regulation of cell adhesion | 0.000809080611094062 |
GO:0042254 | BP | ribosome biogenesis | 0.00282632662576673 |
GO:0051054 | BP | positive regulation of DNA metabolic process | 0.000122502862971051 |
GO:0007249 | BP | canonical NF-kappaB signal transduction | 0.00062528129767312 |
GO:0071216 | BP | cellular response to biotic stimulus | 9.21367647547748e-09 |
GO:0006302 | BP | double-strand break repair | 0.000314576158528541 |
GO:0000793 | CC | condensed chromosome | 3.81917009784548e-07 |
GO:0071214 | BP | cellular response to abiotic stimulus | 0.00460055743431652 |
GO:0104004 | BP | cellular response to environmental stimulus | 0.00460055743431652 |
GO:0045121 | CC | membrane raft | 6.8790318735369e-07 |
GO:0098857 | CC | membrane microdomain | 8.70643088122152e-07 |
GO:0002699 | BP | positive regulation of immune effector process | 1.55085659725375e-10 |
GO:0070663 | BP | regulation of leukocyte proliferation | 3.86488127664675e-09 |
GO:1903039 | BP | positive regulation of leukocyte cell-cell adhesion | 6.66225194354056e-08 |
GO:0001666 | BP | response to hypoxia | 0.000153393502121136 |
GO:0097193 | BP | intrinsic apoptotic signaling pathway | 0.000404586767467915 |
GO:0000775 | CC | chromosome, centromeric region | 7.85440133960293e-11 |
GO:0071496 | BP | cellular response to external stimulus | 0.00262112462037224 |
GO:0002218 | BP | activation of innate immune response | 3.1191314085625e-06 |
GO:0070371 | BP | ERK1 and ERK2 cascade | 0.00122173927524633 |
GO:0033674 | BP | positive regulation of kinase activity | 5.21716506561249e-06 |
GO:0019216 | BP | regulation of lipid metabolic process | 0.000340202471345556 |
GO:0045296 | MF | cadherin binding | 0.000850534584246214 |
GO:0042113 | BP | B cell activation | 2.64909448424591e-09 |
GO:0036293 | BP | response to decreased oxygen levels | 0.000168945114573745 |
GO:0045787 | BP | positive regulation of cell cycle | 0.000372220594779297 |
GO:0044389 | MF | ubiquitin-like protein ligase binding | 0.000137729218965365 |
GO:0098813 | BP | nuclear chromosome segregation | 1.7920746114236e-05 |
GO:0045862 | BP | positive regulation of proteolysis | 0.000452017111908143 |
GO:0140014 | BP | mitotic nuclear division | 4.33094017167064e-10 |
GO:0001822 | BP | kidney development | 1.58731910452784e-05 |
GO:0062012 | BP | regulation of small molecule metabolic process | 0.000134845925585649 |
GO:0010948 | BP | negative regulation of cell cycle process | 3.02631132658632e-06 |
GO:0070482 | BP | response to oxygen levels | 0.00175825854720236 |
GO:1901342 | BP | regulation of vasculature development | 0.00465525485830499 |
GO:0072001 | BP | renal system development | 2.3508552343766e-05 |
GO:0042176 | BP | regulation of protein catabolic process | 0.00335955976427311 |
GO:0048872 | BP | homeostasis of number of cells | 3.57497449590822e-06 |
GO:1902105 | BP | regulation of leukocyte differentiation | 7.09218465245551e-06 |
GO:0007517 | BP | muscle organ development | 0.00114525521982349 |
GO:0060326 | BP | cell chemotaxis | 6.72065949268466e-07 |
GO:1901653 | BP | cellular response to peptide | 0.00466110440224194 |
GO:0030217 | BP | T cell differentiation | 1.97544763623843e-08 |
GO:0002429 | BP | immune response-activating cell surface receptor signaling pathway | 3.27441049438786e-06 |
GO:0046651 | BP | lymphocyte proliferation | 5.904547776441e-09 |
GO:0031589 | BP | cell-substrate adhesion | 0.000242113567838836 |
GO:0106310 | MF | protein serine kinase activity | 0.000605336282329022 |
GO:0002366 | BP | leukocyte activation involved in immune response | 3.84578636566189e-10 |
GO:0002263 | BP | cell activation involved in immune response | 1.25834455294979e-09 |
GO:0022409 | BP | positive regulation of cell-cell adhesion | 2.3002411774465e-07 |
GO:0010639 | BP | negative regulation of organelle organization | 0.000393258292805112 |
GO:0030522 | BP | intracellular receptor signaling pathway | 0.000471579516117464 |
GO:0046982 | MF | protein heterodimerization activity | 5.53751046104366e-05 |
GO:0032943 | BP | mononuclear cell proliferation | 5.18013523451882e-09 |
GO:0006310 | BP | DNA recombination | 1.61584811442777e-06 |
GO:0015631 | MF | tubulin binding | 0.00202082795378162 |
GO:0002449 | BP | lymphocyte mediated immunity | 0.000222088682314545 |
GO:0051251 | BP | positive regulation of lymphocyte activation | 1.14174200261948e-08 |
GO:0001701 | BP | in utero embryonic development | 0.00454113962375184 |
GO:2001233 | BP | regulation of apoptotic signaling pathway | 0.00131916829061069 |
GO:0050767 | BP | regulation of neurogenesis | 0.00043143677323902 |
GO:0016607 | CC | nuclear speck | 0.00340045715818745 |
GO:0002768 | BP | immune response-regulating cell surface receptor signaling pathway | 3.25500222499216e-07 |
GO:0002460 | BP | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.51772835281924e-05 |
GO:0043254 | BP | regulation of protein-containing complex assembly | 0.00179706046878392 |
GO:0031400 | BP | negative regulation of protein modification process | 0.00439809643231373 |
GO:0031252 | CC | cell leading edge | 0.00155172166880842 |
GO:0050727 | BP | regulation of inflammatory response | 0.00153100765894205 |
GO:0045089 | BP | positive regulation of innate immune response | 3.08895954638514e-08 |
GO:0050863 | BP | regulation of T cell activation | 7.21772414710206e-07 |
GO:0032496 | BP | response to lipopolysaccharide | 9.73923639836552e-11 |
GO:0070661 | BP | leukocyte proliferation | 3.02972951021052e-10 |
GO:0051347 | BP | positive regulation of transferase activity | 6.61351023069722e-08 |
GO:0042060 | BP | wound healing | 0.00072592486432655 |
GO:0060537 | BP | muscle tissue development | 0.00189746059450135 |
GO:0043434 | BP | response to peptide hormone | 0.0013724512680254 |
GO:0002696 | BP | positive regulation of leukocyte activation | 6.03222089894027e-10 |
GO:1903037 | BP | regulation of leukocyte cell-cell adhesion | 7.99313113118575e-08 |
GO:0004674 | MF | protein serine/threonine kinase activity | 0.000364188310202905 |
GO:0050900 | BP | leukocyte migration | 8.66241387732975e-07 |
GO:0042692 | BP | muscle cell differentiation | 0.000185303928959587 |
GO:0002833 | BP | positive regulation of response to biotic stimulus | 1.4793025386865e-07 |
GO:0062023 | CC | collagen-containing extracellular matrix | 7.37333773714612e-05 |
GO:0001503 | BP | ossification | 0.000672313072241958 |
GO:0045786 | BP | negative regulation of cell cycle | 6.45860658321173e-07 |
GO:1901987 | BP | regulation of cell cycle phase transition | 0.00141613473141404 |
GO:0002237 | BP | response to molecule of bacterial origin | 6.76838141911279e-11 |
GO:0050867 | BP | positive regulation of cell activation | 6.78389763859611e-10 |
GO:0140694 | BP | non-membrane-bounded organelle assembly | 1.09897151232264e-06 |
GO:0005874 | CC | microtubule | 0.00206650498904933 |
GO:0005819 | CC | spindle | 1.25889381826519e-05 |
GO:0010720 | BP | positive regulation of cell development | 0.000104350146838883 |
GO:0050673 | BP | epithelial cell proliferation | 0.00235336355936056 |
GO:0051345 | BP | positive regulation of hydrolase activity | 0.00173745534175419 |
GO:0002697 | BP | regulation of immune effector process | 1.1270999447756e-11 |
GO:0051960 | BP | regulation of nervous system development | 0.000229645884390728 |
GO:0051656 | BP | establishment of organelle localization | 0.000384864966169974 |
GO:0007159 | BP | leukocyte cell-cell adhesion | 1.75648009479187e-08 |
GO:0007059 | BP | chromosome segregation | 4.20284443875084e-08 |
GO:1903829 | BP | positive regulation of protein localization | 0.000536858403319343 |
GO:0140297 | MF | DNA-binding transcription factor binding | 0.000332750121273878 |
GO:0043410 | BP | positive regulation of MAPK cascade | 9.22264174423929e-05 |
GO:0031667 | BP | response to nutrient levels | 0.00063840511742123 |
GO:0098687 | CC | chromosomal region | 1.69978957464305e-11 |
GO:1903706 | BP | regulation of hemopoiesis | 5.32335633823349e-09 |
GO:0030099 | BP | myeloid cell differentiation | 1.33914668801257e-07 |
GO:0008380 | BP | RNA splicing | 0.000214184901450981 |
GO:0000280 | BP | nuclear division | 6.65278247155347e-08 |
GO:0002443 | BP | leukocyte mediated immunity | 4.67364864319683e-06 |
GO:0030098 | BP | lymphocyte differentiation | 1.7433815778351e-09 |
GO:0045088 | BP | regulation of innate immune response | 1.07481944329464e-08 |
GO:0001228 | MF | DNA-binding transcription activator activity, RNA polymerase II-specific | 1.71818921531707e-05 |
GO:0007264 | BP | small GTPase-mediated signal transduction | 0.000199397333689707 |
GO:0045859 | BP | regulation of protein kinase activity | 8.79024383013968e-07 |
GO:0001216 | MF | DNA-binding transcription activator activity | 8.21366337656784e-06 |
GO:0022613 | BP | ribonucleoprotein complex biogenesis | 3.91508662304529e-05 |
GO:0005925 | CC | focal adhesion | 3.71254570834087e-13 |
GO:0009897 | CC | external side of plasma membrane | 4.8168678385632e-16 |
GO:0030055 | CC | cell-substrate junction | 7.7562925534539e-13 |
GO:0048285 | BP | organelle fission | 1.18392912827174e-06 |
GO:0006935 | BP | chemotaxis | 3.5868968963596e-09 |
GO:0042330 | BP | taxis | 5.55446808606354e-09 |
GO:0022407 | BP | regulation of cell-cell adhesion | 6.92780206298253e-08 |
GO:0045785 | BP | positive regulation of cell adhesion | 1.40822004755667e-09 |
GO:1903131 | BP | mononuclear cell differentiation | 3.50191680280453e-10 |
GO:0002757 | BP | immune response-activating signaling pathway | 6.64373826599585e-09 |
GO:0001819 | BP | positive regulation of cytokine production | 6.74178375904952e-11 |
go_enrichment_tnbc_vs_normal (4).csv
ID | ONTOLOGY | Description | pvalue |
---|---|---|---|
GO:0002181 | BP | cytoplasmic translation | 2.38E-14 |
GO:0002366 | BP | leukocyte activation involved in immune response | 1.12E-10 |
GO:0046632 | BP | alpha-beta T cell differentiation | 1.21E-10 |
GO:0046631 | BP | alpha-beta T cell activation | 3.50E-10 |
GO:0002263 | BP | cell activation involved in immune response | 4.01E-10 |
GO:1903706 | BP | regulation of hemopoiesis | 6.33E-10 |
GO:0071216 | BP | cellular response to biotic stimulus | 7.88E-10 |
GO:1903131 | BP | mononuclear cell differentiation | 2.65E-09 |
GO:0002274 | BP | myeloid leukocyte activation | 2.87E-09 |
GO:0140014 | BP | mitotic nuclear division | 3.86E-09 |
GO:0002237 | BP | response to molecule of bacterial origin | 5.15E-09 |
GO:0032496 | BP | response to lipopolysaccharide | 1.20E-08 |
GO:0030099 | BP | myeloid cell differentiation | 1.29E-08 |
GO:0002697 | BP | regulation of immune effector process | 1.34E-08 |
GO:0030217 | BP | T cell differentiation | 1.41E-08 |
GO:0030098 | BP | lymphocyte differentiation | 1.42E-08 |
GO:0043367 | BP | CD4-positive, alpha-beta T cell differentiation | 1.57E-08 |
GO:0050907 | BP | detection of chemical stimulus involved in sensory perception | 2.10E-08 |
GO:0071219 | BP | cellular response to molecule of bacterial origin | 2.27E-08 |
GO:0045637 | BP | regulation of myeloid cell differentiation | 3.17E-08 |
GO:0002696 | BP | positive regulation of leukocyte activation | 3.49E-08 |
GO:0046635 | BP | positive regulation of alpha-beta T cell activation | 4.02E-08 |
GO:0050867 | BP | positive regulation of cell activation | 4.26E-08 |
GO:0000280 | BP | nuclear division | 6.03E-08 |
GO:0002703 | BP | regulation of leukocyte mediated immunity | 6.22E-08 |
GO:0007088 | BP | regulation of mitotic nuclear division | 6.34E-08 |
GO:0071222 | BP | cellular response to lipopolysaccharide | 6.69E-08 |
GO:0002768 | BP | immune response-regulating cell surface receptor signaling pathway | 7.04E-08 |
GO:0070661 | BP | leukocyte proliferation | 1.09E-07 |
GO:0061644 | BP | protein localization to CENP-A containing chromatin | 1.51E-07 |
GO:0035710 | BP | CD4-positive, alpha-beta T cell activation | 1.57E-07 |
GO:0002285 | BP | lymphocyte activation involved in immune response | 1.97E-07 |
GO:1903039 | BP | positive regulation of leukocyte cell-cell adhesion | 2.31E-07 |
GO:0045088 | BP | regulation of innate immune response | 2.35E-07 |
GO:2000516 | BP | positive regulation of CD4-positive, alpha-beta T cell activation | 2.40E-07 |
GO:0043370 | BP | regulation of CD4-positive, alpha-beta T cell differentiation | 3.05E-07 |
GO:0046634 | BP | regulation of alpha-beta T cell activation | 3.20E-07 |
GO:0001819 | BP | positive regulation of cytokine production | 3.40E-07 |
GO:0000070 | BP | mitotic sister chromatid segregation | 3.47E-07 |
GO:0045785 | BP | positive regulation of cell adhesion | 3.55E-07 |
GO:1902105 | BP | regulation of leukocyte differentiation | 4.00E-07 |
GO:0051783 | BP | regulation of nuclear division | 4.14E-07 |
GO:0006334 | BP | nucleosome assembly | 4.51E-07 |
GO:0032943 | BP | mononuclear cell proliferation | 6.05E-07 |
GO:0050863 | BP | regulation of T cell activation | 6.13E-07 |
GO:0046651 | BP | lymphocyte proliferation | 6.62E-07 |
GO:0032946 | BP | positive regulation of mononuclear cell proliferation | 6.65E-07 |
GO:0002699 | BP | positive regulation of immune effector process | 6.96E-07 |
GO:0051251 | BP | positive regulation of lymphocyte activation | 7.08E-07 |
GO:0070663 | BP | regulation of leukocyte proliferation | 7.54E-07 |
GO:0002819 | BP | regulation of adaptive immune response | 7.61E-07 |
GO:2000514 | BP | regulation of CD4-positive, alpha-beta T cell activation | 7.91E-07 |
GO:0050911 | BP | detection of chemical stimulus involved in sensory perception of smell | 7.95E-07 |
GO:0042102 | BP | positive regulation of T cell proliferation | 8.49E-07 |
GO:0050870 | BP | positive regulation of T cell activation | 8.68E-07 |
GO:0032944 | BP | regulation of mononuclear cell proliferation | 8.84E-07 |
GO:0042093 | BP | T-helper cell differentiation | 8.85E-07 |
GO:0046637 | BP | regulation of alpha-beta T cell differentiation | 8.85E-07 |
GO:0022409 | BP | positive regulation of cell-cell adhesion | 1.10E-06 |
GO:0045089 | BP | positive regulation of innate immune response | 1.15E-06 |
GO:0050671 | BP | positive regulation of lymphocyte proliferation | 1.18E-06 |
GO:0002757 | BP | immune response-activating signaling pathway | 1.37E-06 |
GO:0002287 | BP | alpha-beta T cell activation involved in immune response | 1.44E-06 |
GO:0002293 | BP | alpha-beta T cell differentiation involved in immune response | 1.44E-06 |
GO:0007159 | BP | leukocyte cell-cell adhesion | 1.47E-06 |
GO:0042116 | BP | macrophage activation | 1.68E-06 |
GO:0002429 | BP | immune response-activating cell surface receptor signaling pathway | 1.73E-06 |
GO:0002833 | BP | positive regulation of response to biotic stimulus | 1.89E-06 |
GO:0019722 | BP | calcium-mediated signaling | 2.01E-06 |
GO:0002286 | BP | T cell activation involved in immune response | 2.07E-06 |
GO:0032623 | BP | interleukin-2 production | 2.08E-06 |
GO:0032663 | BP | regulation of interleukin-2 production | 2.08E-06 |
GO:0051784 | BP | negative regulation of nuclear division | 2.08E-06 |
GO:0050670 | BP | regulation of lymphocyte proliferation | 2.10E-06 |
GO:0002822 | BP | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 2.48E-06 |
GO:0002294 | BP | CD4-positive, alpha-beta T cell differentiation involved in immune response | 2.59E-06 |
GO:0007608 | BP | sensory perception of smell | 3.07E-06 |
GO:0002292 | BP | T cell differentiation involved in immune response | 3.15E-06 |
GO:0042113 | BP | B cell activation | 3.37E-06 |
GO:0032743 | BP | positive regulation of interleukin-2 production | 3.43E-06 |
GO:0043372 | BP | positive regulation of CD4-positive, alpha-beta T cell differentiation | 3.80E-06 |
GO:0071459 | BP | protein localization to chromosome, centromeric region | 4.35E-06 |
GO:0046638 | BP | positive regulation of alpha-beta T cell differentiation | 4.53E-06 |
GO:0006968 | BP | cellular defense response | 4.63E-06 |
GO:1903037 | BP | regulation of leukocyte cell-cell adhesion | 4.68E-06 |
GO:0001774 | BP | microglial cell activation | 4.73E-06 |
GO:0045638 | BP | negative regulation of myeloid cell differentiation | 4.97E-06 |
GO:0070665 | BP | positive regulation of leukocyte proliferation | 5.73E-06 |
GO:0048285 | BP | organelle fission | 5.76E-06 |
GO:0002705 | BP | positive regulation of leukocyte mediated immunity | 5.89E-06 |
GO:0022407 | BP | regulation of cell-cell adhesion | 6.18E-06 |
GO:0042098 | BP | T cell proliferation | 7.89E-06 |
GO:0046641 | BP | positive regulation of alpha-beta T cell proliferation | 8.72E-06 |
GO:0006911 | BP | phagocytosis, engulfment | 9.15E-06 |
GO:0045622 | BP | regulation of T-helper cell differentiation | 9.36E-06 |
GO:0034728 | BP | nucleosome organization | 1.14E-05 |
GO:0050000 | BP | chromosome localization | 1.37E-05 |
GO:0045839 | BP | negative regulation of mitotic nuclear division | 1.49E-05 |
GO:0002295 | BP | T-helper cell lineage commitment | 1.57E-05 |
GO:0051310 | BP | metaphase chromosome alignment | 1.69E-05 |
GO:1902107 | BP | positive regulation of leukocyte differentiation | 2.05E-05 |
GO:1903708 | BP | positive regulation of hemopoiesis | 2.05E-05 |
GO:0051303 | BP | establishment of chromosome localization | 2.11E-05 |
GO:0007188 | BP | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 2.14E-05 |
GO:0048872 | BP | homeostasis of number of cells | 2.32E-05 |
GO:0045619 | BP | regulation of lymphocyte differentiation | 2.41E-05 |
GO:0042129 | BP | regulation of T cell proliferation | 2.45E-05 |
GO:0065004 | BP | protein-DNA complex assembly | 2.62E-05 |
GO:0000075 | BP | cell cycle checkpoint signaling | 2.66E-05 |
GO:0002218 | BP | activation of innate immune response | 2.95E-05 |
GO:0007059 | BP | chromosome segregation | 2.97E-05 |
GO:0002269 | BP | leukocyte activation involved in inflammatory response | 3.08E-05 |
GO:0002825 | BP | regulation of T-helper 1 type immune response | 3.38E-05 |
GO:0045787 | BP | positive regulation of cell cycle | 3.66E-05 |
GO:0070670 | BP | response to interleukin-4 | 3.71E-05 |
GO:0050864 | BP | regulation of B cell activation | 3.76E-05 |
GO:0034341 | BP | response to type II interferon | 3.98E-05 |
GO:0001659 | BP | temperature homeostasis | 4.14E-05 |
GO:1902850 | BP | microtubule cytoskeleton organization involved in mitosis | 4.55E-05 |
GO:0045639 | BP | positive regulation of myeloid cell differentiation | 4.62E-05 |
GO:0032609 | BP | type II interferon production | 4.74E-05 |
GO:0032649 | BP | regulation of type II interferon production | 4.74E-05 |
GO:0042330 | BP | taxis | 5.19E-05 |
GO:0045624 | BP | positive regulation of T-helper cell differentiation | 5.50E-05 |
GO:0050900 | BP | leukocyte migration | 5.68E-05 |
GO:0033046 | BP | negative regulation of sister chromatid segregation | 6.04E-05 |
GO:0033048 | BP | negative regulation of mitotic sister chromatid segregation | 6.04E-05 |
GO:0045841 | BP | negative regulation of mitotic metaphase/anaphase transition | 6.04E-05 |
GO:2000816 | BP | negative regulation of mitotic sister chromatid separation | 6.04E-05 |
GO:1905818 | BP | regulation of chromosome separation | 6.14E-05 |
GO:0000819 | BP | sister chromatid segregation | 6.26E-05 |
GO:0072540 | BP | T-helper 17 cell lineage commitment | 6.64E-05 |
GO:0045786 | BP | negative regulation of cell cycle | 6.96E-05 |
GO:0006909 | BP | phagocytosis | 7.02E-05 |
GO:0002275 | BP | myeloid cell activation involved in immune response | 7.11E-05 |
GO:0070884 | BP | regulation of calcineurin-NFAT signaling cascade | 7.14E-05 |
GO:0010965 | BP | regulation of mitotic sister chromatid separation | 7.24E-05 |
GO:0071353 | BP | cellular response to interleukin-4 | 7.41E-05 |
GO:0002886 | BP | regulation of myeloid leukocyte mediated immunity | 7.84E-05 |
GO:0061900 | BP | glial cell activation | 7.84E-05 |
GO:0035967 | BP | cellular response to topologically incorrect protein | 8.14E-05 |
GO:0030218 | BP | erythrocyte differentiation | 8.36E-05 |
GO:0006935 | BP | chemotaxis | 8.38E-05 |
GO:0035914 | BP | skeletal muscle cell differentiation | 8.46E-05 |
GO:0002706 | BP | regulation of lymphocyte mediated immunity | 8.76E-05 |
GO:2001251 | BP | negative regulation of chromosome organization | 8.81E-05 |
GO:0098813 | BP | nuclear chromosome segregation | 9.76E-05 |
GO:0032602 | BP | chemokine production | 0.00010251 |
GO:0002262 | BP | myeloid cell homeostasis | 0.000106584 |
GO:0140694 | BP | non-membrane-bounded organelle assembly | 0.000108394 |
GO:0072538 | BP | T-helper 17 type immune response | 0.000111713 |
GO:0050729 | BP | positive regulation of inflammatory response | 0.000116388 |
GO:0071168 | BP | protein localization to chromatin | 0.000116756 |
GO:0033173 | BP | calcineurin-NFAT signaling cascade | 0.000118595 |
GO:0044786 | BP | cell cycle DNA replication | 0.000118595 |
GO:0043368 | BP | positive T cell selection | 0.000125282 |
GO:0106056 | BP | regulation of calcineurin-mediated signaling | 0.000131597 |
GO:0045058 | BP | T cell selection | 0.000138546 |
GO:0045580 | BP | regulation of T cell differentiation | 0.000138678 |
GO:0034101 | BP | erythrocyte homeostasis | 0.000139142 |
GO:0061614 | BP | miRNA transcription | 0.00014012 |
GO:0051347 | BP | positive regulation of transferase activity | 0.00014627 |
GO:0032642 | BP | regulation of chemokine production | 0.000159237 |
GO:0050731 | BP | positive regulation of peptidyl-tyrosine phosphorylation | 0.000161443 |
GO:0035966 | BP | response to topologically incorrect protein | 0.000169206 |
GO:0032722 | BP | positive regulation of chemokine production | 0.00017194 |
GO:0050766 | BP | positive regulation of phagocytosis | 0.00017194 |
GO:0002526 | BP | acute inflammatory response | 0.000175263 |
GO:0051985 | BP | negative regulation of chromosome segregation | 0.000176304 |
GO:1902100 | BP | negative regulation of metaphase/anaphase transition of cell cycle | 0.000176304 |
GO:1905819 | BP | negative regulation of chromosome separation | 0.000176304 |
GO:0002698 | BP | negative regulation of immune effector process | 0.000183441 |
GO:0043299 | BP | leukocyte degranulation | 0.000185932 |
GO:0042088 | BP | T-helper 1 type immune response | 0.000190047 |
GO:0097720 | BP | calcineurin-mediated signaling | 0.000190047 |
GO:0002700 | BP | regulation of production of molecular mediator of immune response | 0.000197964 |
GO:0007093 | BP | mitotic cell cycle checkpoint signaling | 0.000203513 |
GO:0002830 | BP | positive regulation of type 2 immune response | 0.000203993 |
GO:0045064 | BP | T-helper 2 cell differentiation | 0.000203993 |
GO:0150078 | BP | positive regulation of neuroinflammatory response | 0.000203993 |
GO:2000318 | BP | positive regulation of T-helper 17 type immune response | 0.000203993 |
GO:0007094 | BP | mitotic spindle assembly checkpoint signaling | 0.000204201 |
GO:0071173 | BP | spindle assembly checkpoint signaling | 0.000204201 |
GO:0071174 | BP | mitotic spindle checkpoint signaling | 0.000204201 |
GO:0045582 | BP | positive regulation of T cell differentiation | 0.000205293 |
GO:0032729 | BP | positive regulation of type II interferon production | 0.000206687 |
GO:0007052 | BP | mitotic spindle organization | 0.000207234 |
GO:0002444 | BP | myeloid leukocyte mediated immunity | 0.000213348 |
GO:0034502 | BP | protein localization to chromosome | 0.000219066 |
GO:0090068 | BP | positive regulation of cell cycle process | 0.000226684 |
GO:1902893 | BP | regulation of miRNA transcription | 0.000229697 |
GO:0045653 | BP | negative regulation of megakaryocyte differentiation | 0.000239104 |
GO:0002702 | BP | positive regulation of production of molecular mediator of immune response | 0.000243757 |
GO:0001909 | BP | leukocyte mediated cytotoxicity | 0.000264404 |
GO:0050850 | BP | positive regulation of calcium-mediated signaling | 0.000264417 |
GO:0001906 | BP | cell killing | 0.000273499 |
GO:0043373 | BP | CD4-positive, alpha-beta T cell lineage commitment | 0.000283601 |
GO:0051306 | BP | mitotic sister chromatid separation | 0.000283967 |
GO:0062012 | BP | regulation of small molecule metabolic process | 0.00028524 |
GO:1903557 | BP | positive regulation of tumor necrosis factor superfamily cytokine production | 0.000287897 |
GO:0002824 | BP | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 0.000290475 |
GO:0002573 | BP | myeloid leukocyte differentiation | 0.000294068 |
GO:0097529 | BP | myeloid leukocyte migration | 0.000294068 |
GO:0050727 | BP | regulation of inflammatory response | 0.000295005 |
GO:1901798 | BP | positive regulation of signal transduction by p53 class mediator | 0.000297422 |
GO:0032200 | BP | telomere organization | 0.000309531 |
GO:0044839 | BP | cell cycle G2/M phase transition | 0.00031391 |
GO:0006953 | BP | acute-phase response | 0.000340499 |
GO:0031577 | BP | spindle checkpoint signaling | 0.000340499 |
GO:0099024 | BP | plasma membrane invagination | 0.000345233 |
GO:0002695 | BP | negative regulation of leukocyte activation | 0.000345469 |
GO:0007051 | BP | spindle organization | 0.000345555 |
GO:0045621 | BP | positive regulation of lymphocyte differentiation | 0.000356416 |
GO:0032760 | BP | positive regulation of tumor necrosis factor production | 0.000360874 |
GO:0007200 | BP | phospholipase C-activating G protein-coupled receptor signaling pathway | 0.000374825 |
GO:0050866 | BP | negative regulation of cell activation | 0.000376973 |
GO:0007187 | BP | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 0.000380087 |
GO:1902895 | BP | positive regulation of miRNA transcription | 0.000380087 |
GO:0001732 | BP | formation of cytoplasmic translation initiation complex | 0.000384873 |
GO:0002720 | BP | positive regulation of cytokine production involved in immune response | 0.00038531 |
GO:0051304 | BP | chromosome separation | 0.00038531 |
GO:0002821 | BP | positive regulation of adaptive immune response | 0.000398771 |
GO:1903046 | BP | meiotic cell cycle process | 0.000414554 |
GO:0033047 | BP | regulation of mitotic sister chromatid segregation | 0.000417976 |
GO:0050851 | BP | antigen receptor-mediated signaling pathway | 0.000421716 |
GO:0033260 | BP | nuclear DNA replication | 0.000427779 |
GO:0036297 | BP | interstrand cross-link repair | 0.000427779 |
GO:0045066 | BP | regulatory T cell differentiation | 0.000427779 |
GO:0002228 | BP | natural killer cell mediated immunity | 0.000430217 |
GO:0045859 | BP | regulation of protein kinase activity | 0.000434552 |
GO:0031341 | BP | regulation of cell killing | 0.000482989 |
GO:0032633 | BP | interleukin-4 production | 0.000517351 |
GO:0032673 | BP | regulation of interleukin-4 production | 0.000517351 |
GO:0007204 | BP | positive regulation of cytosolic calcium ion concentration | 0.000525565 |
GO:0001910 | BP | regulation of leukocyte mediated cytotoxicity | 0.000526254 |
GO:1903978 | BP | regulation of microglial cell activation | 0.000529546 |
GO:0071346 | BP | cellular response to type II interferon | 0.000536145 |
GO:0002443 | BP | leukocyte mediated immunity | 0.000537489 |
GO:0002888 | BP | positive regulation of myeloid leukocyte mediated immunity | 0.000570831 |
GO:0006268 | BP | DNA unwinding involved in DNA replication | 0.000570831 |
GO:0070886 | BP | positive regulation of calcineurin-NFAT signaling cascade | 0.000570831 |
GO:0106058 | BP | positive regulation of calcineurin-mediated signaling | 0.000570831 |
GO:0002520 | BP | immune system development | 0.000581793 |
GO:0031663 | BP | lipopolysaccharide-mediated signaling pathway | 0.000583417 |
GO:0072331 | BP | signal transduction by p53 class mediator | 0.000589526 |
GO:0032753 | BP | positive regulation of interleukin-4 production | 0.000599758 |
GO:0045646 | BP | regulation of erythrocyte differentiation | 0.000602236 |
GO:0002708 | BP | positive regulation of lymphocyte mediated immunity | 0.000647494 |
GO:0018108 | BP | peptidyl-tyrosine phosphorylation | 0.000659625 |
GO:0007492 | BP | endoderm development | 0.000675859 |
GO:0000079 | BP | regulation of cyclin-dependent protein serine/threonine kinase activity | 0.000679797 |
GO:0045628 | BP | regulation of T-helper 2 cell differentiation | 0.000703546 |
GO:0033674 | BP | positive regulation of kinase activity | 0.000705522 |
GO:0010948 | BP | negative regulation of cell cycle process | 0.000707288 |
GO:0002715 | BP | regulation of natural killer cell mediated immunity | 0.000712904 |
GO:0042119 | BP | neutrophil activation | 0.000714186 |
GO:0071900 | BP | regulation of protein serine/threonine kinase activity | 0.000726851 |
GO:2000628 | BP | regulation of miRNA metabolic process | 0.000739631 |
GO:0002224 | BP | toll-like receptor signaling pathway | 0.000760337 |
GO:0150077 | BP | regulation of neuroinflammatory response | 0.000774512 |
GO:0050852 | BP | T cell receptor signaling pathway | 0.000790328 |
GO:0060326 | BP | cell chemotaxis | 0.000798546 |
GO:0002758 | BP | innate immune response-activating signaling pathway | 0.000813942 |
GO:0030595 | BP | leukocyte chemotaxis | 0.000836146 |
GO:1904029 | BP | regulation of cyclin-dependent protein kinase activity | 0.000847436 |
GO:0050764 | BP | regulation of phagocytosis | 0.000852437 |
GO:0031570 | BP | DNA integrity checkpoint signaling | 0.000853346 |
GO:0036230 | BP | granulocyte activation | 0.000867723 |
GO:0002687 | BP | positive regulation of leukocyte migration | 0.000892165 |
GO:0070098 | BP | chemokine-mediated signaling pathway | 0.000895031 |
GO:0045589 | BP | regulation of regulatory T cell differentiation | 0.000901132 |
GO:0002367 | BP | cytokine production involved in immune response | 0.000907025 |
GO:0001833 | BP | inner cell mass cell proliferation | 0.000907706 |
GO:0018212 | BP | peptidyl-tyrosine modification | 0.000920513 |
GO:0010324 | BP | membrane invagination | 0.000929295 |
GO:0002360 | BP | T cell lineage commitment | 0.000965504 |
GO:0002828 | BP | regulation of type 2 immune response | 0.000965504 |
GO:0046320 | BP | regulation of fatty acid oxidation | 0.000965504 |
GO:0106106 | BP | cold-induced thermogenesis | 0.001002602 |
GO:2000316 | BP | regulation of T-helper 17 type immune response | 0.001028647 |
GO:1905897 | BP | regulation of response to endoplasmic reticulum stress | 0.001040754 |
GO:0030261 | BP | chromosome condensation | 0.001050812 |
GO:0043300 | BP | regulation of leukocyte degranulation | 0.001050812 |
GO:0003188 | BP | heart valve formation | 0.001056801 |
GO:0038093 | BP | Fc receptor signaling pathway | 0.001081563 |
GO:0038094 | BP | Fc-gamma receptor signaling pathway | 0.001088456 |
GO:1990868 | BP | response to chemokine | 0.001131537 |
GO:1990869 | BP | cellular response to chemokine | 0.001131537 |
GO:0046640 | BP | regulation of alpha-beta T cell proliferation | 0.001153609 |
GO:0045860 | BP | positive regulation of protein kinase activity | 0.001177659 |
GO:0002363 | BP | alpha-beta T cell lineage commitment | 0.001186091 |
GO:0050926 | BP | regulation of positive chemotaxis | 0.001186091 |
GO:0060333 | BP | type II interferon-mediated signaling pathway | 0.001186091 |
GO:0002761 | BP | regulation of myeloid leukocyte differentiation | 0.001191987 |
GO:0008608 | BP | attachment of spindle microtubules to kinetochore | 0.001200394 |
GO:0050848 | BP | regulation of calcium-mediated signaling | 0.001200655 |
GO:0097150 | BP | neuronal stem cell population maintenance | 0.001215658 |
GO:0007517 | BP | muscle organ development | 0.001221464 |
GO:0002312 | BP | B cell activation involved in immune response | 0.001261149 |
GO:1902749 | BP | regulation of cell cycle G2/M phase transition | 0.001271569 |
GO:0006949 | BP | syncytium formation | 0.001331664 |
GO:0120161 | BP | regulation of cold-induced thermogenesis | 0.001393075 |
GO:0140747 | BP | regulation of ncRNA transcription | 0.001421917 |
GO:0090329 | BP | regulation of DNA-templated DNA replication | 0.001475589 |
GO:0002685 | BP | regulation of leukocyte migration | 0.001478022 |
GO:0007095 | BP | mitotic G2 DNA damage checkpoint signaling | 0.001506729 |
GO:0034620 | BP | cellular response to unfolded protein | 0.001509858 |
GO:1990845 | BP | adaptive thermogenesis | 0.001524116 |
GO:0061982 | BP | meiosis I cell cycle process | 0.001542841 |
GO:0030316 | BP | osteoclast differentiation | 0.001545203 |
GO:0043410 | BP | positive regulation of MAPK cascade | 0.001545903 |
GO:0140013 | BP | meiotic nuclear division | 0.00155643 |
GO:0046633 | BP | alpha-beta T cell proliferation | 0.001633962 |
GO:0042267 | BP | natural killer cell mediated cytotoxicity | 0.001644554 |
GO:0002763 | BP | positive regulation of myeloid leukocyte differentiation | 0.001666628 |
GO:0002887 | BP | negative regulation of myeloid leukocyte mediated immunity | 0.001726631 |
GO:0034154 | BP | toll-like receptor 7 signaling pathway | 0.001726631 |
GO:0045835 | BP | negative regulation of meiotic nuclear division | 0.001726631 |
GO:0051256 | BP | mitotic spindle midzone assembly | 0.001726631 |
GO:1904238 | BP | pericyte cell differentiation | 0.001726631 |
GO:0072539 | BP | T-helper 17 cell differentiation | 0.001773491 |
GO:0043010 | BP | camera-type eye development | 0.001790547 |
GO:0045840 | BP | positive regulation of mitotic nuclear division | 0.001807503 |
GO:0051321 | BP | meiotic cell cycle | 0.001827625 |
GO:0098739 | BP | import across plasma membrane | 0.001831627 |
GO:0002718 | BP | regulation of cytokine production involved in immune response | 0.001862717 |
GO:0001706 | BP | endoderm formation | 0.001864528 |
GO:0043030 | BP | regulation of macrophage activation | 0.001864528 |
GO:2000630 | BP | positive regulation of miRNA metabolic process | 0.001877426 |
GO:0002065 | BP | columnar/cuboidal epithelial cell differentiation | 0.001889403 |
GO:0006261 | BP | DNA-templated DNA replication | 0.001899123 |
GO:1901988 | BP | negative regulation of cell cycle phase transition | 0.001903045 |
GO:0042770 | BP | signal transduction in response to DNA damage | 0.001943117 |
GO:0042092 | BP | type 2 immune response | 0.001997124 |
GO:0050912 | BP | detection of chemical stimulus involved in sensory perception of taste | 0.001997124 |
GO:0010586 | BP | miRNA metabolic process | 0.00199785 |
GO:0045165 | BP | cell fate commitment | 0.002000971 |
GO:0006310 | BP | DNA recombination | 0.002025219 |
GO:0001696 | BP | gastric acid secretion | 0.002106251 |
GO:0009812 | BP | flavonoid metabolic process | 0.002106251 |
GO:0043301 | BP | negative regulation of leukocyte degranulation | 0.002106251 |
GO:0060100 | BP | positive regulation of phagocytosis, engulfment | 0.002106251 |
GO:0060732 | BP | positive regulation of inositol phosphate biosynthetic process | 0.002106251 |
GO:1905155 | BP | positive regulation of membrane invagination | 0.002106251 |
GO:0001838 | BP | embryonic epithelial tube formation | 0.002111292 |
GO:0007189 | BP | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 0.002111436 |
GO:0006986 | BP | response to unfolded protein | 0.002148312 |
GO:0042269 | BP | regulation of natural killer cell mediated cytotoxicity | 0.002221606 |
GO:0045930 | BP | negative regulation of mitotic cell cycle | 0.002226882 |
GO:0010878 | BP | cholesterol storage | 0.002304946 |
GO:0050927 | BP | positive regulation of positive chemotaxis | 0.002304946 |
GO:0090280 | BP | positive regulation of calcium ion import | 0.002304946 |
GO:0045055 | BP | regulated exocytosis | 0.002342211 |
GO:0050730 | BP | regulation of peptidyl-tyrosine phosphorylation | 0.002342211 |
GO:0010919 | BP | regulation of inositol phosphate biosynthetic process | 0.002345496 |
GO:0044771 | BP | meiotic cell cycle phase transition | 0.002345496 |
GO:0060099 | BP | regulation of phagocytosis, engulfment | 0.002345496 |
GO:1905153 | BP | regulation of membrane invagination | 0.002345496 |
GO:0072593 | BP | reactive oxygen species metabolic process | 0.002365036 |
GO:0007260 | BP | tyrosine phosphorylation of STAT protein | 0.00239294 |
GO:0060562 | BP | epithelial tube morphogenesis | 0.002404167 |
GO:0060143 | BP | positive regulation of syncytium formation by plasma membrane fusion | 0.002407741 |
GO:0045652 | BP | regulation of megakaryocyte differentiation | 0.002427481 |
GO:0009914 | BP | hormone transport | 0.002467793 |
GO:1902969 | BP | mitotic DNA replication | 0.002470159 |
GO:0051383 | BP | kinetochore organization | 0.002480068 |
GO:2001135 | BP | regulation of endocytic recycling | 0.002480068 |
GO:0002281 | BP | macrophage activation involved in immune response | 0.002507194 |
GO:0007076 | BP | mitotic chromosome condensation | 0.002507194 |
GO:0010885 | BP | regulation of cholesterol storage | 0.002507194 |
GO:0051447 | BP | negative regulation of meiotic cell cycle | 0.002507194 |
GO:0002637 | BP | regulation of immunoglobulin production | 0.002516113 |
GO:0045123 | BP | cellular extravasation | 0.002516113 |
GO:0002704 | BP | negative regulation of leukocyte mediated immunity | 0.002606106 |
GO:0050854 | BP | regulation of antigen receptor-mediated signaling pathway | 0.002606106 |
GO:0001580 | BP | detection of chemical stimulus involved in sensory perception of bitter taste | 0.002668973 |
GO:0006260 | BP | DNA replication | 0.002715069 |
GO:0009266 | BP | response to temperature stimulus | 0.002737994 |
GO:0008630 | BP | intrinsic apoptotic signaling pathway in response to DNA damage | 0.002806979 |
GO:0045926 | BP | negative regulation of growth | 0.00285824 |
GO:0042531 | BP | positive regulation of tyrosine phosphorylation of STAT protein | 0.002925509 |
GO:1901224 | BP | positive regulation of non-canonical NF-kappaB signal transduction | 0.002925509 |
GO:0002717 | BP | positive regulation of natural killer cell mediated immunity | 0.002927758 |
GO:0001824 | BP | blastocyst development | 0.002946709 |
GO:0022626 | CC | cytosolic ribosome | 3.76E-16 |
GO:0022625 | CC | cytosolic large ribosomal subunit | 3.69E-12 |
GO:0009897 | CC | external side of plasma membrane | 8.63E-10 |
GO:0000775 | CC | chromosome, centromeric region | 1.33E-08 |
GO:0043505 | CC | CENP-A containing nucleosome | 1.56E-07 |
GO:0061638 | CC | CENP-A containing chromatin | 1.56E-07 |
GO:0000786 | CC | nucleosome | 3.46E-07 |
GO:0000940 | CC | outer kinetochore | 3.82E-07 |
GO:0022627 | CC | cytosolic small ribosomal subunit | 5.33E-07 |
GO:0098687 | CC | chromosomal region | 7.13E-07 |
GO:0034506 | CC | chromosome, centromeric core domain | 1.00E-06 |
GO:0005925 | CC | focal adhesion | 4.03E-06 |
GO:0070821 | CC | tertiary granule membrane | 5.27E-06 |
GO:0045121 | CC | membrane raft | 7.59E-06 |
GO:0098857 | CC | membrane microdomain | 9.45E-06 |
GO:0030055 | CC | cell-substrate junction | 9.70E-06 |
GO:0044391 | CC | ribosomal subunit | 2.60E-05 |
GO:0000779 | CC | condensed chromosome, centromeric region | 5.02E-05 |
GO:0000793 | CC | condensed chromosome | 6.14E-05 |
GO:0000776 | CC | kinetochore | 0.000226898 |
GO:0005819 | CC | spindle | 0.00023311 |
GO:0001891 | CC | phagocytic cup | 0.000307022 |
GO:0001772 | CC | immunological synapse | 0.000381904 |
GO:0000792 | CC | heterochromatin | 0.000404032 |
GO:0005840 | CC | ribosome | 0.000451683 |
GO:0070820 | CC | tertiary granule | 0.000557287 |
GO:0015934 | CC | large ribosomal subunit | 0.000634492 |
GO:0062023 | CC | collagen-containing extracellular matrix | 0.001000258 |
GO:0005852 | CC | eukaryotic translation initiation factor 3 complex | 0.001077592 |
GO:0044853 | CC | plasma membrane raft | 0.001157972 |
GO:0016282 | CC | eukaryotic 43S preinitiation complex | 0.001177979 |
GO:0071162 | CC | CMG complex | 0.001753598 |
GO:0000922 | CC | spindle pole | 0.00176296 |
GO:0005581 | CC | collagen trimer | 0.001982914 |
GO:0030527 | MF | structural constituent of chromatin | 3.22E-12 |
GO:0140375 | MF | immune receptor activity | 6.25E-07 |
GO:0046982 | MF | protein heterodimerization activity | 7.46E-07 |
GO:0001216 | MF | DNA-binding transcription activator activity | 1.63E-06 |
GO:0001228 | MF | DNA-binding transcription activator activity, RNA polymerase II-specific | 3.32E-06 |
GO:0004984 | MF | olfactory receptor activity | 8.59E-06 |
GO:0033691 | MF | sialic acid binding | 1.07E-05 |
GO:0033549 | MF | MAP kinase phosphatase activity | 4.12E-05 |
GO:0001217 | MF | DNA-binding transcription repressor activity | 5.81E-05 |
GO:0003735 | MF | structural constituent of ribosome | 8.35E-05 |
GO:0035259 | MF | nuclear glucocorticoid receptor binding | 8.76E-05 |
GO:0035591 | MF | signaling adaptor activity | 0.000261743 |
GO:0017017 | MF | MAP kinase tyrosine/serine/threonine phosphatase activity | 0.000385458 |
GO:0097110 | MF | scaffold protein binding | 0.000391931 |
GO:0019957 | MF | C-C chemokine binding | 0.000431432 |
GO:0001227 | MF | DNA-binding transcription repressor activity, RNA polymerase II-specific | 0.000467381 |
GO:0008017 | MF | microtubule binding | 0.00047043 |
GO:0004896 | MF | cytokine receptor activity | 0.000567248 |
GO:0008330 | MF | protein tyrosine/threonine phosphatase activity | 0.000589334 |
GO:0033550 | MF | MAP kinase tyrosine phosphatase activity | 0.000589334 |
go_enrichment_non_tnbc_vs_normal (5).csv
ID | ONTOLOGY | Description | pvalue |
---|---|---|---|
GO:0002181 | BP | cytoplasmic translation | 2.58E-16 |
GO:0002366 | BP | leukocyte activation involved in immune response | 3.21E-11 |
GO:0002263 | BP | cell activation involved in immune response | 5.25E-11 |
GO:0002274 | BP | myeloid leukocyte activation | 8.42E-11 |
GO:0002697 | BP | regulation of immune effector process | 8.77E-10 |
GO:0046631 | BP | alpha-beta T cell activation | 8.90E-10 |
GO:1903706 | BP | regulation of hemopoiesis | 1.88E-09 |
GO:1903131 | BP | mononuclear cell differentiation | 2.01E-09 |
GO:0001819 | BP | positive regulation of cytokine production | 2.15E-09 |
GO:0030099 | BP | myeloid cell differentiation | 3.03E-09 |
GO:0050867 | BP | positive regulation of cell activation | 3.23E-09 |
GO:0002699 | BP | positive regulation of immune effector process | 3.42E-09 |
GO:0002825 | BP | regulation of T-helper 1 type immune response | 4.39E-09 |
GO:0002696 | BP | positive regulation of leukocyte activation | 5.93E-09 |
GO:0002822 | BP | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 9.33E-09 |
GO:0035710 | BP | CD4-positive, alpha-beta T cell activation | 1.04E-08 |
GO:0002819 | BP | regulation of adaptive immune response | 1.13E-08 |
GO:0002685 | BP | regulation of leukocyte migration | 1.59E-08 |
GO:0045637 | BP | regulation of myeloid cell differentiation | 1.71E-08 |
GO:0006334 | BP | nucleosome assembly | 3.36E-08 |
GO:0046632 | BP | alpha-beta T cell differentiation | 3.60E-08 |
GO:0045785 | BP | positive regulation of cell adhesion | 3.79E-08 |
GO:0002703 | BP | regulation of leukocyte mediated immunity | 4.71E-08 |
GO:0042088 | BP | T-helper 1 type immune response | 4.89E-08 |
GO:0035148 | BP | tube formation | 4.94E-08 |
GO:0061644 | BP | protein localization to CENP-A containing chromatin | 5.53E-08 |
GO:1902893 | BP | regulation of miRNA transcription | 6.15E-08 |
GO:0030098 | BP | lymphocyte differentiation | 6.16E-08 |
GO:0072331 | BP | signal transduction by p53 class mediator | 9.40E-08 |
GO:0061614 | BP | miRNA transcription | 1.11E-07 |
GO:0050900 | BP | leukocyte migration | 1.25E-07 |
GO:0070661 | BP | leukocyte proliferation | 1.34E-07 |
GO:0050731 | BP | positive regulation of peptidyl-tyrosine phosphorylation | 1.55E-07 |
GO:0034728 | BP | nucleosome organization | 1.66E-07 |
GO:1902894 | BP | negative regulation of miRNA transcription | 1.97E-07 |
GO:0030217 | BP | T cell differentiation | 2.10E-07 |
GO:0001838 | BP | embryonic epithelial tube formation | 2.89E-07 |
GO:0042770 | BP | signal transduction in response to DNA damage | 3.13E-07 |
GO:0072175 | BP | epithelial tube formation | 3.20E-07 |
GO:2000514 | BP | regulation of CD4-positive, alpha-beta T cell activation | 3.38E-07 |
GO:0022409 | BP | positive regulation of cell-cell adhesion | 3.40E-07 |
GO:0002444 | BP | myeloid leukocyte mediated immunity | 3.72E-07 |
GO:0051251 | BP | positive regulation of lymphocyte activation | 3.73E-07 |
GO:0030330 | BP | DNA damage response, signal transduction by p53 class mediator | 4.13E-07 |
GO:0043367 | BP | CD4-positive, alpha-beta T cell differentiation | 4.20E-07 |
GO:1903039 | BP | positive regulation of leukocyte cell-cell adhesion | 4.26E-07 |
GO:0070663 | BP | regulation of leukocyte proliferation | 4.49E-07 |
GO:2000628 | BP | regulation of miRNA metabolic process | 5.34E-07 |
GO:0002237 | BP | response to molecule of bacterial origin | 5.52E-07 |
GO:0140747 | BP | regulation of ncRNA transcription | 5.90E-07 |
GO:2000629 | BP | negative regulation of miRNA metabolic process | 6.37E-07 |
GO:0002824 | BP | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 6.38E-07 |
GO:1902105 | BP | regulation of leukocyte differentiation | 6.65E-07 |
GO:0002687 | BP | positive regulation of leukocyte migration | 6.80E-07 |
GO:0022407 | BP | regulation of cell-cell adhesion | 7.84E-07 |
GO:0045088 | BP | regulation of innate immune response | 8.32E-07 |
GO:0032496 | BP | response to lipopolysaccharide | 9.56E-07 |
GO:0042330 | BP | taxis | 1.04E-06 |
GO:0097191 | BP | extrinsic apoptotic signaling pathway | 1.15E-06 |
GO:0006935 | BP | chemotaxis | 1.17E-06 |
GO:0050730 | BP | regulation of peptidyl-tyrosine phosphorylation | 1.17E-06 |
GO:0046634 | BP | regulation of alpha-beta T cell activation | 1.27E-06 |
GO:0001732 | BP | formation of cytoplasmic translation initiation complex | 1.38E-06 |
GO:0002275 | BP | myeloid cell activation involved in immune response | 1.63E-06 |
GO:0045638 | BP | negative regulation of myeloid cell differentiation | 1.63E-06 |
GO:0002886 | BP | regulation of myeloid leukocyte mediated immunity | 1.63E-06 |
GO:0060562 | BP | epithelial tube morphogenesis | 1.70E-06 |
GO:0071216 | BP | cellular response to biotic stimulus | 1.80E-06 |
GO:0002285 | BP | lymphocyte activation involved in immune response | 2.08E-06 |
GO:0002705 | BP | positive regulation of leukocyte mediated immunity | 2.15E-06 |
GO:0030316 | BP | osteoclast differentiation | 2.19E-06 |
GO:0050671 | BP | positive regulation of lymphocyte proliferation | 2.37E-06 |
GO:0002821 | BP | positive regulation of adaptive immune response | 2.43E-06 |
GO:0046651 | BP | lymphocyte proliferation | 2.50E-06 |
GO:0140014 | BP | mitotic nuclear division | 2.64E-06 |
GO:0032946 | BP | positive regulation of mononuclear cell proliferation | 2.86E-06 |
GO:0042113 | BP | B cell activation | 3.31E-06 |
GO:0050670 | BP | regulation of lymphocyte proliferation | 3.55E-06 |
GO:0070665 | BP | positive regulation of leukocyte proliferation | 3.68E-06 |
GO:1904238 | BP | pericyte cell differentiation | 3.94E-06 |
GO:0001701 | BP | in utero embryonic development | 4.41E-06 |
GO:0016331 | BP | morphogenesis of embryonic epithelium | 4.70E-06 |
GO:0032944 | BP | regulation of mononuclear cell proliferation | 5.01E-06 |
GO:0071459 | BP | protein localization to chromosome, centromeric region | 5.20E-06 |
GO:0045089 | BP | positive regulation of innate immune response | 5.73E-06 |
GO:0002573 | BP | myeloid leukocyte differentiation | 5.74E-06 |
GO:0009612 | BP | response to mechanical stimulus | 5.85E-06 |
GO:0071674 | BP | mononuclear cell migration | 6.15E-06 |
GO:0032943 | BP | mononuclear cell proliferation | 6.19E-06 |
GO:0098781 | BP | ncRNA transcription | 6.25E-06 |
GO:0008625 | BP | extrinsic apoptotic signaling pathway via death domain receptors | 6.27E-06 |
GO:0032602 | BP | chemokine production | 6.30E-06 |
GO:0002702 | BP | positive regulation of production of molecular mediator of immune response | 6.72E-06 |
GO:0002833 | BP | positive regulation of response to biotic stimulus | 6.79E-06 |
GO:0042116 | BP | macrophage activation | 6.93E-06 |
GO:0046635 | BP | positive regulation of alpha-beta T cell activation | 7.49E-06 |
GO:0010586 | BP | miRNA metabolic process | 7.98E-06 |
GO:0002218 | BP | activation of innate immune response | 8.31E-06 |
GO:0048872 | BP | homeostasis of number of cells | 8.71E-06 |
GO:0097529 | BP | myeloid leukocyte migration | 1.05E-05 |
GO:0032642 | BP | regulation of chemokine production | 1.06E-05 |
GO:1903037 | BP | regulation of leukocyte cell-cell adhesion | 1.10E-05 |
GO:0002827 | BP | positive regulation of T-helper 1 type immune response | 1.18E-05 |
GO:0030595 | BP | leukocyte chemotaxis | 1.20E-05 |
GO:0018212 | BP | peptidyl-tyrosine modification | 1.23E-05 |
GO:0000075 | BP | cell cycle checkpoint signaling | 1.26E-05 |
GO:0043410 | BP | positive regulation of MAPK cascade | 1.27E-05 |
GO:0050870 | BP | positive regulation of T cell activation | 1.31E-05 |
GO:0032722 | BP | positive regulation of chemokine production | 1.35E-05 |
GO:0002286 | BP | T cell activation involved in immune response | 1.37E-05 |
GO:0018108 | BP | peptidyl-tyrosine phosphorylation | 1.40E-05 |
GO:0043299 | BP | leukocyte degranulation | 1.44E-05 |
GO:0070098 | BP | chemokine-mediated signaling pathway | 1.45E-05 |
GO:0060326 | BP | cell chemotaxis | 1.45E-05 |
GO:0007159 | BP | leukocyte cell-cell adhesion | 1.53E-05 |
GO:0060749 | BP | mammary gland alveolus development | 1.57E-05 |
GO:0061377 | BP | mammary gland lobule development | 1.57E-05 |
GO:0002520 | BP | immune system development | 1.59E-05 |
GO:0071356 | BP | cellular response to tumor necrosis factor | 1.64E-05 |
GO:0002262 | BP | myeloid cell homeostasis | 1.73E-05 |
GO:2000516 | BP | positive regulation of CD4-positive, alpha-beta T cell activation | 1.76E-05 |
GO:0000077 | BP | DNA damage checkpoint signaling | 1.90E-05 |
GO:2001233 | BP | regulation of apoptotic signaling pathway | 1.92E-05 |
GO:0050864 | BP | regulation of B cell activation | 1.96E-05 |
GO:1990868 | BP | response to chemokine | 2.03E-05 |
GO:1990869 | BP | cellular response to chemokine | 2.03E-05 |
GO:0050920 | BP | regulation of chemotaxis | 2.05E-05 |
GO:0045859 | BP | regulation of protein kinase activity | 2.08E-05 |
GO:0071260 | BP | cellular response to mechanical stimulus | 2.13E-05 |
GO:0045624 | BP | positive regulation of T-helper cell differentiation | 2.17E-05 |
GO:0045786 | BP | negative regulation of cell cycle | 2.22E-05 |
GO:0010720 | BP | positive regulation of cell development | 2.22E-05 |
GO:0071496 | BP | cellular response to external stimulus | 2.24E-05 |
GO:0097193 | BP | intrinsic apoptotic signaling pathway | 2.25E-05 |
GO:0050926 | BP | regulation of positive chemotaxis | 2.36E-05 |
GO:0048732 | BP | gland development | 2.38E-05 |
GO:0003158 | BP | endothelium development | 2.38E-05 |
GO:0045670 | BP | regulation of osteoclast differentiation | 2.42E-05 |
GO:0071219 | BP | cellular response to molecule of bacterial origin | 2.67E-05 |
GO:0045055 | BP | regulated exocytosis | 2.69E-05 |
GO:0001841 | BP | neural tube formation | 2.90E-05 |
GO:0045165 | BP | cell fate commitment | 3.25E-05 |
GO:0042093 | BP | T-helper cell differentiation | 3.29E-05 |
GO:1902107 | BP | positive regulation of leukocyte differentiation | 3.52E-05 |
GO:1903708 | BP | positive regulation of hemopoiesis | 3.52E-05 |
GO:0043370 | BP | regulation of CD4-positive, alpha-beta T cell differentiation | 3.57E-05 |
GO:1902895 | BP | positive regulation of miRNA transcription | 3.57E-05 |
GO:0050921 | BP | positive regulation of chemotaxis | 3.67E-05 |
GO:0006909 | BP | phagocytosis | 3.79E-05 |
GO:0032623 | BP | interleukin-2 production | 4.04E-05 |
GO:0032663 | BP | regulation of interleukin-2 production | 4.04E-05 |
GO:0048863 | BP | stem cell differentiation | 4.21E-05 |
GO:0002287 | BP | alpha-beta T cell activation involved in immune response | 4.37E-05 |
GO:0002293 | BP | alpha-beta T cell differentiation involved in immune response | 4.37E-05 |
GO:0002757 | BP | immune response-activating signaling pathway | 4.49E-05 |
GO:1903557 | BP | positive regulation of tumor necrosis factor superfamily cytokine production | 4.51E-05 |
GO:0002888 | BP | positive regulation of myeloid leukocyte mediated immunity | 4.61E-05 |
GO:0002688 | BP | regulation of leukocyte chemotaxis | 4.76E-05 |
GO:0071222 | BP | cellular response to lipopolysaccharide | 4.77E-05 |
GO:1901873 | BP | regulation of post-translational protein modification | 4.80E-05 |
GO:0002761 | BP | regulation of myeloid leukocyte differentiation | 4.83E-05 |
GO:0007093 | BP | mitotic cell cycle checkpoint signaling | 4.88E-05 |
GO:1903320 | BP | regulation of protein modification by small protein conjugation or removal | 5.06E-05 |
GO:0050927 | BP | positive regulation of positive chemotaxis | 5.41E-05 |
GO:0070371 | BP | ERK1 and ERK2 cascade | 5.50E-05 |
GO:0032760 | BP | positive regulation of tumor necrosis factor production | 6.01E-05 |
GO:0002292 | BP | T cell differentiation involved in immune response | 6.29E-05 |
GO:0031570 | BP | DNA integrity checkpoint signaling | 6.51E-05 |
GO:0031396 | BP | regulation of protein ubiquitination | 6.87E-05 |
GO:0014020 | BP | primary neural tube formation | 7.30E-05 |
GO:0033209 | BP | tumor necrosis factor-mediated signaling pathway | 7.33E-05 |
GO:0002294 | BP | CD4-positive, alpha-beta T cell differentiation involved in immune response | 7.50E-05 |
GO:0045639 | BP | positive regulation of myeloid cell differentiation | 8.02E-05 |
GO:0002720 | BP | positive regulation of cytokine production involved in immune response | 8.34E-05 |
GO:0002706 | BP | regulation of lymphocyte mediated immunity | 8.55E-05 |
GO:2000630 | BP | positive regulation of miRNA metabolic process | 8.63E-05 |
GO:1903305 | BP | regulation of regulated secretory pathway | 8.65E-05 |
GO:0048568 | BP | embryonic organ development | 8.71E-05 |
GO:0045652 | BP | regulation of megakaryocyte differentiation | 8.96E-05 |
GO:0032200 | BP | telomere organization | 9.39E-05 |
GO:0034154 | BP | toll-like receptor 7 signaling pathway | 9.50E-05 |
GO:0043372 | BP | positive regulation of CD4-positive, alpha-beta T cell differentiation | 9.69E-05 |
GO:0045446 | BP | endothelial cell differentiation | 9.98E-05 |
GO:0050863 | BP | regulation of T cell activation | 0.00010328 |
GO:0002828 | BP | regulation of type 2 immune response | 0.000103997 |
GO:0044773 | BP | mitotic DNA damage checkpoint signaling | 0.000104871 |
GO:0042098 | BP | T cell proliferation | 0.000105528 |
GO:0002700 | BP | regulation of production of molecular mediator of immune response | 0.000107565 |
GO:0045653 | BP | negative regulation of megakaryocyte differentiation | 0.000110021 |
GO:0072079 | BP | nephron tubule formation | 0.000110021 |
GO:0032729 | BP | positive regulation of type II interferon production | 0.00011072 |
GO:0001843 | BP | neural tube closure | 0.000112414 |
GO:0031571 | BP | mitotic G1 DNA damage checkpoint signaling | 0.000116227 |
GO:0044819 | BP | mitotic G1/S transition checkpoint signaling | 0.000116227 |
GO:0043300 | BP | regulation of leukocyte degranulation | 0.000118264 |
GO:0065004 | BP | protein-DNA complex assembly | 0.000120123 |
GO:0036037 | BP | CD8-positive, alpha-beta T cell activation | 0.000120464 |
GO:0071214 | BP | cellular response to abiotic stimulus | 0.000121481 |
GO:0104004 | BP | cellular response to environmental stimulus | 0.000121481 |
GO:0034101 | BP | erythrocyte homeostasis | 0.000126542 |
GO:0043368 | BP | positive T cell selection | 0.000131762 |
GO:0032609 | BP | type II interferon production | 0.000133053 |
GO:0032649 | BP | regulation of type II interferon production | 0.000133053 |
GO:0001666 | BP | response to hypoxia | 0.000135779 |
GO:1901224 | BP | positive regulation of non-canonical NF-kappaB signal transduction | 0.000150235 |
GO:0021781 | BP | glial cell fate commitment | 0.000152727 |
GO:2001234 | BP | negative regulation of apoptotic signaling pathway | 0.000155878 |
GO:0060606 | BP | tube closure | 0.000158531 |
GO:0050866 | BP | negative regulation of cell activation | 0.00016004 |
GO:0034612 | BP | response to tumor necrosis factor | 0.000165442 |
GO:0051960 | BP | regulation of nervous system development | 0.000166323 |
GO:0030218 | BP | erythrocyte differentiation | 0.000171182 |
GO:0021915 | BP | neural tube development | 0.000171968 |
GO:0072332 | BP | intrinsic apoptotic signaling pathway by p53 class mediator | 0.000173216 |
GO:0071347 | BP | cellular response to interleukin-1 | 0.000176458 |
GO:0002690 | BP | positive regulation of leukocyte chemotaxis | 0.000191195 |
GO:0045930 | BP | negative regulation of mitotic cell cycle | 0.000200467 |
GO:0007204 | BP | positive regulation of cytosolic calcium ion concentration | 0.000201604 |
GO:0019827 | BP | stem cell population maintenance | 0.000201669 |
GO:0071675 | BP | regulation of mononuclear cell migration | 0.000203082 |
GO:1901796 | BP | regulation of signal transduction by p53 class mediator | 0.000203885 |
GO:0007088 | BP | regulation of mitotic nuclear division | 0.000204571 |
GO:0045671 | BP | negative regulation of osteoclast differentiation | 0.000211683 |
GO:0048864 | BP | stem cell development | 0.000211817 |
GO:0046637 | BP | regulation of alpha-beta T cell differentiation | 0.00021453 |
GO:0036293 | BP | response to decreased oxygen levels | 0.000226859 |
GO:0043030 | BP | regulation of macrophage activation | 0.000227232 |
GO:0071168 | BP | protein localization to chromatin | 0.000227232 |
GO:0032755 | BP | positive regulation of interleukin-6 production | 0.000232788 |
GO:0001822 | BP | kidney development | 0.000233036 |
GO:0019058 | BP | viral life cycle | 0.000233036 |
GO:0017157 | BP | regulation of exocytosis | 0.000238542 |
GO:1902905 | BP | positive regulation of supramolecular fiber organization | 0.000241814 |
GO:0002269 | BP | leukocyte activation involved in inflammatory response | 0.000250301 |
GO:2001236 | BP | regulation of extrinsic apoptotic signaling pathway | 0.000250686 |
GO:0042092 | BP | type 2 immune response | 0.000250978 |
GO:0061098 | BP | positive regulation of protein tyrosine kinase activity | 0.000256944 |
GO:0070059 | BP | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 0.000258474 |
GO:0006977 | BP | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 0.000258688 |
GO:1901874 | BP | negative regulation of post-translational protein modification | 0.000263676 |
GO:0002295 | BP | T-helper cell lineage commitment | 0.000269787 |
GO:0016338 | BP | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules | 0.000271787 |
GO:0045063 | BP | T-helper 1 cell differentiation | 0.000271787 |
GO:0042102 | BP | positive regulation of T cell proliferation | 0.00027229 |
GO:0098727 | BP | maintenance of cell number | 0.000272361 |
GO:0034341 | BP | response to type II interferon | 0.000278677 |
GO:0006911 | BP | phagocytosis, engulfment | 0.000284868 |
GO:0036230 | BP | granulocyte activation | 0.000284868 |
GO:0061028 | BP | establishment of endothelial barrier | 0.000284868 |
GO:0071479 | BP | cellular response to ionizing radiation | 0.000285747 |
GO:0061138 | BP | morphogenesis of a branching epithelium | 0.000294865 |
GO:0044409 | BP | symbiont entry into host | 0.000303194 |
GO:0051495 | BP | positive regulation of cytoskeleton organization | 0.000310925 |
GO:0043516 | BP | regulation of DNA damage response, signal transduction by p53 class mediator | 0.000313573 |
GO:0007254 | BP | JNK cascade | 0.00031647 |
GO:0002695 | BP | negative regulation of leukocyte activation | 0.000318467 |
GO:0072538 | BP | T-helper 17 type immune response | 0.000323813 |
GO:0051347 | BP | positive regulation of transferase activity | 0.000325413 |
GO:0030879 | BP | mammary gland development | 0.000330353 |
GO:0007492 | BP | endoderm development | 0.000342096 |
GO:0002762 | BP | negative regulation of myeloid leukocyte differentiation | 0.000342537 |
GO:0046638 | BP | positive regulation of alpha-beta T cell differentiation | 0.000342537 |
GO:0002758 | BP | innate immune response-activating signaling pathway | 0.000346867 |
GO:1903321 | BP | negative regulation of protein modification by small protein conjugation or removal | 0.000352796 |
GO:0070372 | BP | regulation of ERK1 and ERK2 cascade | 0.000353545 |
GO:0046718 | BP | symbiont entry into host cell | 0.000362898 |
GO:0031341 | BP | regulation of cell killing | 0.000363488 |
GO:1900744 | BP | regulation of p38MAPK cascade | 0.000367566 |
GO:0030219 | BP | megakaryocyte differentiation | 0.000380679 |
GO:0045860 | BP | positive regulation of protein kinase activity | 0.000385025 |
GO:0002360 | BP | T cell lineage commitment | 0.000385639 |
GO:0002708 | BP | positive regulation of lymphocyte mediated immunity | 0.000390928 |
GO:0045628 | BP | regulation of T-helper 2 cell differentiation | 0.000403619 |
GO:0044774 | BP | mitotic DNA integrity checkpoint signaling | 0.000408192 |
GO:0000070 | BP | mitotic sister chromatid segregation | 0.000413674 |
GO:0045622 | BP | regulation of T-helper cell differentiation | 0.000416557 |
GO:0046640 | BP | regulation of alpha-beta T cell proliferation | 0.000416557 |
GO:0031589 | BP | cell-substrate adhesion | 0.000452283 |
GO:0045619 | BP | regulation of lymphocyte differentiation | 0.000453997 |
GO:0038094 | BP | Fc-gamma receptor signaling pathway | 0.00046371 |
GO:1901798 | BP | positive regulation of signal transduction by p53 class mediator | 0.00046371 |
GO:0072001 | BP | renal system development | 0.000470065 |
GO:0036297 | BP | interstrand cross-link repair | 0.000471191 |
GO:0031400 | BP | negative regulation of protein modification process | 0.000481573 |
GO:0050684 | BP | regulation of mRNA processing | 0.000486901 |
GO:0051345 | BP | positive regulation of hydrolase activity | 0.000486965 |
GO:0030213 | BP | hyaluronan biosynthetic process | 0.000503337 |
GO:0072678 | BP | T cell migration | 0.000507152 |
GO:0001774 | BP | microglial cell activation | 0.000513787 |
GO:0034502 | BP | protein localization to chromosome | 0.000518334 |
GO:0051053 | BP | negative regulation of DNA metabolic process | 0.000518943 |
GO:0002686 | BP | negative regulation of leukocyte migration | 0.000522404 |
GO:0032635 | BP | interleukin-6 production | 0.000527171 |
GO:0032675 | BP | regulation of interleukin-6 production | 0.000527171 |
GO:0002363 | BP | alpha-beta T cell lineage commitment | 0.000539195 |
GO:0001894 | BP | tissue homeostasis | 0.000541684 |
GO:0002221 | BP | pattern recognition receptor signaling pathway | 0.000541684 |
GO:0060249 | BP | anatomical structure homeostasis | 0.000541684 |
GO:0140694 | BP | non-membrane-bounded organelle assembly | 0.000543317 |
GO:0043373 | BP | CD4-positive, alpha-beta T cell lineage commitment | 0.000570978 |
GO:0033674 | BP | positive regulation of kinase activity | 0.000581484 |
GO:0014009 | BP | glial cell proliferation | 0.000585537 |
GO:0046633 | BP | alpha-beta T cell proliferation | 0.00058724 |
GO:0140467 | BP | integrated stress response signaling | 0.00058724 |
GO:0002830 | BP | positive regulation of type 2 immune response | 0.000598428 |
GO:0032328 | BP | alanine transport | 0.000598428 |
GO:1903236 | BP | regulation of leukocyte tethering or rolling | 0.000598428 |
GO:0050727 | BP | regulation of inflammatory response | 0.000606257 |
GO:0038061 | BP | non-canonical NF-kappaB signal transduction | 0.000619859 |
GO:0001763 | BP | morphogenesis of a branching structure | 0.000622158 |
GO:0008630 | BP | intrinsic apoptotic signaling pathway in response to DNA damage | 0.000646907 |
GO:0042771 | BP | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 0.000670546 |
GO:0002381 | BP | immunoglobulin production involved in immunoglobulin-mediated immune response | 0.000675944 |
GO:0002548 | BP | monocyte chemotaxis | 0.000679472 |
GO:0010212 | BP | response to ionizing radiation | 0.000683517 |
GO:0071346 | BP | cellular response to type II interferon | 0.000687295 |
GO:0045123 | BP | cellular extravasation | 0.000710897 |
GO:0042476 | BP | odontogenesis | 0.00071195 |
GO:0045621 | BP | positive regulation of lymphocyte differentiation | 0.00071195 |
GO:0000280 | BP | nuclear division | 0.00072412 |
GO:0014032 | BP | neural crest cell development | 0.000732973 |
GO:0001659 | BP | temperature homeostasis | 0.000746707 |
GO:0042119 | BP | neutrophil activation | 0.000764809 |
GO:0002460 | BP | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 0.00076597 |
GO:0035019 | BP | somatic stem cell population maintenance | 0.000786732 |
GO:0010948 | BP | negative regulation of cell cycle process | 0.00078709 |
GO:0043484 | BP | regulation of RNA splicing | 0.000799026 |
GO:0048754 | BP | branching morphogenesis of an epithelial tube | 0.000807952 |
GO:0060840 | BP | artery development | 0.000814403 |
GO:0071900 | BP | regulation of protein serine/threonine kinase activity | 0.000824465 |
GO:0042129 | BP | regulation of T cell proliferation | 0.000849341 |
GO:0035966 | BP | response to topologically incorrect protein | 0.000851294 |
GO:0031334 | BP | positive regulation of protein-containing complex assembly | 0.000853031 |
GO:0033627 | BP | cell adhesion mediated by integrin | 0.000871328 |
GO:0031667 | BP | response to nutrient levels | 0.000898184 |
GO:0050673 | BP | epithelial cell proliferation | 0.000947065 |
GO:0002224 | BP | toll-like receptor signaling pathway | 0.000983515 |
GO:0038066 | BP | p38MAPK cascade | 0.000987608 |
GO:0001910 | BP | regulation of leukocyte mediated cytotoxicity | 0.000998039 |
GO:0007160 | BP | cell-matrix adhesion | 0.001000971 |
GO:0048844 | BP | artery morphogenesis | 0.001001158 |
GO:0045582 | BP | positive regulation of T cell differentiation | 0.001014382 |
GO:0010332 | BP | response to gamma radiation | 0.0010399 |
GO:0050767 | BP | regulation of neurogenesis | 0.001047959 |
GO:0043588 | BP | skin development | 0.001049821 |
GO:0002327 | BP | immature B cell differentiation | 0.001051866 |
GO:0007406 | BP | negative regulation of neuroblast proliferation | 0.001051866 |
GO:0045625 | BP | regulation of T-helper 1 cell differentiation | 0.001051866 |
GO:0001885 | BP | endothelial cell development | 0.001055457 |
GO:0030888 | BP | regulation of B cell proliferation | 0.001055457 |
GO:0002443 | BP | leukocyte mediated immunity | 0.001074816 |
GO:0008360 | BP | regulation of cell shape | 0.001077571 |
GO:0002526 | BP | acute inflammatory response | 0.001081934 |
GO:1990845 | BP | adaptive thermogenesis | 0.001090372 |
GO:0048169 | BP | regulation of long-term neuronal synaptic plasticity | 0.001111628 |
GO:0002768 | BP | immune response-regulating cell surface receptor signaling pathway | 0.001111775 |
GO:0002367 | BP | cytokine production involved in immune response | 0.00112337 |
GO:0045920 | BP | negative regulation of exocytosis | 0.001124723 |
GO:0050818 | BP | regulation of coagulation | 0.001139704 |
GO:0061900 | BP | glial cell activation | 0.001142919 |
GO:2000404 | BP | regulation of T cell migration | 0.001200421 |
GO:0045740 | BP | positive regulation of DNA replication | 0.001204706 |
GO:0003018 | BP | vascular process in circulatory system | 0.001221654 |
GO:0034113 | BP | heterotypic cell-cell adhesion | 0.001222952 |
GO:0042255 | BP | ribosome assembly | 0.001222952 |
GO:0006986 | BP | response to unfolded protein | 0.001233945 |
GO:0046328 | BP | regulation of JNK cascade | 0.001233945 |
GO:0070555 | BP | response to interleukin-1 | 0.001233945 |
GO:0022612 | BP | gland morphogenesis | 0.001238262 |
GO:0002863 | BP | positive regulation of inflammatory response to antigenic stimulus | 0.001239925 |
GO:0043301 | BP | negative regulation of leukocyte degranulation | 0.001239925 |
GO:0060732 | BP | positive regulation of inositol phosphate biosynthetic process | 0.001239925 |
GO:0032743 | BP | positive regulation of interleukin-2 production | 0.001273946 |
GO:0046320 | BP | regulation of fatty acid oxidation | 0.001273946 |
GO:0050901 | BP | leukocyte tethering or rolling | 0.001273946 |
GO:0110110 | BP | positive regulation of animal organ morphogenesis | 0.001273946 |
GO:2000177 | BP | regulation of neural precursor cell proliferation | 0.001281635 |
GO:0002718 | BP | regulation of cytokine production involved in immune response | 0.001291148 |
GO:0021675 | BP | nerve development | 0.001310886 |
GO:0071706 | BP | tumor necrosis factor superfamily cytokine production | 0.001317383 |
GO:1903555 | BP | regulation of tumor necrosis factor superfamily cytokine production | 0.001317383 |
GO:0002283 | BP | neutrophil activation involved in immune response | 0.001334533 |
GO:0035743 | BP | CD4-positive, alpha-beta T cell cytokine production | 0.001334533 |
GO:0010919 | BP | regulation of inositol phosphate biosynthetic process | 0.001334779 |
GO:0043374 | BP | CD8-positive, alpha-beta T cell differentiation | 0.001334779 |
GO:0035914 | BP | skeletal muscle cell differentiation | 0.001343663 |
GO:0019722 | BP | calcium-mediated signaling | 0.001360412 |
GO:0031295 | BP | T cell costimulation | 0.001385643 |
GO:0035850 | BP | epithelial cell differentiation involved in kidney development | 0.001385643 |
GO:0001503 | BP | ossification | 0.001413737 |
GO:0001706 | BP | endoderm formation | 0.001417409 |
GO:0002064 | BP | epithelial cell development | 0.001423083 |
GO:2000316 | BP | regulation of T-helper 17 type immune response | 0.001439105 |
GO:0022604 | BP | regulation of cell morphogenesis | 0.001447214 |
GO:0007369 | BP | gastrulation | 0.0014729 |
GO:0051310 | BP | metaphase chromosome alignment | 0.001478849 |
GO:2001237 | BP | negative regulation of extrinsic apoptotic signaling pathway | 0.001478849 |
GO:0072073 | BP | kidney epithelium development | 0.001482821 |
GO:0070482 | BP | response to oxygen levels | 0.001513291 |
GO:0050819 | BP | negative regulation of coagulation | 0.001531469 |
GO:0002562 | BP | somatic diversification of immune receptors via germline recombination within a single locus | 0.001531707 |
GO:0016444 | BP | somatic cell DNA recombination | 0.001531707 |
GO:2000401 | BP | regulation of lymphocyte migration | 0.001531707 |
GO:0035264 | BP | multicellular organism growth | 0.001570327 |
GO:0051783 | BP | regulation of nuclear division | 0.001570327 |
GO:0043010 | BP | camera-type eye development | 0.00158632 |
GO:0030856 | BP | regulation of epithelial cell differentiation | 0.00161101 |
GO:0007162 | BP | negative regulation of cell adhesion | 0.00161232 |
GO:0002438 | BP | acute inflammatory response to antigenic stimulus | 0.001620369 |
GO:0072012 | BP | glomerulus vasculature development | 0.001620369 |
GO:0072009 | BP | nephron epithelium development | 0.00163236 |
GO:0070664 | BP | negative regulation of leukocyte proliferation | 0.001706544 |
GO:0001656 | BP | metanephros development | 0.001749031 |
GO:0014033 | BP | neural crest cell differentiation | 0.001749031 |
GO:0061097 | BP | regulation of protein tyrosine kinase activity | 0.001773267 |
GO:0031397 | BP | negative regulation of protein ubiquitination | 0.001813641 |
GO:0042509 | BP | regulation of tyrosine phosphorylation of STAT protein | 0.001813641 |
GO:0050729 | BP | positive regulation of inflammatory response | 0.001816477 |
GO:0043369 | BP | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment | 0.001817122 |
GO:0030890 | BP | positive regulation of B cell proliferation | 0.001845697 |
GO:0090596 | BP | sensory organ morphogenesis | 0.001902694 |
GO:0045058 | BP | T cell selection | 0.001905643 |
GO:0009266 | BP | response to temperature stimulus | 0.001945625 |
GO:0007517 | BP | muscle organ development | 0.002004181 |
GO:0033273 | BP | response to vitamin | 0.002020654 |
GO:0060333 | BP | type II interferon-mediated signaling pathway | 0.002027521 |
GO:0045580 | BP | regulation of T cell differentiation | 0.00204374 |
GO:1901988 | BP | negative regulation of cell cycle phase transition | 0.002049879 |
GO:0031294 | BP | lymphocyte costimulation | 0.002053627 |
GO:0050994 | BP | regulation of lipid catabolic process | 0.002061057 |
GO:0032835 | BP | glomerulus development | 0.002093358 |
GO:1900046 | BP | regulation of hemostasis | 0.002093358 |
GO:0002200 | BP | somatic diversification of immune receptors | 0.002101517 |
GO:0001709 | BP | cell fate determination | 0.002129692 |
GO:0002714 | BP | positive regulation of B cell mediated immunity | 0.002129692 |
GO:0002891 | BP | positive regulation of immunoglobulin mediated immune response | 0.002129692 |
GO:0060563 | BP | neuroepithelial cell differentiation | 0.002129692 |
GO:0042060 | BP | wound healing | 0.002171665 |
GO:0002709 | BP | regulation of T cell mediated immunity | 0.002202541 |
GO:0046641 | BP | positive regulation of alpha-beta T cell proliferation | 0.002247866 |
GO:0014013 | BP | regulation of gliogenesis | 0.002252046 |
GO:0048024 | BP | regulation of mRNA splicing, via spliceosome | 0.002252046 |
GO:1902106 | BP | negative regulation of leukocyte differentiation | 0.002252046 |
GO:0032640 | BP | tumor necrosis factor production | 0.002276932 |
GO:0032680 | BP | regulation of tumor necrosis factor production | 0.002276932 |
GO:0050000 | BP | chromosome localization | 0.002350865 |
GO:0016032 | BP | viral process | 0.002383419 |
GO:0002437 | BP | inflammatory response to antigenic stimulus | 0.002384767 |
GO:2000179 | BP | positive regulation of neural precursor cell proliferation | 0.002392032 |
GO:0150063 | BP | visual system development | 0.002398395 |
GO:0010721 | BP | negative regulation of cell development | 0.002419573 |
GO:0061448 | BP | connective tissue development | 0.002419573 |
GO:0014015 | BP | positive regulation of gliogenesis | 0.002435739 |
GO:0007200 | BP | phospholipase C-activating G protein-coupled receptor signaling pathway | 0.002447846 |
GO:0035967 | BP | cellular response to topologically incorrect protein | 0.002447846 |
GO:0106106 | BP | cold-induced thermogenesis | 0.002519364 |
GO:0006968 | BP | cellular defense response | 0.002565304 |
GO:0010517 | BP | regulation of phospholipase activity | 0.002565304 |
GO:0051962 | BP | positive regulation of nervous system development | 0.002573495 |
GO:0001704 | BP | formation of primary germ layer | 0.002621975 |
GO:0007098 | BP | centrosome cycle | 0.002662652 |
GO:0000353 | BP | formation of quadruple SL/U4/U5/U6 snRNP | 0.002696153 |
GO:0000365 | BP | mRNA trans splicing, via spliceosome | 0.002696153 |
GO:0002855 | BP | regulation of natural killer cell mediated immune response to tumor cell | 0.002696153 |
GO:0045291 | BP | mRNA trans splicing, SL addition | 0.002696153 |
GO:1901222 | BP | regulation of non-canonical NF-kappaB signal transduction | 0.002704907 |
GO:0002431 | BP | Fc receptor mediated stimulatory signaling pathway | 0.002705634 |
GO:1900745 | BP | positive regulation of p38MAPK cascade | 0.002705634 |
GO:0030261 | BP | chromosome condensation | 0.002755898 |
GO:0002712 | BP | regulation of B cell mediated immunity | 0.002777173 |
GO:0002889 | BP | regulation of immunoglobulin mediated immune response | 0.002777173 |
GO:0070301 | BP | cellular response to hydrogen peroxide | 0.002817579 |
GO:0002067 | BP | glandular epithelial cell differentiation | 0.002823913 |
GO:0050766 | BP | positive regulation of phagocytosis | 0.002823913 |
GO:0072006 | BP | nephron development | 0.002858269 |
GO:0050678 | BP | regulation of epithelial cell proliferation | 0.002859503 |
GO:0002524 | BP | hypersensitivity | 0.002881139 |
GO:0032930 | BP | positive regulation of superoxide anion generation | 0.002881139 |
GO:0045064 | BP | T-helper 2 cell differentiation | 0.002881139 |
GO:0072087 | BP | renal vesicle development | 0.002881139 |
GO:2000318 | BP | positive regulation of T-helper 17 type immune response | 0.002881139 |
GO:0001654 | BP | eye development | 0.002899635 |
GO:0046330 | BP | positive regulation of JNK cascade | 0.002927856 |
GO:0002698 | BP | negative regulation of immune effector process | 0.002929958 |
GO:1900047 | BP | negative regulation of hemostasis | 0.002977933 |
GO:0001547 | BP | antral ovarian follicle growth | 0.002996608 |
GO:0006995 | BP | cellular response to nitrogen starvation | 0.002996608 |
GO:0010752 | BP | regulation of cGMP-mediated signaling | 0.002996608 |
GO:0043562 | BP | cellular response to nitrogen levels | 0.002996608 |
GO:0043517 | BP | positive regulation of DNA damage response, signal transduction by p53 class mediator | 0.003024756 |
GO:0055091 | BP | phospholipid homeostasis | 0.003024756 |
GO:1900034 | BP | regulation of cellular response to heat | 0.003024756 |
GO:0001833 | BP | inner cell mass cell proliferation | 0.003081394 |
GO:0007100 | BP | mitotic centrosome separation | 0.003081394 |
GO:0050930 | BP | induction of positive chemotaxis | 0.003081394 |
GO:0070167 | BP | regulation of biomineral tissue development | 0.003111415 |
GO:2000403 | BP | positive regulation of lymphocyte migration | 0.003193426 |
GO:0098742 | BP | cell-cell adhesion via plasma-membrane adhesion molecules | 0.003225319 |
GO:0046686 | BP | response to cadmium ion | 0.003225587 |
GO:1905517 | BP | macrophage migration | 0.003225587 |
GO:0002637 | BP | regulation of immunoglobulin production | 0.003246674 |
GO:0045445 | BP | myoblast differentiation | 0.003252333 |
GO:0042692 | BP | muscle cell differentiation | 0.00325741 |
GO:0051701 | BP | biological process involved in interaction with host | 0.003266069 |
GO:0060218 | BP | hematopoietic stem cell differentiation | 0.003266441 |
GO:0001649 | BP | osteoblast differentiation | 0.003301976 |
GO:1903707 | BP | negative regulation of hemopoiesis | 0.003354869 |
GO:0042475 | BP | odontogenesis of dentin-containing tooth | 0.003375928 |
GO:0061351 | BP | neural precursor cell proliferation | 0.003398064 |
GO:0007188 | BP | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 0.003441658 |
GO:0048880 | BP | sensory system development | 0.003443353 |
GO:0051098 | BP | regulation of binding | 0.003458275 |
GO:0120161 | BP | regulation of cold-induced thermogenesis | 0.003467348 |
GO:0032753 | BP | positive regulation of interleukin-4 production | 0.003494428 |
GO:0071480 | BP | cellular response to gamma radiation | 0.003494428 |
GO:0001892 | BP | embryonic placenta development | 0.003496555 |
GO:0048708 | BP | astrocyte differentiation | 0.003496555 |
GO:0050871 | BP | positive regulation of B cell activation | 0.003604483 |
GO:0030278 | BP | regulation of ossification | 0.003628598 |
GO:0002204 | BP | somatic recombination of immunoglobulin genes involved in immune response | 0.003638901 |
GO:0002208 | BP | somatic diversification of immunoglobulins involved in immune response | 0.003638901 |
GO:0002639 | BP | positive regulation of immunoglobulin production | 0.003638901 |
GO:0045190 | BP | isotype switching | 0.003638901 |
GO:0051090 | BP | regulation of DNA-binding transcription factor activity | 0.003694412 |
GO:0072210 | BP | metanephric nephron development | 0.003701091 |
GO:0007044 | BP | cell-substrate junction assembly | 0.003738809 |
GO:0003007 | BP | heart morphogenesis | 0.003750619 |
GO:0001782 | BP | B cell homeostasis | 0.003763778 |
GO:0030212 | BP | hyaluronan metabolic process | 0.003763778 |
GO:0071353 | BP | cellular response to interleukin-4 | 0.003763778 |
GO:0043254 | BP | regulation of protein-containing complex assembly | 0.00377032 |
GO:1901987 | BP | regulation of cell cycle phase transition | 0.003782898 |
GO:0032757 | BP | positive regulation of interleukin-8 production | 0.003797683 |
GO:0045576 | BP | mast cell activation | 0.003799177 |
GO:0022408 | BP | negative regulation of cell-cell adhesion | 0.003832709 |
GO:0007249 | BP | canonical NF-kappaB signal transduction | 0.00383874 |
GO:0051250 | BP | negative regulation of lymphocyte activation | 0.00384533 |
GO:0002065 | BP | columnar/cuboidal epithelial cell differentiation | 0.003910611 |
GO:0072676 | BP | lymphocyte migration | 0.003910611 |
GO:0010469 | BP | regulation of signaling receptor activity | 0.003924313 |
GO:1901991 | BP | negative regulation of mitotic cell cycle phase transition | 0.003951017 |
GO:0045662 | BP | negative regulation of myoblast differentiation | 0.003952222 |
GO:1903306 | BP | negative regulation of regulated secretory pathway | 0.003952222 |
GO:0007094 | BP | mitotic spindle assembly checkpoint signaling | 0.004017633 |
GO:0045646 | BP | regulation of erythrocyte differentiation | 0.004017633 |
GO:0071173 | BP | spindle assembly checkpoint signaling | 0.004017633 |
GO:0071174 | BP | mitotic spindle checkpoint signaling | 0.004017633 |
GO:0099601 | BP | regulation of neurotransmitter receptor activity | 0.004017633 |
GO:0007015 | BP | actin filament organization | 0.004019998 |
GO:0051303 | BP | establishment of chromosome localization | 0.004059016 |
GO:1905954 | BP | positive regulation of lipid localization | 0.004059016 |
GO:0019233 | BP | sensory perception of pain | 0.004167126 |
GO:1904029 | BP | regulation of cyclin-dependent protein kinase activity | 0.004167126 |
GO:0044839 | BP | cell cycle G2/M phase transition | 0.004175612 |
GO:0001909 | BP | leukocyte mediated cytotoxicity | 0.004208959 |
GO:0035987 | BP | endodermal cell differentiation | 0.004230786 |
GO:2001242 | BP | regulation of intrinsic apoptotic signaling pathway | 0.004251474 |
GO:0007411 | BP | axon guidance | 0.00431357 |
GO:0022618 | BP | protein-RNA complex assembly | 0.00431357 |
GO:0097485 | BP | neuron projection guidance | 0.00431357 |
GO:0019216 | BP | regulation of lipid metabolic process | 0.004332092 |
GO:0061437 | BP | renal system vasculature development | 0.004334028 |
GO:0061440 | BP | kidney vasculature development | 0.004334028 |
GO:0051017 | BP | actin filament bundle assembly | 0.004349828 |
GO:0007187 | BP | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 0.004356889 |
GO:0071677 | BP | positive regulation of mononuclear cell migration | 0.004360693 |
GO:0042531 | BP | positive regulation of tyrosine phosphorylation of STAT protein | 0.004408831 |
GO:0016447 | BP | somatic recombination of immunoglobulin gene segments | 0.004411578 |
GO:0030183 | BP | B cell differentiation | 0.004418818 |
GO:0046599 | BP | regulation of centriole replication | 0.004450108 |
GO:2000027 | BP | regulation of animal organ morphogenesis | 0.004488926 |
GO:0038127 | BP | ERBB signaling pathway | 0.004497755 |
GO:0070374 | BP | positive regulation of ERK1 and ERK2 cascade | 0.00449792 |
GO:0022626 | CC | cytosolic ribosome | 8.05E-17 |
GO:0005925 | CC | focal adhesion | 7.01E-14 |
GO:0030055 | CC | cell-substrate junction | 1.49E-13 |
GO:0009897 | CC | external side of plasma membrane | 2.04E-12 |
GO:0022625 | CC | cytosolic large ribosomal subunit | 6.52E-11 |
GO:0022627 | CC | cytosolic small ribosomal subunit | 2.65E-09 |
GO:0044391 | CC | ribosomal subunit | 4.97E-08 |
GO:0043505 | CC | CENP-A containing nucleosome | 5.02E-08 |
GO:0061638 | CC | CENP-A containing chromatin | 5.02E-08 |
GO:0034506 | CC | chromosome, centromeric core domain | 3.33E-07 |
GO:0000786 | CC | nucleosome | 6.09E-07 |
GO:0033290 | CC | eukaryotic 48S preinitiation complex | 2.60E-06 |
GO:0070993 | CC | translation preinitiation complex | 4.13E-06 |
GO:0015935 | CC | small ribosomal subunit | 4.34E-06 |
GO:0005852 | CC | eukaryotic translation initiation factor 3 complex | 7.18E-06 |
GO:0016282 | CC | eukaryotic 43S preinitiation complex | 1.09E-05 |
GO:0098984 | CC | neuron to neuron synapse | 2.98E-05 |
GO:0005840 | CC | ribosome | 3.46E-05 |
GO:0099572 | CC | postsynaptic specialization | 4.71E-05 |
GO:0001725 | CC | stress fiber | 5.37E-05 |
GO:0097517 | CC | contractile actin filament bundle | 5.37E-05 |
GO:0045121 | CC | membrane raft | 6.29E-05 |
GO:0098857 | CC | membrane microdomain | 7.56E-05 |
GO:0042641 | CC | actomyosin | 8.30E-05 |
GO:0000940 | CC | outer kinetochore | 0.000102023 |
GO:0032279 | CC | asymmetric synapse | 0.000152209 |
GO:0014069 | CC | postsynaptic density | 0.000161387 |
GO:0031252 | CC | cell leading edge | 0.000244319 |
GO:0000775 | CC | chromosome, centromeric region | 0.00030263 |
GO:0032432 | CC | actin filament bundle | 0.000310153 |
GO:0070821 | CC | tertiary granule membrane | 0.000313051 |
GO:0015934 | CC | large ribosomal subunit | 0.000347067 |
GO:0001726 | CC | ruffle | 0.000502419 |
GO:0032587 | CC | ruffle membrane | 0.000646896 |
GO:0098978 | CC | glutamatergic synapse | 0.000716443 |
GO:0031256 | CC | leading edge membrane | 0.000800329 |
GO:0031091 | CC | platelet alpha granule | 0.000880122 |
GO:0031093 | CC | platelet alpha granule lumen | 0.001143878 |
GO:0009925 | CC | basal plasma membrane | 0.001460735 |
GO:0005884 | CC | actin filament | 0.001620462 |
GO:0001891 | CC | phagocytic cup | 0.001690423 |
GO:0005581 | CC | collagen trimer | 0.001823101 |
GO:0062023 | CC | collagen-containing extracellular matrix | 0.001824235 |
GO:0098636 | CC | protein complex involved in cell adhesion | 0.002443597 |
GO:0070820 | CC | tertiary granule | 0.002734772 |
GO:0001533 | CC | cornified envelope | 0.002922042 |
GO:0045178 | CC | basal part of cell | 0.002935259 |
GO:0016323 | CC | basolateral plasma membrane | 0.003018377 |
GO:0000779 | CC | condensed chromosome, centromeric region | 0.003128201 |
GO:0030527 | MF | structural constituent of chromatin | 3.66E-13 |
GO:0001216 | MF | DNA-binding transcription activator activity | 1.98E-09 |
GO:0001228 | MF | DNA-binding transcription activator activity, RNA polymerase II-specific | 5.04E-09 |
GO:0003735 | MF | structural constituent of ribosome | 4.59E-07 |
GO:0045296 | MF | cadherin binding | 2.64E-06 |
GO:0044389 | MF | ubiquitin-like protein ligase binding | 3.48E-06 |
GO:0031625 | MF | ubiquitin protein ligase binding | 4.90E-06 |
GO:0001217 | MF | DNA-binding transcription repressor activity | 7.46E-06 |
GO:0019955 | MF | cytokine binding | 1.10E-05 |
GO:0005178 | MF | integrin binding | 2.13E-05 |
GO:0140297 | MF | DNA-binding transcription factor binding | 2.63E-05 |
GO:0008017 | MF | microtubule binding | 2.66E-05 |
GO:0046982 | MF | protein heterodimerization activity | 4.36E-05 |
GO:0001227 | MF | DNA-binding transcription repressor activity, RNA polymerase II-specific | 5.03E-05 |
GO:0097110 | MF | scaffold protein binding | 7.46E-05 |
GO:0140272 | MF | exogenous protein binding | 0.000101261 |
GO:0033549 | MF | MAP kinase phosphatase activity | 0.000127393 |
GO:0033691 | MF | sialic acid binding | 0.00015909 |
GO:0001618 | MF | virus receptor activity | 0.000167809 |
GO:0031072 | MF | heat shock protein binding | 0.000176514 |
GO:0140375 | MF | immune receptor activity | 0.000228741 |
GO:0005126 | MF | cytokine receptor binding | 0.000388545 |
GO:0004896 | MF | cytokine receptor activity | 0.000406404 |
GO:0022858 | MF | alanine transmembrane transporter activity | 0.000712107 |
GO:0042826 | MF | histone deacetylase binding | 0.000739901 |
GO:0019957 | MF | C-C chemokine binding | 0.000753927 |
GO:0045236 | MF | CXCR chemokine receptor binding | 0.000761528 |
GO:0015631 | MF | tubulin binding | 0.000821776 |
GO:0030544 | MF | Hsp70 protein binding | 0.001023969 |
GO:0019956 | MF | chemokine binding | 0.00103161 |
GO:0042169 | MF | SH2 domain binding | 0.001090968 |
GO:0008009 | MF | chemokine activity | 0.00116349 |
kegg_enrichment_her2_vs_normal (5).csv
ID | category | subcategory | Description | pvalue |
---|---|---|---|---|
hsa05171 | Human Diseases | Infectious disease: viral | Coronavirus disease - COVID-19 | 7.16E-10 |
hsa04613 | Organismal Systems | Immune system | Neutrophil extracellular trap formation | 1.09E-09 |
hsa05322 | Human Diseases | Immune disease | Systemic lupus erythematosus | 4.05E-08 |
hsa05034 | Human Diseases | Substance dependence | Alcoholism | 4.38E-07 |
hsa04061 | Environmental Information Processing | Signaling molecules and interaction | Viral protein interaction with cytokine and cytokine receptor | 5.38E-06 |
hsa04640 | Organismal Systems | Immune system | Hematopoietic cell lineage | 5.13E-05 |
hsa05203 | Human Diseases | Cancer: overview | Viral carcinogenesis | 9.65E-05 |
hsa04060 | Environmental Information Processing | Signaling molecules and interaction | Cytokine-cytokine receptor interaction | 0.000129226 |
hsa03010 | Genetic Information Processing | Translation | Ribosome | 0.000218109 |
hsa04110 | Cellular Processes | Cell growth and death | Cell cycle | 0.000246403 |
hsa04148 | Cellular Processes | Transport and catabolism | Efferocytosis | 0.000273099 |
hsa04380 | Organismal Systems | Development and regeneration | Osteoclast differentiation | 0.000303406 |
hsa04115 | Cellular Processes | Cell growth and death | p53 signaling pathway | 0.000374728 |
hsa04659 | Organismal Systems | Immune system | Th17 cell differentiation | 0.000473171 |
hsa04210 | Cellular Processes | Cell growth and death | Apoptosis | 0.000765145 |
hsa04064 | Environmental Information Processing | Signal transduction | NF-kappa B signaling pathway | 0.000780091 |
hsa05166 | Human Diseases | Infectious disease: viral | Human T-cell leukemia virus 1 infection | 0.000882178 |
hsa03460 | Genetic Information Processing | Replication and repair | Fanconi anemia pathway | 0.002317738 |
kegg_enrichment_tnbc_vs_normal (2).csv
ID | category | subcategory | Description | pvalue |
---|---|---|---|---|
hsa05171 | Human Diseases | Infectious disease: viral | Coronavirus disease - COVID-19 | 4.37E-11 |
hsa05322 | Human Diseases | Immune disease | Systemic lupus erythematosus | 1.80E-10 |
hsa04613 | Organismal Systems | Immune system | Neutrophil extracellular trap formation | 5.31E-09 |
hsa04380 | Organismal Systems | Development and regeneration | Osteoclast differentiation | 3.67E-06 |
hsa04659 | Organismal Systems | Immune system | Th17 cell differentiation | 4.35E-06 |
hsa04740 | Organismal Systems | Sensory system | Olfactory transduction | 9.51E-06 |
hsa05034 | Human Diseases | Substance dependence | Alcoholism | 1.22E-05 |
hsa04061 | Environmental Information Processing | Signaling molecules and interaction | Viral protein interaction with cytokine and cytokine receptor | 3.15E-05 |
hsa04658 | Organismal Systems | Immune system | Th1 and Th2 cell differentiation | 9.38E-05 |
hsa04640 | Organismal Systems | Immune system | Hematopoietic cell lineage | 0.000112307 |
hsa05166 | Human Diseases | Infectious disease: viral | Human T-cell leukemia virus 1 infection | 0.00023967 |
hsa03010 | Genetic Information Processing | Translation | Ribosome | 0.000270392 |
hsa04672 | Organismal Systems | Immune system | Intestinal immune network for IgA production | 0.000452716 |
hsa05202 | Human Diseases | Cancer: overview | Transcriptional misregulation in cancer | 0.001273433 |
hsa04060 | Environmental Information Processing | Signaling molecules and interaction | Cytokine-cytokine receptor interaction | 0.001522903 |
hsa05203 | Human Diseases | Cancer: overview | Viral carcinogenesis | 0.002046085 |
hsa04610 | Organismal Systems | Immune system | Complement and coagulation cascades | 0.002228527 |
hsa04110 | Cellular Processes | Cell growth and death | Cell cycle | 0.002387406 |
kegg_enrichment_non_tnbc_vs_normal.csv
ID | category | subcategory | Description | pvalue |
---|---|---|---|---|
hsa05171 | Human Diseases | Infectious disease: viral | Coronavirus disease - COVID-19 | 5.23E-11 |
hsa05322 | Human Diseases | Immune disease | Systemic lupus erythematosus | 5.40E-09 |
hsa04613 | Organismal Systems | Immune system | Neutrophil extracellular trap formation | 5.95E-09 |
hsa04061 | Environmental Information Processing | Signaling molecules and interaction | Viral protein interaction with cytokine and cytokine receptor | 7.43E-07 |
hsa05034 | Human Diseases | Substance dependence | Alcoholism | 7.32E-06 |
hsa04115 | Cellular Processes | Cell growth and death | p53 signaling pathway | 2.29E-05 |
hsa04380 | Organismal Systems | Development and regeneration | Osteoclast differentiation | 7.89E-05 |
hsa03010 | Genetic Information Processing | Translation | Ribosome | 0.000115535 |
hsa04060 | Environmental Information Processing | Signaling molecules and interaction | Cytokine-cytokine receptor interaction | 0.000122955 |
hsa04514 | Environmental Information Processing | Signaling molecules and interaction | Cell adhesion molecules | 0.000184458 |
hsa04148 | Cellular Processes | Transport and catabolism | Efferocytosis | 0.000263935 |
hsa03460 | Genetic Information Processing | Replication and repair | Fanconi anemia pathway | 0.000362375 |
hsa04064 | Environmental Information Processing | Signal transduction | NF-kappa B signaling pathway | 0.00037786 |
hsa05203 | Human Diseases | Cancer: overview | Viral carcinogenesis | 0.000467974 |
hsa05134 | Human Diseases | Infectious disease: bacterial | Legionellosis | 0.000564038 |
hsa05202 | Human Diseases | Cancer: overview | Transcriptional misregulation in cancer | 0.000845566 |
hsa04668 | Environmental Information Processing | Signal transduction | TNF signaling pathway | 0.001327569 |
reactome_enrichment_her2_vs_normal.csv
ID | Description | pvalue |
---|---|---|
R-HSA-72689 | Formation of a pool of free 40S subunits | 6.43E-20 |
R-HSA-156842 | Eukaryotic Translation Elongation | 1.23E-19 |
R-HSA-156902 | Peptide chain elongation | 4.59E-19 |
R-HSA-72706 | GTP hydrolysis and joining of the 60S ribosomal subunit | 3.95E-18 |
R-HSA-2408557 | Selenocysteine synthesis | 6.54E-18 |
R-HSA-72764 | Eukaryotic Translation Termination | 6.54E-18 |
R-HSA-156827 | L13a-mediated translational silencing of Ceruloplasmin expression | 8.54E-18 |
R-HSA-192823 | Viral mRNA Translation | 2.50E-17 |
R-HSA-72613 | Eukaryotic Translation Initiation | 3.94E-16 |
R-HSA-72737 | Cap-dependent Translation Initiation | 3.94E-16 |
R-HSA-975956 | Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 1.92E-15 |
R-HSA-9633012 | Response of EIF2AK4 (GCN2) to amino acid deficiency | 3.14E-15 |
R-HSA-927802 | Nonsense-Mediated Decay (NMD) | 3.06E-14 |
R-HSA-975957 | Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 3.06E-14 |
R-HSA-168273 | Influenza Viral RNA Transcription and Replication | 4.71E-14 |
R-HSA-2299718 | Condensation of Prophase Chromosomes | 8.15E-14 |
R-HSA-427359 | SIRT1 negatively regulates rRNA expression | 2.35E-13 |
R-HSA-1799339 | SRP-dependent cotranslational protein targeting to membrane | 2.44E-13 |
R-HSA-2408522 | Selenoamino acid metabolism | 2.81E-13 |
R-HSA-73728 | RNA Polymerase I Promoter Opening | 2.82E-13 |
R-HSA-168255 | Influenza Infection | 3.04E-13 |
R-HSA-5334118 | DNA methylation | 3.94E-13 |
R-HSA-5625886 | Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | 5.33E-13 |
R-HSA-5250924 | B-WICH complex positively regulates rRNA expression | 8.97E-13 |
R-HSA-912446 | Meiotic recombination | 1.46E-12 |
R-HSA-68616 | Assembly of the ORC complex at the origin of replication | 4.37E-12 |
R-HSA-195258 | RHO GTPase Effectors | 4.63E-12 |
R-HSA-3214815 | HDACs deacetylate histones | 4.99E-12 |
R-HSA-9821002 | Chromatin modifications during the maternal to zygotic transition (MZT) | 5.38E-12 |
R-HSA-9710421 | Defective pyroptosis | 6.49E-12 |
R-HSA-9610379 | HCMV Late Events | 7.81E-12 |
R-HSA-9609690 | HCMV Early Events | 1.38E-11 |
R-HSA-2559582 | Senescence-Associated Secretory Phenotype (SASP) | 2.78E-11 |
R-HSA-212300 | PRC2 methylates histones and DNA | 3.47E-11 |
R-HSA-69620 | Cell Cycle Checkpoints | 5.04E-11 |
R-HSA-9609646 | HCMV Infection | 1.31E-10 |
R-HSA-9616222 | Transcriptional regulation of granulopoiesis | 1.58E-10 |
R-HSA-73772 | RNA Polymerase I Promoter Escape | 3.22E-10 |
R-HSA-5625740 | RHO GTPases activate PKNs | 3.40E-10 |
R-HSA-68886 | M Phase | 3.56E-10 |
R-HSA-606279 | Deposition of new CENPA-containing nucleosomes at the centromere | 3.96E-10 |
R-HSA-774815 | Nucleosome assembly | 3.96E-10 |
R-HSA-427389 | ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | 4.33E-10 |
R-HSA-2559583 | Cellular Senescence | 4.38E-10 |
R-HSA-2559586 | DNA Damage/Telomere Stress Induced Senescence | 5.01E-10 |
R-HSA-5250913 | Positive epigenetic regulation of rRNA expression | 6.65E-10 |
R-HSA-5578749 | Transcriptional regulation by small RNAs | 6.65E-10 |
R-HSA-68875 | Mitotic Prophase | 1.08E-09 |
R-HSA-8936459 | RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | 1.26E-09 |
R-HSA-198933 | Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | 1.33E-09 |
R-HSA-2559580 | Oxidative Stress Induced Senescence | 2.85E-09 |
R-HSA-977225 | Amyloid fiber formation | 3.77E-09 |
R-HSA-9645723 | Diseases of programmed cell death | 4.11E-09 |
R-HSA-201722 | Formation of the beta-catenin:TCF transactivating complex | 4.50E-09 |
R-HSA-1500620 | Meiosis | 5.78E-09 |
R-HSA-5693567 | HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 6.27E-09 |
R-HSA-5693538 | Homology Directed Repair | 1.41E-08 |
R-HSA-8868773 | rRNA processing in the nucleus and cytosol | 1.43E-08 |
R-HSA-9735869 | SARS-CoV-1 modulates host translation machinery | 1.43E-08 |
R-HSA-1912408 | Pre-NOTCH Transcription and Translation | 1.54E-08 |
R-HSA-73864 | RNA Polymerase I Transcription | 1.98E-08 |
R-HSA-72702 | Ribosomal scanning and start codon recognition | 2.01E-08 |
R-HSA-68877 | Mitotic Prometaphase | 2.07E-08 |
R-HSA-5250941 | Negative epigenetic regulation of rRNA expression | 2.08E-08 |
R-HSA-73854 | RNA Polymerase I Promoter Clearance | 2.08E-08 |
R-HSA-6791226 | Major pathway of rRNA processing in the nucleolus and cytosol | 2.23E-08 |
R-HSA-211000 | Gene Silencing by RNA | 2.54E-08 |
R-HSA-9670095 | Inhibition of DNA recombination at telomere | 2.63E-08 |
R-HSA-72695 | Formation of the ternary complex, and subsequently, the 43S complex | 3.01E-08 |
R-HSA-1912422 | Pre-NOTCH Expression and Processing | 3.67E-08 |
R-HSA-73886 | Chromosome Maintenance | 3.69E-08 |
R-HSA-427413 | NoRC negatively regulates rRNA expression | 3.85E-08 |
R-HSA-110328 | Recognition and association of DNA glycosylase with site containing an affected pyrimidine | 4.42E-08 |
R-HSA-110329 | Cleavage of the damaged pyrimidine | 4.42E-08 |
R-HSA-73928 | Depyrimidination | 4.42E-08 |
R-HSA-9816359 | Maternal to zygotic transition (MZT) | 4.87E-08 |
R-HSA-69473 | G2/M DNA damage checkpoint | 4.89E-08 |
R-HSA-1474165 | Reproduction | 5.39E-08 |
R-HSA-171306 | Packaging Of Telomere Ends | 6.30E-08 |
R-HSA-5693607 | Processing of DNA double-strand break ends | 8.16E-08 |
R-HSA-72649 | Translation initiation complex formation | 8.87E-08 |
R-HSA-2500257 | Resolution of Sister Chromatid Cohesion | 9.53E-08 |
R-HSA-72312 | rRNA processing | 9.88E-08 |
R-HSA-9711097 | Cellular response to starvation | 1.76E-07 |
R-HSA-72662 | Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | 1.85E-07 |
R-HSA-73929 | Base-Excision Repair, AP Site Formation | 1.91E-07 |
R-HSA-1266695 | Interleukin-7 signaling | 2.28E-07 |
R-HSA-5663220 | RHO GTPases Activate Formins | 2.33E-07 |
R-HSA-9018519 | Estrogen-dependent gene expression | 2.48E-07 |
R-HSA-5617472 | Activation of anterior HOX genes in hindbrain development during early embryogenesis | 3.09E-07 |
R-HSA-5619507 | Activation of HOX genes during differentiation | 3.09E-07 |
R-HSA-110330 | Recognition and association of DNA glycosylase with site containing an affected purine | 3.34E-07 |
R-HSA-110331 | Cleavage of the damaged purine | 3.34E-07 |
R-HSA-73927 | Depurination | 3.34E-07 |
R-HSA-5693532 | DNA Double-Strand Break Repair | 3.41E-07 |
R-HSA-9821993 | Replacement of protamines by nucleosomes in the male pronucleus | 3.99E-07 |
R-HSA-141424 | Amplification of signal from the kinetochores | 4.25E-07 |
R-HSA-141444 | Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | 4.25E-07 |
R-HSA-9648025 | EML4 and NUDC in mitotic spindle formation | 9.19E-07 |
R-HSA-9692914 | SARS-CoV-1-host interactions | 1.20E-06 |
R-HSA-9754678 | SARS-CoV-2 modulates host translation machinery | 1.25E-06 |
R-HSA-157579 | Telomere Maintenance | 1.77E-06 |
R-HSA-3214858 | RMTs methylate histone arginines | 1.97E-06 |
R-HSA-8939211 | ESR-mediated signaling | 2.13E-06 |
R-HSA-5693571 | Nonhomologous End-Joining (NHEJ) | 2.39E-06 |
R-HSA-3214841 | PKMTs methylate histone lysines | 4.18E-06 |
R-HSA-69481 | G2/M Checkpoints | 5.64E-06 |
R-HSA-69306 | DNA Replication | 6.40E-06 |
R-HSA-5693568 | Resolution of D-loop Structures through Holliday Junction Intermediates | 6.89E-06 |
R-HSA-5693565 | Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | 1.00E-05 |
R-HSA-9006931 | Signaling by Nuclear Receptors | 1.03E-05 |
R-HSA-69618 | Mitotic Spindle Checkpoint | 1.05E-05 |
R-HSA-69002 | DNA Replication Pre-Initiation | 1.25E-05 |
R-HSA-9010553 | Regulation of expression of SLITs and ROBOs | 1.27E-05 |
R-HSA-9709603 | Impaired BRCA2 binding to PALB2 | 1.39E-05 |
R-HSA-5693537 | Resolution of D-Loop Structures | 1.54E-05 |
R-HSA-1221632 | Meiotic synapsis | 1.61E-05 |
R-HSA-5693606 | DNA Double Strand Break Response | 1.61E-05 |
R-HSA-212165 | Epigenetic regulation of gene expression | 1.65E-05 |
R-HSA-449147 | Signaling by Interleukins | 2.87E-05 |
R-HSA-73894 | DNA Repair | 2.88E-05 |
R-HSA-6791312 | TP53 Regulates Transcription of Cell Cycle Genes | 3.33E-05 |
R-HSA-9701192 | Defective homologous recombination repair (HRR) due to BRCA1 loss of function | 3.88E-05 |
R-HSA-9701193 | Defective homologous recombination repair (HRR) due to PALB2 loss of function | 3.88E-05 |
R-HSA-9704331 | Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | 3.88E-05 |
R-HSA-9704646 | Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | 3.88E-05 |
R-HSA-9678108 | SARS-CoV-1 Infection | 5.52E-05 |
R-HSA-3214847 | HATs acetylate histones | 8.19E-05 |
R-HSA-68867 | Assembly of the pre-replicative complex | 8.19E-05 |
R-HSA-73884 | Base Excision Repair | 9.44E-05 |
R-HSA-380108 | Chemokine receptors bind chemokines | 0.000138669 |
R-HSA-8939236 | RUNX1 regulates transcription of genes involved in differentiation of HSCs | 0.00014793 |
R-HSA-5685942 | HDR through Homologous Recombination (HRR) | 0.000149771 |
R-HSA-157118 | Signaling by NOTCH | 0.000160531 |
R-HSA-112409 | RAF-independent MAPK1/3 activation | 0.000181885 |
R-HSA-6783783 | Interleukin-10 signaling | 0.000197225 |
R-HSA-69273 | Cyclin A/B1/B2 associated events during G2/M transition | 0.000202125 |
R-HSA-9705462 | Inactivation of CSF3 (G-CSF) signaling | 0.000202125 |
R-HSA-5693554 | Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | 0.000217455 |
R-HSA-5689901 | Metalloprotease DUBs | 0.000234434 |
R-HSA-3214842 | HDMs demethylate histones | 0.00031133 |
R-HSA-5357905 | Regulation of TNFR1 signaling | 0.000331078 |
R-HSA-8866654 | E3 ubiquitin ligases ubiquitinate target proteins | 0.000371309 |
R-HSA-8852135 | Protein ubiquitination | 0.00037527 |
R-HSA-72766 | Translation | 0.000402399 |
R-HSA-9674555 | Signaling by CSF3 (G-CSF) | 0.000457683 |
R-HSA-9020958 | Interleukin-21 signaling | 0.000578753 |
R-HSA-6785807 | Interleukin-4 and Interleukin-13 signaling | 0.000590419 |
R-HSA-2995383 | Initiation of Nuclear Envelope (NE) Reformation | 0.000738288 |
R-HSA-72163 | mRNA Splicing - Major Pathway | 0.000984011 |
R-HSA-68882 | Mitotic Anaphase | 0.00109645 |
R-HSA-6783310 | Fanconi Anemia Pathway | 0.001227125 |
R-HSA-2555396 | Mitotic Metaphase and Anaphase | 0.001308836 |
R-HSA-376176 | Signaling by ROBO receptors | 0.00144037 |
R-HSA-2565942 | Regulation of PLK1 Activity at G2/M Transition | 0.001607334 |
R-HSA-2173788 | Downregulation of TGF-beta receptor signaling | 0.001704075 |
R-HSA-6783589 | Interleukin-6 family signaling | 0.001721824 |
R-HSA-5693579 | Homologous DNA Pairing and Strand Exchange | 0.001828845 |
R-HSA-9675136 | Diseases of DNA Double-Strand Break Repair | 0.001976535 |
R-HSA-9701190 | Defective homologous recombination repair (HRR) due to BRCA2 loss of function | 0.001976535 |
R-HSA-8878171 | Transcriptional regulation by RUNX1 | 0.002016142 |
R-HSA-380270 | Recruitment of mitotic centrosome proteins and complexes | 0.002175218 |
R-HSA-380287 | Centrosome maturation | 0.002175218 |
R-HSA-2514853 | Condensation of Prometaphase Chromosomes | 0.0021778 |
R-HSA-9664873 | Pexophagy | 0.0021778 |
R-HSA-5685938 | HDR through Single Strand Annealing (SSA) | 0.002291877 |
R-HSA-8854518 | AURKA Activation by TPX2 | 0.002390675 |
R-HSA-201681 | TCF dependent signaling in response to WNT | 0.002402507 |
R-HSA-72172 | mRNA Splicing | 0.002681945 |
R-HSA-209560 | NF-kB is activated and signals survival | 0.002697302 |
R-HSA-75035 | Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | 0.002697302 |
R-HSA-9675135 | Diseases of DNA repair | 0.00320834 |
R-HSA-72203 | Processing of Capped Intron-Containing Pre-mRNA | 0.003319655 |
R-HSA-5693616 | Presynaptic phase of homologous DNA pairing and strand exchange | 0.003354464 |
R-HSA-446728 | Cell junction organization | 0.003683925 |
R-HSA-202733 | Cell surface interactions at the vascular wall | 0.003696857 |
R-HSA-380320 | Recruitment of NuMA to mitotic centrosomes | 0.004383698 |
R-HSA-5213460 | RIPK1-mediated regulated necrosis | 0.004611838 |
R-HSA-5675482 | Regulation of necroptotic cell death | 0.004611838 |
R-HSA-110056 | MAPK3 (ERK1) activation | 0.005112795 |
R-HSA-75893 | TNF signaling | 0.005357635 |
R-HSA-420499 | Class C/3 (Metabotropic glutamate/pheromone receptors) | 0.005603001 |
reactome_enrichment_tnbc_vs_normal.csv
ID | Description | pvalue |
---|---|---|
R-HSA-72689 | Formation of a pool of free 40S subunits | 7.84E-20 |
R-HSA-156902 | Peptide chain elongation | 3.16E-19 |
R-HSA-72706 | GTP hydrolysis and joining of the 60S ribosomal subunit | 1.37E-18 |
R-HSA-156827 | L13a-mediated translational silencing of Ceruloplasmin expression | 2.88E-18 |
R-HSA-156842 | Eukaryotic Translation Elongation | 5.89E-18 |
R-HSA-192823 | Viral mRNA Translation | 1.90E-17 |
R-HSA-72764 | Eukaryotic Translation Termination | 4.05E-17 |
R-HSA-72613 | Eukaryotic Translation Initiation | 4.21E-17 |
R-HSA-72737 | Cap-dependent Translation Initiation | 4.21E-17 |
R-HSA-2408557 | Selenocysteine synthesis | 2.61E-16 |
R-HSA-975956 | Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 3.55E-16 |
R-HSA-927802 | Nonsense-Mediated Decay (NMD) | 3.36E-15 |
R-HSA-975957 | Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 3.36E-15 |
R-HSA-9633012 | Response of EIF2AK4 (GCN2) to amino acid deficiency | 4.30E-15 |
R-HSA-5334118 | DNA methylation | 9.80E-14 |
R-HSA-1799339 | SRP-dependent cotranslational protein targeting to membrane | 1.15E-13 |
R-HSA-9821002 | Chromatin modifications during the maternal to zygotic transition (MZT) | 3.33E-13 |
R-HSA-73728 | RNA Polymerase I Promoter Opening | 4.87E-13 |
R-HSA-427359 | SIRT1 negatively regulates rRNA expression | 5.01E-13 |
R-HSA-2408522 | Selenoamino acid metabolism | 6.60E-13 |
R-HSA-2299718 | Condensation of Prophase Chromosomes | 1.36E-12 |
R-HSA-9710421 | Defective pyroptosis | 2.87E-12 |
R-HSA-9616222 | Transcriptional regulation of granulopoiesis | 7.84E-12 |
R-HSA-212300 | PRC2 methylates histones and DNA | 1.63E-11 |
R-HSA-3214815 | HDACs deacetylate histones | 2.34E-11 |
R-HSA-2559582 | Senescence-Associated Secretory Phenotype (SASP) | 4.90E-11 |
R-HSA-68616 | Assembly of the ORC complex at the origin of replication | 5.46E-11 |
R-HSA-9645723 | Diseases of programmed cell death | 1.47E-10 |
R-HSA-2559580 | Oxidative Stress Induced Senescence | 2.29E-10 |
R-HSA-5625886 | Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | 2.32E-10 |
R-HSA-2559583 | Cellular Senescence | 2.46E-10 |
R-HSA-912446 | Meiotic recombination | 4.88E-10 |
R-HSA-606279 | Deposition of new CENPA-containing nucleosomes at the centromere | 9.71E-10 |
R-HSA-774815 | Nucleosome assembly | 9.71E-10 |
R-HSA-427389 | ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | 1.12E-09 |
R-HSA-5250924 | B-WICH complex positively regulates rRNA expression | 1.22E-09 |
R-HSA-1912408 | Pre-NOTCH Transcription and Translation | 1.31E-09 |
R-HSA-2559586 | DNA Damage/Telomere Stress Induced Senescence | 1.44E-09 |
R-HSA-168273 | Influenza Viral RNA Transcription and Replication | 2.20E-09 |
R-HSA-198933 | Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | 3.76E-09 |
R-HSA-201722 | Formation of the beta-catenin:TCF transactivating complex | 4.48E-09 |
R-HSA-1500620 | Meiosis | 1.13E-08 |
R-HSA-8936459 | RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | 5.49E-08 |
R-HSA-171306 | Packaging Of Telomere Ends | 7.47E-08 |
R-HSA-168255 | Influenza Infection | 1.17E-07 |
R-HSA-1266695 | Interleukin-7 signaling | 1.44E-07 |
R-HSA-1912422 | Pre-NOTCH Expression and Processing | 1.65E-07 |
R-HSA-1474165 | Reproduction | 1.93E-07 |
R-HSA-9711097 | Cellular response to starvation | 2.74E-07 |
R-HSA-5250913 | Positive epigenetic regulation of rRNA expression | 2.81E-07 |
R-HSA-110328 | Recognition and association of DNA glycosylase with site containing an affected pyrimidine | 2.89E-07 |
R-HSA-110329 | Cleavage of the damaged pyrimidine | 2.89E-07 |
R-HSA-73928 | Depyrimidination | 2.89E-07 |
R-HSA-9752946 | Expression and translocation of olfactory receptors | 3.39E-07 |
R-HSA-9610379 | HCMV Late Events | 4.09E-07 |
R-HSA-9735869 | SARS-CoV-1 modulates host translation machinery | 4.29E-07 |
R-HSA-381753 | Olfactory Signaling Pathway | 4.33E-07 |
R-HSA-110330 | Recognition and association of DNA glycosylase with site containing an affected purine | 4.51E-07 |
R-HSA-110331 | Cleavage of the damaged purine | 4.51E-07 |
R-HSA-73927 | Depurination | 4.51E-07 |
R-HSA-9609690 | HCMV Early Events | 4.58E-07 |
R-HSA-1221632 | Meiotic synapsis | 4.73E-07 |
R-HSA-72649 | Translation initiation complex formation | 5.48E-07 |
R-HSA-72702 | Ribosomal scanning and start codon recognition | 5.48E-07 |
R-HSA-72695 | Formation of the ternary complex, and subsequently, the 43S complex | 7.77E-07 |
R-HSA-68875 | Mitotic Prophase | 9.47E-07 |
R-HSA-72662 | Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | 1.11E-06 |
R-HSA-73929 | Base-Excision Repair, AP Site Formation | 1.18E-06 |
R-HSA-112409 | RAF-independent MAPK1/3 activation | 1.34E-06 |
R-HSA-73772 | RNA Polymerase I Promoter Escape | 1.46E-06 |
R-HSA-9816359 | Maternal to zygotic transition (MZT) | 1.63E-06 |
R-HSA-9018519 | Estrogen-dependent gene expression | 1.75E-06 |
R-HSA-9670095 | Inhibition of DNA recombination at telomere | 2.41E-06 |
R-HSA-9010553 | Regulation of expression of SLITs and ROBOs | 2.76E-06 |
R-HSA-977225 | Amyloid fiber formation | 2.95E-06 |
R-HSA-5625740 | RHO GTPases activate PKNs | 3.86E-06 |
R-HSA-3214847 | HATs acetylate histones | 4.85E-06 |
R-HSA-6783783 | Interleukin-10 signaling | 4.95E-06 |
R-HSA-9754678 | SARS-CoV-2 modulates host translation machinery | 5.83E-06 |
R-HSA-9821993 | Replacement of protamines by nucleosomes in the male pronucleus | 7.71E-06 |
R-HSA-195258 | RHO GTPase Effectors | 8.65E-06 |
R-HSA-69473 | G2/M DNA damage checkpoint | 1.00E-05 |
R-HSA-69620 | Cell Cycle Checkpoints | 1.04E-05 |
R-HSA-5578749 | Transcriptional regulation by small RNAs | 1.25E-05 |
R-HSA-8939236 | RUNX1 regulates transcription of genes involved in differentiation of HSCs | 1.50E-05 |
R-HSA-9609646 | HCMV Infection | 1.70E-05 |
R-HSA-6785807 | Interleukin-4 and Interleukin-13 signaling | 1.79E-05 |
R-HSA-427413 | NoRC negatively regulates rRNA expression | 1.88E-05 |
R-HSA-5693567 | HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 1.90E-05 |
R-HSA-73864 | RNA Polymerase I Transcription | 2.50E-05 |
R-HSA-202733 | Cell surface interactions at the vascular wall | 2.52E-05 |
R-HSA-211000 | Gene Silencing by RNA | 2.52E-05 |
R-HSA-69306 | DNA Replication | 2.63E-05 |
R-HSA-5250941 | Negative epigenetic regulation of rRNA expression | 2.64E-05 |
R-HSA-73854 | RNA Polymerase I Promoter Clearance | 2.64E-05 |
R-HSA-68886 | M Phase | 2.88E-05 |
R-HSA-5693538 | Homology Directed Repair | 3.29E-05 |
R-HSA-3214858 | RMTs methylate histone arginines | 3.38E-05 |
R-HSA-6791226 | Major pathway of rRNA processing in the nucleolus and cytosol | 3.73E-05 |
R-HSA-3214842 | HDMs demethylate histones | 3.77E-05 |
R-HSA-5693571 | Nonhomologous End-Joining (NHEJ) | 3.83E-05 |
R-HSA-5617472 | Activation of anterior HOX genes in hindbrain development during early embryogenesis | 4.14E-05 |
R-HSA-5619507 | Activation of HOX genes during differentiation | 4.14E-05 |
R-HSA-9705462 | Inactivation of CSF3 (G-CSF) signaling | 9.77E-05 |
R-HSA-376176 | Signaling by ROBO receptors | 0.000111589 |
R-HSA-418594 | G alpha (i) signalling events | 0.00012649 |
R-HSA-73886 | Chromosome Maintenance | 0.00013133 |
R-HSA-5693565 | Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | 0.00013817 |
R-HSA-9006931 | Signaling by Nuclear Receptors | 0.000162632 |
R-HSA-3214841 | PKMTs methylate histone lysines | 0.000163468 |
R-HSA-5693607 | Processing of DNA double-strand break ends | 0.00018515 |
R-HSA-420499 | Class C/3 (Metabotropic glutamate/pheromone receptors) | 0.000196582 |
R-HSA-5693606 | DNA Double Strand Break Response | 0.000209096 |
R-HSA-449147 | Signaling by Interleukins | 0.000223669 |
R-HSA-8868773 | rRNA processing in the nucleus and cytosol | 0.000266384 |
R-HSA-5693532 | DNA Double-Strand Break Repair | 0.000286468 |
R-HSA-500792 | GPCR ligand binding | 0.000313178 |
R-HSA-68867 | Assembly of the pre-replicative complex | 0.000333 |
R-HSA-8939211 | ESR-mediated signaling | 0.000365708 |
R-HSA-69481 | G2/M Checkpoints | 0.000424672 |
R-HSA-69002 | DNA Replication Pre-Initiation | 0.000442899 |
R-HSA-380108 | Chemokine receptors bind chemokines | 0.000505265 |
R-HSA-5689901 | Metalloprotease DUBs | 0.000637169 |
R-HSA-72312 | rRNA processing | 0.000861351 |
R-HSA-8878171 | Transcriptional regulation by RUNX1 | 0.000917368 |
R-HSA-110056 | MAPK3 (ERK1) activation | 0.000949089 |
R-HSA-9020958 | Interleukin-21 signaling | 0.000949089 |
R-HSA-73884 | Base Excision Repair | 0.000997742 |
R-HSA-2500257 | Resolution of Sister Chromatid Cohesion | 0.0010192 |
R-HSA-9674555 | Signaling by CSF3 (G-CSF) | 0.001083627 |
R-HSA-5693568 | Resolution of D-loop Structures through Holliday Junction Intermediates | 0.001125534 |
R-HSA-141424 | Amplification of signal from the kinetochores | 0.001189321 |
R-HSA-141444 | Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | 0.001189321 |
R-HSA-9692914 | SARS-CoV-1-host interactions | 0.001189321 |
R-HSA-68877 | Mitotic Prometaphase | 0.001384965 |
R-HSA-5663220 | RHO GTPases Activate Formins | 0.001508037 |
R-HSA-176974 | Unwinding of DNA | 0.001541196 |
R-HSA-212165 | Epigenetic regulation of gene expression | 0.001645215 |
R-HSA-157118 | Signaling by NOTCH | 0.001832039 |
R-HSA-373076 | Class A/1 (Rhodopsin-like receptors) | 0.00185184 |
R-HSA-5693537 | Resolution of D-Loop Structures | 0.001927849 |
R-HSA-157579 | Telomere Maintenance | 0.002382612 |
R-HSA-2559584 | Formation of Senescence-Associated Heterochromatin Foci (SAHF) | 0.002527003 |
R-HSA-6783310 | Fanconi Anemia Pathway | 0.003052725 |
R-HSA-6783589 | Interleukin-6 family signaling | 0.003446661 |
R-HSA-9709603 | Impaired BRCA2 binding to PALB2 | 0.003446661 |
R-HSA-1059683 | Interleukin-6 signaling | 0.003473346 |
R-HSA-2514853 | Condensation of Prometaphase Chromosomes | 0.003473346 |
R-HSA-9664873 | Pexophagy | 0.003473346 |
reactome_enrichment_non_tnbc_vs_normal.csv
ID | Description | pvalue |
---|---|---|
R-HSA-72706 | GTP hydrolysis and joining of the 60S ribosomal subunit | 2.43E-22 |
R-HSA-156827 | L13a-mediated translational silencing of Ceruloplasmin expression | 5.60E-22 |
R-HSA-72689 | Formation of a pool of free 40S subunits | 7.52E-22 |
R-HSA-72613 | Eukaryotic Translation Initiation | 1.09E-20 |
R-HSA-72737 | Cap-dependent Translation Initiation | 1.09E-20 |
R-HSA-156842 | Eukaryotic Translation Elongation | 8.57E-20 |
R-HSA-156902 | Peptide chain elongation | 3.24E-19 |
R-HSA-2408557 | Selenocysteine synthesis | 4.63E-18 |
R-HSA-192823 | Viral mRNA Translation | 1.79E-17 |
R-HSA-72764 | Eukaryotic Translation Termination | 3.10E-17 |
R-HSA-9633012 | Response of EIF2AK4 (GCN2) to amino acid deficiency | 7.51E-17 |
R-HSA-975956 | Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 2.42E-16 |
R-HSA-927802 | Nonsense-Mediated Decay (NMD) | 1.06E-15 |
R-HSA-975957 | Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 1.06E-15 |
R-HSA-3214815 | HDACs deacetylate histones | 3.45E-14 |
R-HSA-1799339 | SRP-dependent cotranslational protein targeting to membrane | 1.77E-13 |
R-HSA-73728 | RNA Polymerase I Promoter Opening | 2.23E-13 |
R-HSA-2559582 | Senescence-Associated Secretory Phenotype (SASP) | 1.38E-12 |
R-HSA-5334118 | DNA methylation | 2.14E-12 |
R-HSA-72649 | Translation initiation complex formation | 2.74E-12 |
R-HSA-72702 | Ribosomal scanning and start codon recognition | 2.74E-12 |
R-HSA-2408522 | Selenoamino acid metabolism | 3.02E-12 |
R-HSA-427359 | SIRT1 negatively regulates rRNA expression | 7.60E-12 |
R-HSA-72662 | Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | 8.35E-12 |
R-HSA-2299718 | Condensation of Prophase Chromosomes | 1.29E-11 |
R-HSA-1912408 | Pre-NOTCH Transcription and Translation | 1.54E-11 |
R-HSA-5625886 | Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | 1.66E-11 |
R-HSA-72695 | Formation of the ternary complex, and subsequently, the 43S complex | 1.75E-11 |
R-HSA-9821002 | Chromatin modifications during the maternal to zygotic transition (MZT) | 2.37E-11 |
R-HSA-9616222 | Transcriptional regulation of granulopoiesis | 2.92E-11 |
R-HSA-8936459 | RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | 6.72E-11 |
R-HSA-427389 | ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | 7.41E-11 |
R-HSA-912446 | Meiotic recombination | 1.11E-10 |
R-HSA-9609690 | HCMV Early Events | 3.17E-10 |
R-HSA-168255 | Influenza Infection | 4.84E-10 |
R-HSA-68616 | Assembly of the ORC complex at the origin of replication | 5.38E-10 |
R-HSA-212300 | PRC2 methylates histones and DNA | 6.51E-10 |
R-HSA-9710421 | Defective pyroptosis | 6.51E-10 |
R-HSA-1912422 | Pre-NOTCH Expression and Processing | 9.20E-10 |
R-HSA-201722 | Formation of the beta-catenin:TCF transactivating complex | 9.70E-10 |
R-HSA-9735869 | SARS-CoV-1 modulates host translation machinery | 1.48E-09 |
R-HSA-168273 | Influenza Viral RNA Transcription and Replication | 1.57E-09 |
R-HSA-2559586 | DNA Damage/Telomere Stress Induced Senescence | 1.66E-09 |
R-HSA-2559583 | Cellular Senescence | 1.85E-09 |
R-HSA-9645723 | Diseases of programmed cell death | 3.20E-09 |
R-HSA-5625740 | RHO GTPases activate PKNs | 3.52E-09 |
R-HSA-2559580 | Oxidative Stress Induced Senescence | 6.39E-09 |
R-HSA-9711097 | Cellular response to starvation | 9.04E-09 |
R-HSA-977225 | Amyloid fiber formation | 9.12E-09 |
R-HSA-606279 | Deposition of new CENPA-containing nucleosomes at the centromere | 2.38E-08 |
R-HSA-774815 | Nucleosome assembly | 2.38E-08 |
R-HSA-9816359 | Maternal to zygotic transition (MZT) | 3.81E-08 |
R-HSA-171306 | Packaging Of Telomere Ends | 5.36E-08 |
R-HSA-110330 | Recognition and association of DNA glycosylase with site containing an affected purine | 6.51E-08 |
R-HSA-110331 | Cleavage of the damaged purine | 6.51E-08 |
R-HSA-73927 | Depurination | 6.51E-08 |
R-HSA-9610379 | HCMV Late Events | 6.59E-08 |
R-HSA-9609646 | HCMV Infection | 7.61E-08 |
R-HSA-6785807 | Interleukin-4 and Interleukin-13 signaling | 8.45E-08 |
R-HSA-195258 | RHO GTPase Effectors | 1.04E-07 |
R-HSA-5250924 | B-WICH complex positively regulates rRNA expression | 1.34E-07 |
R-HSA-157118 | Signaling by NOTCH | 1.49E-07 |
R-HSA-110328 | Recognition and association of DNA glycosylase with site containing an affected pyrimidine | 1.56E-07 |
R-HSA-110329 | Cleavage of the damaged pyrimidine | 1.56E-07 |
R-HSA-73928 | Depyrimidination | 1.56E-07 |
R-HSA-3214858 | RMTs methylate histone arginines | 1.62E-07 |
R-HSA-5693567 | HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 2.32E-07 |
R-HSA-449147 | Signaling by Interleukins | 3.29E-07 |
R-HSA-9821993 | Replacement of protamines by nucleosomes in the male pronucleus | 3.48E-07 |
R-HSA-5693538 | Homology Directed Repair | 4.39E-07 |
R-HSA-73929 | Base-Excision Repair, AP Site Formation | 6.14E-07 |
R-HSA-6791226 | Major pathway of rRNA processing in the nucleolus and cytosol | 8.68E-07 |
R-HSA-6783783 | Interleukin-10 signaling | 9.76E-07 |
R-HSA-72766 | Translation | 1.05E-06 |
R-HSA-9754678 | SARS-CoV-2 modulates host translation machinery | 1.08E-06 |
R-HSA-8868773 | rRNA processing in the nucleus and cytosol | 1.10E-06 |
R-HSA-9010553 | Regulation of expression of SLITs and ROBOs | 1.13E-06 |
R-HSA-5617472 | Activation of anterior HOX genes in hindbrain development during early embryogenesis | 1.56E-06 |
R-HSA-5619507 | Activation of HOX genes during differentiation | 1.56E-06 |
R-HSA-5693532 | DNA Double-Strand Break Repair | 2.63E-06 |
R-HSA-9692914 | SARS-CoV-1-host interactions | 2.67E-06 |
R-HSA-5250913 | Positive epigenetic regulation of rRNA expression | 3.03E-06 |
R-HSA-73772 | RNA Polymerase I Promoter Escape | 3.31E-06 |
R-HSA-1500620 | Meiosis | 4.47E-06 |
R-HSA-72312 | rRNA processing | 5.20E-06 |
R-HSA-5693568 | Resolution of D-loop Structures through Holliday Junction Intermediates | 6.16E-06 |
R-HSA-5578749 | Transcriptional regulation by small RNAs | 7.56E-06 |
R-HSA-9018519 | Estrogen-dependent gene expression | 1.08E-05 |
R-HSA-198933 | Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | 1.10E-05 |
R-HSA-9670095 | Inhibition of DNA recombination at telomere | 1.15E-05 |
R-HSA-1474165 | Reproduction | 1.21E-05 |
R-HSA-5693537 | Resolution of D-Loop Structures | 1.38E-05 |
R-HSA-73864 | RNA Polymerase I Transcription | 1.38E-05 |
R-HSA-73854 | RNA Polymerase I Promoter Clearance | 1.51E-05 |
R-HSA-9012852 | Signaling by NOTCH3 | 1.56E-05 |
R-HSA-68875 | Mitotic Prophase | 1.60E-05 |
R-HSA-8939211 | ESR-mediated signaling | 1.96E-05 |
R-HSA-427413 | NoRC negatively regulates rRNA expression | 2.65E-05 |
R-HSA-3214842 | HDMs demethylate histones | 2.89E-05 |
R-HSA-8878171 | Transcriptional regulation by RUNX1 | 3.09E-05 |
R-HSA-5250941 | Negative epigenetic regulation of rRNA expression | 3.47E-05 |
R-HSA-5693606 | DNA Double Strand Break Response | 3.68E-05 |
R-HSA-380108 | Chemokine receptors bind chemokines | 4.25E-05 |
R-HSA-69473 | G2/M DNA damage checkpoint | 4.59E-05 |
R-HSA-5663220 | RHO GTPases Activate Formins | 4.99E-05 |
R-HSA-5689901 | Metalloprotease DUBs | 5.75E-05 |
R-HSA-8939236 | RUNX1 regulates transcription of genes involved in differentiation of HSCs | 6.06E-05 |
R-HSA-5693607 | Processing of DNA double-strand break ends | 6.11E-05 |
R-HSA-5693565 | Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | 6.15E-05 |
R-HSA-9006931 | Signaling by Nuclear Receptors | 9.44E-05 |
R-HSA-6791312 | TP53 Regulates Transcription of Cell Cycle Genes | 9.79E-05 |
R-HSA-1980143 | Signaling by NOTCH1 | 0.00011084 |
R-HSA-2500257 | Resolution of Sister Chromatid Cohesion | 0.000136623 |
R-HSA-5693571 | Nonhomologous End-Joining (NHEJ) | 0.000142349 |
R-HSA-6804116 | TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | 0.000145138 |
R-HSA-376176 | Signaling by ROBO receptors | 0.000162668 |
R-HSA-9701192 | Defective homologous recombination repair (HRR) due to BRCA1 loss of function | 0.000186882 |
R-HSA-9701193 | Defective homologous recombination repair (HRR) due to PALB2 loss of function | 0.000186882 |
R-HSA-9704331 | Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | 0.000186882 |
R-HSA-9704646 | Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | 0.000186882 |
R-HSA-201681 | TCF dependent signaling in response to WNT | 0.000188557 |
R-HSA-2644602 | Signaling by NOTCH1 PEST Domain Mutants in Cancer | 0.000210889 |
R-HSA-2644603 | Signaling by NOTCH1 in Cancer | 0.000210889 |
R-HSA-2644606 | Constitutive Signaling by NOTCH1 PEST Domain Mutants | 0.000210889 |
R-HSA-2894858 | Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | 0.000210889 |
R-HSA-2894862 | Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | 0.000210889 |
R-HSA-9664873 | Pexophagy | 0.000212238 |
R-HSA-141424 | Amplification of signal from the kinetochores | 0.000214912 |
R-HSA-141444 | Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | 0.000214912 |
R-HSA-3214841 | PKMTs methylate histone lysines | 0.000217285 |
R-HSA-9648025 | EML4 and NUDC in mitotic spindle formation | 0.000226748 |
R-HSA-3214847 | HATs acetylate histones | 0.00025428 |
R-HSA-69620 | Cell Cycle Checkpoints | 0.000311856 |
R-HSA-68877 | Mitotic Prometaphase | 0.00032289 |
R-HSA-5633008 | TP53 Regulates Transcription of Cell Death Genes | 0.00033546 |
R-HSA-6783310 | Fanconi Anemia Pathway | 0.000371 |
R-HSA-9709603 | Impaired BRCA2 binding to PALB2 | 0.0003888 |
R-HSA-1266695 | Interleukin-7 signaling | 0.000400888 |
R-HSA-2691230 | Signaling by NOTCH1 HD Domain Mutants in Cancer | 0.00049225 |
R-HSA-2691232 | Constitutive Signaling by NOTCH1 HD Domain Mutants | 0.00049225 |
R-HSA-446728 | Cell junction organization | 0.000499264 |
R-HSA-1221632 | Meiotic synapsis | 0.000519606 |
R-HSA-1236394 | Signaling by ERBB4 | 0.000553847 |
R-HSA-68886 | M Phase | 0.000666148 |
R-HSA-9031628 | NGF-stimulated transcription | 0.000672776 |
R-HSA-198725 | Nuclear Events (kinase and transcription factor activation) | 0.00076379 |
R-HSA-5685942 | HDR through Homologous Recombination (HRR) | 0.000766394 |
R-HSA-9013507 | NOTCH3 Activation and Transmission of Signal to the Nucleus | 0.000817876 |
R-HSA-5693554 | Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | 0.000822992 |
R-HSA-1500931 | Cell-Cell communication | 0.000834894 |
R-HSA-2122947 | NOTCH1 Intracellular Domain Regulates Transcription | 0.000837142 |
R-HSA-73884 | Base Excision Repair | 0.000851333 |
R-HSA-9831926 | Nephron development | 0.0008691 |
R-HSA-202733 | Cell surface interactions at the vascular wall | 0.00105577 |
R-HSA-211000 | Gene Silencing by RNA | 0.00105577 |
R-HSA-6803205 | TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | 0.001135087 |
R-HSA-9825892 | Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | 0.001135087 |
R-HSA-418594 | G alpha (i) signalling events | 0.001187601 |
R-HSA-205043 | NRIF signals cell death from the nucleus | 0.001337584 |
R-HSA-6783589 | Interleukin-6 family signaling | 0.001612977 |
R-HSA-9634638 | Estrogen-dependent nuclear events downstream of ESR-membrane signaling | 0.001612977 |
R-HSA-8848021 | Signaling by PTK6 | 0.001644137 |
R-HSA-9006927 | Signaling by Non-Receptor Tyrosine Kinases | 0.001644137 |
R-HSA-9678108 | SARS-CoV-1 Infection | 0.00190988 |
R-HSA-9708530 | Regulation of BACH1 activity | 0.002085124 |
R-HSA-6806003 | Regulation of TP53 Expression and Degradation | 0.002118467 |
R-HSA-500792 | GPCR ligand binding | 0.002149585 |
R-HSA-209560 | NF-kB is activated and signals survival | 0.002575199 |
R-HSA-2122948 | Activated NOTCH1 Transmits Signal to the Nucleus | 0.002598412 |
R-HSA-5669034 | TNFs bind their physiological receptors | 0.002754216 |
R-HSA-9705462 | Inactivation of CSF3 (G-CSF) signaling | 0.003026489 |
R-HSA-112409 | RAF-independent MAPK1/3 activation | 0.003124898 |
R-HSA-73886 | Chromosome Maintenance | 0.003584318 |
R-HSA-6804757 | Regulation of TP53 Degradation | 0.003671907 |
R-HSA-3247509 | Chromatin modifying enzymes | 0.00417078 |
R-HSA-4839726 | Chromatin organization | 0.00417078 |
R-HSA-1251985 | Nuclear signaling by ERBB4 | 0.004307633 |
R-HSA-8866654 | E3 ubiquitin ligases ubiquitinate target proteins | 0.004417383 |
R-HSA-216083 | Integrin cell surface interactions | 0.004553511 |
R-HSA-114452 | Activation of BH3-only proteins | 0.004643157 |
R-HSA-9674555 | Signaling by CSF3 (G-CSF) | 0.004643157 |
R-HSA-9658195 | Leishmania infection | 0.004881863 |
R-HSA-9824443 | Parasitic Infection Pathways | 0.004881863 |
R-HSA-5621480 | Dectin-2 family | 0.004983818 |
R-HSA-69618 | Mitotic Spindle Checkpoint | 0.00499069 |
R-HSA-1474244 | Extracellular matrix organization | 0.005163107 |
R-HSA-420499 | Class C/3 (Metabotropic glutamate/pheromone receptors) | 0.00520552 |
R-HSA-2029481 | FCGR activation | 0.005733196 |
R-HSA-6803207 | TP53 Regulates Transcription of Caspase Activators and Caspases | 0.005733196 |
R-HSA-6803211 | TP53 Regulates Transcription of Death Receptors and Ligands | 0.005733196 |